methotrexate has been researched along with Bone Cancer in 824 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 302 (36.65) | 18.7374 |
1990's | 187 (22.69) | 18.2507 |
2000's | 137 (16.63) | 29.6817 |
2010's | 156 (18.93) | 24.3611 |
2020's | 42 (5.10) | 2.80 |
Authors | Studies |
---|---|
Chen, X; Deng, Y; Li, Y; Li, Z; Wei, D; Xiang, F; Xu, Y | 1 |
Bajpai, J; Banavali, SD; Khan, SA; Kumar, VS; Mailankody, S | 1 |
Aoki, Y; Bouvet, M; Hamada, K; Han, Q; Hoffman, RM; Kubota, Y; Masaki, N; Nishida, K; Tome, Y; Yamamoto, J | 1 |
Abe, K; Furukawa, T; Hashimoto, H; Ishizu, T; Iwata, S; Kawano, Y; Kobayashi, E; Maeda-Minami, A; Mano, Y; Miyazaki, S; Shimoi, T; Yamaguchi, M | 1 |
De Pinieux, G; Le Nail, LR; Narciso, B; Salaün, H; Simon, C; Vegas, H; Vinceneux, A | 1 |
Alcasabas, AP; Blair, S; Dhamne, C; Lam, C; Leung, KWP; Loh, AHP; Monsereenusorn, C; Oh, BLZ; Photia, A; Puhaindran, ME; Rodriguez-Galindo, C; Rujkijyanont, P; Soh, SY; Traivaree, C; Veerapan, P; Wang, E | 1 |
Alemi, F; Farsad-Akhtar, N; Malakoti, F; Maleki, M; Mohammadi, E; Yousefi, B | 1 |
Majidinia, M; Malakoti, F; Sanapour, N; Shanebandi, D; Soleimanpour, J; Targhazeh, N; Yousefi, B | 1 |
Cheng, H; Ran, S; Shao, C; Sun, W; Wan, Y; Yin, X; Zhang, M; Zhu, Z | 1 |
Elhasid, R; Levin, D; Manisterski, M; Peled, Y; Shiran, S; Shukrun, R | 1 |
Chekhonin, VP; Li, H; Li, S; Li, Z; Lin, Y; Ma, W; Peltzer, K; Wang, J; Wang, X; Wu, H; Xu, G; Xu, Y; Xue, Y; Zhang, C; Zhang, J | 1 |
Khyavi, PA; Shanehbandi, D; Soleimanpour, J; Valizadeh, A; Yousefi, B | 1 |
Bielack, SS; Blattmann, C; Borkhardt, A; Csóka, M; Hassenpflug, W; Hecker-Nolting, S; Kabíčková, E; Kager, L; Kessler, T; Kevric, M; Kratz, C; Kühne, T; Lehrnbecher, T; Mayer-Steinacker, R; Mettmann, V; Metzler, M; Reichardt, P; Rossig, C; Sorg, B; von Luettichau, I; Windhager, R | 1 |
Gomes, CMF; Martins-Neves, SR; Sampaio-Ribeiro, G | 1 |
Hills, F; Low, K; Roberts, HC; Stordal, B | 1 |
An, HY; Bai, B; Sun, MX; Sun, YB | 1 |
Cohen, IJ; Sadeh, M; Toledano, H | 1 |
Fu, D | 1 |
Hashida, N; Isshiki, K; Sakai, M; Sato, S; Shima, H; Shimada, H; Takimoto, T | 1 |
Aydilek, E; Brökers, N; Schanz, J | 1 |
Chen, G; Ji, C; Li, J; Li, M; Long, Z; Lu, Y; Wang, Q; Wang, Z; Xiang, L; Yu, H | 1 |
Chang, YL; Chen, WM; Chou, YC; Huang, KW; Hung, GY; Lee, HC; Wang, SF; Wu, PK | 1 |
Mehrvar, A; Mehrvar, N; Sadeghi, Y; Tashvighi, M | 1 |
Bernhardt, MB; Cheng, WS; Foster, JH; Rainusso, N; Wang, LL; Young, EP | 1 |
Li, J; Li, R; Lu, X; Zhang, B; Zhang, Y | 1 |
Binder, AF; Birchmeier, K; Burdette, S; Galanis, P; Handley, N; Piddoubny, M | 1 |
Fujiwara, T; Jeys, LM; Parry, MC; Stevenson, JD; Sumathi, V; Tsoi, K; Tsuda, Y | 1 |
Li, X; Liu, Y; Shen, J; Xu, R; Yu, X; Zhang, X | 1 |
Aguado, L; Gutiérrez, M; Idoate, MÁ; Moreno-Artero, E; Querol-Cisneros, E; Rodríguez-Garijo, N; Tomás-Velázquez, A | 1 |
Alemi, F; Asemi, Z; Bazavar, M; Fazli, J; Ma, B; Maleki, M; Mohammadi, E; Valizadeh, A; Xing, S; Yousefi, B | 1 |
Bao, Q; Cheng, J; Han, J; Hu, Y; Liu, X; Song, R; Wang, W; Wang, Z; Wu, S; Yao, Y; Yu, L; Yu, W; Yu, X; Yu, Y; Zhang, G; Zhang, W; Zhao, M | 1 |
Fried, M; Krämer, I; Kühn, M; Rosentreter, J | 1 |
Doval, DC; Jain, S; Kapoor, G; Sharma, P; Tripathi, R; Verma, P | 1 |
Alsdorf, WH; Bokemeyer, C; Frenzel, C; Karagiannis, P; Langebrake, C | 1 |
Anderson, PM; Gennatas, S; Gulia, A; Huang, PH; Jones, RL; Smrke, A | 1 |
Cao, S; Hao, Y; Peng, C; Ren, Z; Zhang, P; Zhu, J | 1 |
Xiang, RM; Yan, JP | 1 |
Demir, B; Demir, E; Sütcüoğlu, O; Ünsal, O; Yazıcı, O | 1 |
Hiraga, H; Ozaki, T | 1 |
Guruprasad, CS; Nair, M; Prasanth, VR; Rajeswari, B; Sugath, BS; Thankamony, P | 1 |
Le, T; Shahriyari, L; Su, S | 1 |
Gehrs, BC; Meyer, WH; Palacios, MF; Pokala, HR; Pratap, S | 1 |
Li, S; Xiong, Y; Zhang, X | 1 |
Holt, GE; Lipshultz, ER; Lipshultz, SE; Ramasamy, R; Yechieli, R | 1 |
da Motta Girardi, D; da Silva Rocha, LS; Feher, O; Negrão, MV | 1 |
Bahrami, A; Billups, CA; Daryani, VM; Daw, NC; Kunkel, M; Loeb, DM; Mao, S; McCarville, MB; Navid, F; Neel, M; Pappo, AS; Rao, BN; Reikes Willert, J; Santana, VM; Shulkin, BL; Smith, W; Stewart, CF; Ward, D; Wu, J | 1 |
Deng, ZP; Ding, Y; Jin, T; Li, B; Liu, BY; Niu, XH; Sun, Y | 1 |
Bajpai, J; Banavali, SD; Chandrakanth, MV; Chandrasekharan, A; Ghosh, J; Gupta, S; Khan, A; Khurana, S; Rekhi, B; Simha, V; Talreja, V; Vora, T | 1 |
Gupta, A; Hopyan, S; Koo, A; Renzi, S; Taylor, T; Tsimerman, E | 1 |
Avan, A; de Sá Lopes, AC; Dos Santos Cavalcanti, A; Gholamin, S; Hanae Kasai Brunswick, T; Kahn, SA; Leite Duarte, ME; Matheus Guimarães, JA; Meohas, W; Razavi, M; Ribeiro, GO | 1 |
Fang, GW; Liu, W; Xue, Y; Zhang, YJ; Zhao, X | 1 |
Jayakrishnan, A; Kumar, TSS; Prasad, SR | 1 |
Han, Z; Shi, L | 1 |
Bompas, E; Bouvier, C; Brisse, HJ; Brugieres, L; Castex, MP; Cheurfa, N; Corradini, N; Delaye, J; Entz-Werlé, N; Gaspar, N; Gentet, JC; Italiano, A; Le Deley, MC; Lervat, C; Marec-Berard, P; Mascard, E; Occean, BV; Pacquement, H; Piperno-Neumann, S; Redini, F; Saumet, L; Schmitt, C; Tabone, MD; Verite-Goulard, C | 1 |
Katsumi, H; Sakane, T; Yamamoto, A; Yamashita, S | 1 |
Bagatell, R; Balamuth, N; Balis, F; Fox, E; Levin, K; Segers, B; Womer, R; Zhu, Y | 1 |
Collier, CD; Getty, PJ; Greenfield, EM; Knafler, GJ; Morris, WZ; Wirtz, EC | 1 |
Engelhardt, M; Füllgraf, H; Hager, S; Herget, GW; Marks, R; Südkamp, NP | 1 |
Bai, J; Cui, Y; Ding, L; Han, X; Li, R; Wang, C; Zhou, Y | 1 |
Nath, A; Sims, E; Sugalski, A | 1 |
Bouazza, N; Brugieres, L; Corradini, N; Entz-Werle, N; Fresneau, B; Freycon, C; Gaspar, N; Gentet, JC; Laurence, V; Le Deley, MC; Le Teuff, G; Lervat, C; Lui, G; Mahier Ait Oukhatar, C; Marec Berard, P; Millot, F; Pacquement, H; Piperno-Neumann, S; Schneider, P; Taque, S; Treluyer, JM | 1 |
Kawai, A; Kobayashi, H; Ogura, K; Shinoda, Y; Tanaka, S; Tsuda, Y | 1 |
Berber, M; Dincaslan, H; Incesoy Ozdemir, S; Tacyildiz, N; Unal, E; Yavuz, G | 1 |
Grant, R; Gupta, AA; Hendershot, E; Mills, D; Nicksy, D; Ramachandran, N; Riss, V; Shaikh, F; Taylor, T; Volpe, J | 1 |
de Jong, L; Desar, I; Heidema, W; Jansen, R; Kaal, S; Schreuder, B; van der Graaf, W; van Erp, N; Weidema, M | 1 |
Li, Z; Xu, R; Xu, W; Xu, Y; Zhu, X | 1 |
Cheng, WTF; Chu, HM; Fong, PS; Hui, KH; Lam, TN | 1 |
Bubalo, J; Dang, T; Davis, LE; Fu, R; Gundle, KR; Paxton, J; Ryan, CW; Stork, L; Wippel, B | 1 |
Anninga, J; Antal, I; Arndt, C; Bernstein, M; Bielack, SS; Brown, KLB; Butterfass-Bahloul, T; Calaminus, G; Capra, M; Dhooge, C; Eriksson, M; Flanagan, AM; Friedel, G; Gebhardt, MC; Gelderblom, H; Goldsby, R; Gorlick, R; Grier, HE; Grimer, R; Hawkins, DS; Hecker-Nolting, S; Hogendoorn, P; Ingleby, FC; Isakoff, MS; Janeway, KA; Jovic, G; Kabickova, E; Kager, L; Krailo, MD; Kühne, T; Lang, S; Lau, CC; Leavey, PJ; Lessnick, SL; Marina, N; Mascarenhas, L; Mayer-Steinacker, R; Meyers, PA; Nagarajan, R; Randall, RL; Rechnitzer, C; Reichardt, P; Renard, M; Schwartz, CL; Smeland, S; Strauss, S; Sundby Hall, K; Sydes, MR; Teot, L; Timmermann, B; von Kalle, T; Whelan, J | 1 |
Bao, S; Chan, ACL; Chan, JKC; Lau, GTC; Yau, DTW; Zheng, Z | 1 |
Gao, HD; Hou, ZL; Tang, QX; Wang, LC; Wang, Y | 1 |
Chen, P; Li, S; Pei, Y; Qiu, E; Wang, W; Zhang, X; Zheng, K | 1 |
Abboud, MR; Abou Ali, B; Akel, S; Boulos, F; El-Solh, H; Ghanem, KM; Haidar, R; Muwakkit, SA; Saab, R; Saghieh, S; Salman, M; Tamim, H | 1 |
Feng, A; Han, C; Liu, R; Lv, Y; Mao, Y; Tian, Y; Xu, D; Yu, D; Zhang, S; Zhao, Y; Zhu, Q | 1 |
Anract, P; Bertucci, F; Blay, JY; Bompas, E; Brugieres, L; Collard, O; Cupissol, D; de Pinieux, G; Delaye, J; Duffaud, F; Italiano, A; Laurence, V; Le Cesne, A; Le Deley, MC; Occean, BV; Penel, N; Perrin, C; Piperno-Neumann, S; Ray-Coquard, I; Rios, M | 1 |
Aoki, Y; Araki, N; Hashimoto, N; Ieguchi, M; Kudawara, I; Kuratsu, S; Matsumine, A; Mori, S; Myoui, A; Naka, N; Nakanishi, H; Ueda, T; Yoshikawa, H | 1 |
Alberghini, M; Antonescu, CR; Bertoni, F; Cesari, M; Ferrari, C; Ferrari, S; Maki, RG; Marchesi, E; Mavrogenis, A; Paioli, A; Palmerini, E; Picci, P; Ruggieri, P; Staals, EL | 1 |
Bi, W; Han, G; Jia, J; Wang, W; Xu, M | 1 |
Arush, MW; Ash, S; Bonda-Shkedi, E; Cohen, IJ; Goshen, Y; Kaplinsky, C; Yaniv, I | 1 |
Charoenkwan, P; Choeyprasert, W; Natesirinilkul, R; Sittipreechacharn, S | 1 |
Byun, BH; Cho, WH; Choi, CW; Jeon, DG; Koh, JS; Kong, CB; Lee, SY; Lim, I; Lim, SM; Song, WS | 1 |
Hou, WG; Liu, Y; Ma, C; Sun, XH; Zhao, HX; Zhao, YL | 1 |
Golovko, TS; Gulak, LO; Kobys, VL; Konovalenko, VF; Matyushok, OF; Repinа, NV; Tarasova, TO; Zaharycheva, EV | 1 |
Bai, SB; Bao, YX; Chen, HX; Luo, X; Zhong, JJ | 1 |
Bienemann, K; Hanenberg, H; Howe, SJ; Kramm, CM; Sena-Esteves, M; Staege, MS | 1 |
Crews, KR; Navid, F; Panetta, JC; Scott, JR; Ward, DA | 1 |
Cai, HQ; Li, YC; Wang, ZG; Xu, YL; Yang, J | 1 |
Chauhan, N; Christensen, R; Daugherty, C; Howard, SC; Jayaprakash, N; King, TR; Pui, CH; Rush, JE; Schwartz, S; Widemann, BC | 1 |
Boye, K; Del Prever, AB; Eriksson, M; Fagioli, F; Ferrari, S; Hall, KS; Lindholm, P; Saeter, G; Skjeldal, S; Tienghi, A | 1 |
Bain, E; Birhiray, RE; Reeves, DJ | 1 |
Bisogno, G; Marzollo, A | 1 |
Bruneau, B; Chappé, C; Gandemer, V; Robert, G; Taque, S | 1 |
Li, B; Li, H; Li, Y; Sun, L; Ye, Z; Zhang, J | 1 |
Diller, L; Duffey-Lind, E; Ebb, D; Grier, H; Kenney, LB; Sklar, CA | 1 |
Bickels, J; Flusser, G; Gortzak, Y; Issakov, J; Kolander, Y; Kushnir, I; Merimsky, O | 1 |
Fukuoka, N; Houchi, H; Kosaka, S; Motoki, T; Takeuchi, T; Tanaka, H; Watanabe, M; Yamaguchi, K | 1 |
Jaffe, N | 7 |
Chen, H; Chen, P; Duan, Z; He, W; Wang, H; Wang, J; Zou, JX | 1 |
Pei, FX; Song, YC; Yang, XN; Zeng, JC; Zhang, H | 1 |
Dolžan, V; Goričar, K; Jazbec, J; Kovač, V; Lamovec, J; Zakotnik, B | 1 |
Fu, WM; Hsieh, IS; Yang, RS | 1 |
Chang, WH; Chen, PC; Chen, WM; Chiou, HJ; Hsu, HE; Hung, GY; Wu, HT; Yen, CC; Yen, HJ | 1 |
Xu, M; Xu, S; Yu, X | 1 |
Wang, W; Wang, Z; Xiao, X | 1 |
Anninga, J; Bernstein, M; Bielack, SS; Böhling, T; Butterfass-Bahloul, T; Calaminus, G; Capra, M; Deffenbaugh, C; Dhooge, C; Eriksson, M; Flanagan, AM; Gelderblom, H; Goorin, A; Gorlick, R; Gosheger, G; Grimer, RJ; Hall, KS; Helmke, K; Hogendoorn, PC; Hook, JM; Jovic, G; Jundt, G; Kager, L; Krailo, M; Kuehne, T; Lau, CC; Letson, GD; Marina, N; Meyer, J; Meyers, PA; Morris, C; Mottl, H; Nadel, H; Nagarajan, R; Randall, RL; Schomberg, P; Schwarz, R; Smeland, S; Sydes, MR; Teot, LA; Whelan, JS | 1 |
Lin, F; Shen, Z; Tang, L; Yao, Y; Yu, W | 1 |
Anurathapan, U; Choeyprasert, W; Chuansumrit, A; Hongeng, S; Nartthanarung, A; Pakakasama, S; Sirachainan, N; Songdej, D | 1 |
Mills, DK; Sun, L | 1 |
Benini, S; Ferrari, S; Gambarotti, M; Hattinger, CM; Magagnoli, G; Michelacci, F; Palmerini, E; Picci, P; Sella, F; Serra, M | 1 |
Cheng, C; Crews, KR; Jeha, S; Molinelli, AR; Navid, F; Relling, MV; Scott, JR; Stewart, CF; Swanson, HD; Ward, DA; Zhou, Y | 1 |
Kyr, M; Neradil, J; Pavlasova, G; Sramek, M; Sterba, J; Veselska, R | 1 |
Allen, PK; Arzu, I; Dabaja, B; Fayad, LE; Medeiros, LJ; Oki, Y; Pinnix, CC; Reed, VK; Rodriguez, A; Shihadeh, F; Tao, R; Westin, JR | 1 |
Wang, YP; Yang, ZP | 1 |
Baumhoer, D; Bernstein, M; Bielack, SS; Böhling, T; Brennan, B; Butterfass-Bahloul, T; Calaminus, G; Deffenbaugh, C; Dhooge, C; Eriksson, M; Gebhardt, M; Gelderblom, H; Gerss, J; Goorin, A; Gorlick, R; Helmke, K; Hogendoorn, PC; Hoogerbrugge, PM; Hook, JM; Jovic, G; Jürgens, H; Kager, L; Krailo, MD; Kühne, T; Lau, CC; Letson, GD; Marina, N; Meyer, J; Meyers, P; Michelagnoli, M; Morris, C; Nadel, H; Nagarajan, R; Pápai, Z; Picton, S; Randall, RL; Reichardt, P; Renard, M; Schomberg, P; Seddon, B; Smeland, S; Sundby Hall, K; Sydes, MR; Teot, LA; Tunn, PU; van den Berg, H; Werner, M; Whelan, JS; Windhager, R | 1 |
Chen, YY; Chiang, PH; Hsieh, MC; Huang, CH; Rau, KM; Su, YL | 1 |
Duan, H; Gong, RR; Xiong, Y; Yang, XR | 1 |
Choi, W; Corn, P; Czerniak, B; Dinney, C; Kamat, AM; Lee, IL; Matin, SF; McConkey, DJ; Millikan, RE; Porten, S; Shen, Y; Siefker-Radtke, AO | 1 |
Ash, S; Cohen, IJ; Issakov, J; Kollender, Y; Shkalim-Zemer, V; Toledano, H; Yaniv, I | 1 |
Bakhshi, S; Batra, A; Khan, SA; Nataraj, V; Rastogi, S; Sharma, MC; Vishnubhatla, S | 1 |
Bernstein, ML; Devidas, M; Gebhardt, MC; Goorin, AM; Grier, HE; Healey, JH; Krailo, MD; Lipshultz, SE; Meyers, PA; Sato, JK; Schwartz, CL; Steinherz, LJ; Teot, LA; Wexler, LH | 1 |
Herrington, JD; Tran, HX | 1 |
Chintagumpala, M; Helman, L; Hicks, MJ; Jo, E; Krance, R; Lau, C; Meyer, W; Murray, J; Venkatramani, R | 1 |
Ferrari, S; Serra, M | 1 |
Bishop, MW; Brinkman, TM; Cheung, YT; Daryani, VM; Edelmann, MN; Hudson, MM; Kimberg, C; Krull, KR; Liu, W; Mulrooney, DA; Ness, KK; Robison, LL; Srivastava, DK; Stewart, CF | 1 |
Effinger, KE; Link, MP | 1 |
Li, M; Liu, BM; Wang, SY; Yin, BS; Zhang, WG; Zou, JY | 1 |
Ding, M; Huang, J; Jin, Q; Liu, K; Ni, J; Song, D; Wang, J | 1 |
Bernstein, ML; DuBois, SG; Gorlick, RG; Janeway, KA; Krailo, MD; Marina, N; Morris, CD; Randall, RL; Teot, LA; Villaluna, D | 1 |
Abdul-Rahman, O; Bai, P; Dér, Á; Fodor, T; Kiss, B; Nagy, L; Szántó, M | 1 |
Gan, ZH; Han, K; Hu, HY; Li, KP; Lin, SC; Liu, Y; Lu, ZG; Min, DL; Tseng, KF; Zhao, RH; Zhou, Y | 1 |
Dinçaslan, H; Ensari, A; Kiremitçi, S; Özçakar, ZB; Taktak, A; Yalçınkaya, F; Yılmaz, S | 1 |
Djerada, Z; Feliu, C; Gozalo, C; Marquet, B; Millart, H; Oudart, JB | 1 |
Adachi, S; Heike, T; Hiramatsu, H; Nodomi, S; Okamoto, T; Saida, S; Umeda, K; Watanabe, K | 1 |
Bi, WZ; Han, G; Huang, JQ; Jia, JP; Mao, BB; Wang, DY; Wang, W; Wu, YN; Xu, M | 1 |
Biason, P; Fanelli, M; Ferrari, S; Gagno, S; Giodini, L; Hattinger, CM; Iacoboni, E; Picci, P; Roli, A; Roncato, R; Scotlandi, K; Serra, M; Tavanti, E; Toffoli, G; Vella, S | 1 |
Antal, P; Arany, A; Csoka, M; Csordas, K; Eipel, O; Erdelyi, DJ; Gezsi, A; Hegyi, M; Kovacs, GT; Kutszegi, N; Muller, J; Semsei, AF; Szalai, C | 1 |
Deng, P; Junger, WG; Qi, B; Sun, D; Wang, C; Wang, T; Xia, Y; Yao, J; Yu, T; Zhang, X | 1 |
Fanelli, M; Hattinger, CM; Picci, P; Serra, M; Tavanti, E; Vella, S | 1 |
Fujiki, M; Kawai, A; Miyamoto, S; Setsu, N | 1 |
Chu, W; Cui, S; Huang, Y; Liao, Y; Yan, M; Yang, C; Zhang, X; Zhao, C | 1 |
Chakraborty, J; Ray, S; Sa, B; Saha, S | 1 |
Bielack, SS; Ferrari, S; Helman, LJ; Marina, N; Reaman, GH; Smeland, S; Whelan, JS | 1 |
Joh, T; Kamiya, T; Kataoka, H; Kubota, E; Mizoshita, T; Mori, Y; Ogasawara, N; Okamoto, Y; Sasaki, M; Shimura, T; Wada, T | 1 |
Draenert, FG; Draenert, K | 1 |
Arndt, CA; Hawkins, DS; Hoots, WK; Inwards, CY; Kleinerman, ES; Koshkina, NV; Morales-Arias, JA; Munsell, MF; Rodriguez, NI | 1 |
Gorlick, R; Jaffe, N | 1 |
Goldwasser, F; Mir, O; Ropert, S | 1 |
Cendros, JM; Colom, H; Domenech, J; Farré, R; Mangues, MA; Pardo, N; Peraire, C; Soy, D; Torrent, M | 1 |
Bjornard, K; Jayabose, S; Kudlowitz, D; Nowicki, TS; Sandoval, C | 1 |
Marrodán, L; Patiño-García, A; San-Julián, M; Sierrasesúmaga, L; Zalacaín, M | 1 |
de Camargo, B; van Dalen, EC | 1 |
Fujimoto, T; Hamada, K; Hashimoto, N; Hatazawa, J; Inoue, A; Myoui, A; Tomita, Y; Yoshikawa, H | 1 |
Kalicanin-Markovska, M; Kostadinova-Kunovska, S; Samardziski, M; Tolevska, C; Zafiroski, G; Zafirova-Ivanovska, B | 1 |
Cheok, MH; Evans, WE; Kager, L | 1 |
Gunes, D; Gurcu, O; Koroglu, T; Olgun, N; Ozguven, AA; Uysal, K | 1 |
Abate, ME; Bacci, G; Balladelli, A; Cesari, M; Ferrari, S; Longhi, A; Palmerini, E; Pratelli, L; Staals, E | 1 |
Jeon, SC; Kim, JH; Koh, HC; Lee, YH; Lim, YJ; Oh, SH | 1 |
Ferraresi, V; Prencipe, U; Salducca, N; Zoccali, C | 1 |
Hamaguchi, T; Hirashima, Y; Kato, K; Nakajima, TE; Okita, NT; Shimada, Y; Shirao, K; Takahari, D; Takashima, A; Yamada, Y | 1 |
Botchkina, GI; Bruheim, S; Fodstad, O; Formentini, A; Gavin, E; Ju, J; Kornmann, M; Kudo, K; Song, B; Wan, Y; Wang, Y; Xi, Y | 1 |
Cohen, IJ | 2 |
Bargagli, E; Bertelli, P; Gonnelli, S; Olivieri, C; Penza, F; Rottoli, P; Volterrani, L | 1 |
Abdelaziz, NN; Abdelhafeez, ZM; Essa, AE; Gado, NM; Kamel, TH; Salem, DA | 1 |
Edwards, MS; Fairbank, J; Midgely, P | 1 |
Alexandre, J; Anract, P; Babinet, A; Durand, JP; Enkaoua, E; Goldwasser, F; Larousserie, F; Mir, O; Ropert, S | 1 |
Carlo, B; Fabbriciani, C; Maccauro, G; Rosa, MA; Rossi, B; Scaramuzzo, L; Schinzari, G; Signorelli, D | 1 |
Hata, K; Hirai, I; Maebeya, S; Miki, Y; Oota, F; Tanaka, T; Tanino, H | 1 |
Grier, HE; Janeway, KA | 1 |
Bergerat, JP; Gérout, AC; Herbrecht, R; Kemmel, V; Lescoute, A; Levêque, D; Lutz, P; N'guyen, A; Santucci, R; Schneider, F | 1 |
Bouzón-Alejandro, M; Couselo, JM; Maneiro-Freire, M; Oulego-Erroz, I; Vázquez-Donsión, M | 1 |
Buchbinder, D; Casillas, J; Linetsky, M; Steinberg, G | 1 |
Aomori, T; Fujita, Y; Horiuchi, R; Nakamura, K; Nakamura, T; Nishiba, H; Okada, Y; Shinozaki, H; Takagishi, K; Watanabe, H; Yamamoto, K; Yanagawa, T | 1 |
Alberer, M; Albert, MH; Benz, MR; Bergmann, C; Hartrampf, S; Hilberath, J; Hoefele, J; Pawlita, I; Schmid, I; Weber, LT | 1 |
Baker, L; Curry, JO; Gorlick, R; Levy, AS; Mahadeo, KM; Santizo, R | 1 |
Lin, JR; Wang, ZC; Zhang, WM | 1 |
Womer, RB | 1 |
Abramson, SJ; Bartolotta, R; Chou, A; Hwang, S; Katz, DS; Meyers, P; Price, AP | 1 |
Al-Turkmani, MR; Kellogg, MD; Law, T; Narla, A | 1 |
Milone, MC | 1 |
Balis, FM; Fox, E | 1 |
Huang, G; Jia, Q; Shen, JN; Wang, J; Xie, XB; Yin, JQ; Zou, CY | 1 |
Cho, WH; Jeon, DG; Jung, ST; Koh, JS; Kong, CB; Lee, JA; Lee, SY; Shin, DS; Song, WS; Yoo, JY | 1 |
Bi, WZ; Han, G; Lu, SB; Wang, DJ; Wang, Y; Zhang, L; Zhao, B | 1 |
Cho, Y; Choi, Y; Chung, SH; Jung, GH; Kim, JD; Kim, JY | 1 |
Cho, J; Cho, WH; Jeon, DG; Kim, DH; Kim, MS; Koh, JS; Kong, CB; Lee, JA; Lee, SY; Lim, JS; Song, WS; Yoo, JY | 1 |
Alvegaard, TA; Bjerkehagen, B; Björk, O; Brosjö, O; Bruland, OS; Hall, KS; Hjorth, L; Jakobson, A; Monge, OR; Osterlundh, G; Smeland, S | 1 |
Doan, NB; Forscher, C; Goff, C; Iwanski, GB; Koeffler, HP; Lee, DH; Said, JW; Thoennissen, NH | 1 |
Abramson, SJ; Chou, AJ; Gorlick, R; Healey, JH; Kellick, MG; Laquaglia, MP; Merola, PR; Meyers, PA; Morris, CD; Wexler, LH | 1 |
Anderson, LD; Collins, RH; Kirk, A; Levitt, D; Naina, HV; Scaglioni, PP; Vusirikala, M | 1 |
Ito, N; Koiwai, K; Kubo, N; Nakayama, A; Ogiwara, H; Takeuchi, N; Tsujimoto, K | 1 |
de Camargo, B; van As, JW; van Dalen, EC | 1 |
Benemei, S; Calvani, AM; Lapi, F; Mugelli, A; Pugi, A; Tondo, A; Vannacci, A; Vietri, M | 1 |
Liang, Y; Shen, JN; Tang, QL; Wang, J; Xie, XB; Yin, JQ; Zhao, ZQ; Zou, CY | 1 |
Caccuri, A; Fanelli, M; Hattinger, CM; Landuzzi, L; Lollini, PL; Manara, MC; Michelacci, F; Nicoletti, G; Pasello, M; Picci, P; Scotlandi, K; Serra, M | 1 |
Andersen, AM; Hall, KS; Holmboe, L; Mørkrid, L; Slørdal, L | 1 |
Dong, Y; Lin, F; Shen, Z; Sun, Y; Tang, L; Wang, Q; Yao, Y; Yu, W; Zheng, S | 1 |
Klapkova, E; Kotaska, K; Kukacka, J; Prusa, R; Suchanska, I; Urinovska, R | 1 |
Acar, H; Aydemir, E; Bayrak, OF; Gulluoglu, S; Ozen, M; Sahin, F; Sevli, S; Yalvac, ME | 1 |
Bahrami, A; Davidoff, AM; Fernandez-Pineda, I; Green, JF; McGregor, LM; Sandoval, JA | 1 |
Hill, N; Johansson, ÅM; Karlsson, MO; Perisoglou, M; Standing, JF; Whelan, J | 1 |
Ahmed, N; Brawley, VS; Ghazi, A; Gottschalk, S; Hicks, MJ; Rainusso, N; Rosen, JM | 1 |
Baumhoer, D; Bielack, S; Ebner, F; Greulich, M; Müller, J; Ott, M; Rehnitz, D; Rempen, A; Schaetzle, S; Wilhelm, M; Zils, K | 1 |
Borges, KS; Castro-Gamero, AM; da Silva Silveira, V; de Paula Gomes Queiroz, R; Lira, RC; Scrideli, CA; Tone, LG; Umezawa, K; Valera, FC | 1 |
Fukunaga, S; Futani, H; Okamoto, N; Ono, J; Otsuka, Y; Tanizawa, T; Terada, N; Tomatsuri, M; Tsukamoto, Y; Yoshiya, S | 1 |
Alberghini, M; Bacci, G; Bertulli, R; Bisogno, G; Capanna, R; Cefalo, G; Comandone, A; Fagioli, F; Ferrari, S; Linari, A; Palmerini, E; Parafioriti, A; Picci, P; Ruggieri, P; Tamburini, A | 1 |
Maki, RG | 1 |
Iwamoto, Y; Tanaka, K | 1 |
Cságoly, E; Csordás, K; Eipel, OT; Erdélyi, DJ; Gulácsi, A; Hegyi, M; Kovács, GT; Lautner-Csorba, O; Müller, J; Nemes, K | 1 |
Deutsch, EC; Lynch, DR; Perlman, SL; Seyer, LA; Yu, J | 1 |
Gafton, GI; Gudz', IuV; Ivanova, TV; Krzhivitskiĭ, PI; Kupatadze, DD; Lazareva, IuR; Levchenko, EV; Nabokov, VV; Novik, VI; Petrov, VG; Punanov, IuA; Safonova, SA | 1 |
Akbulut, H; Demirkazik, A; Dincol, D; Dogan, M; Icli, F; Karabulut, HG; Tukun, A; Utkan, G; Yalcin, B | 1 |
Friesenbichler, J; Leithner, A; Obermayer-Pietsch, B; Pirker-Frühauf, UM; Urban, EC | 1 |
Lin, F; Min, D; Shen, Z; Tan, L; Yao, Y; Yu, W; Zheng, S | 1 |
Choy, E; Duan, Z; Hornicek, FJ; Liu, X; Mankin, H; Yang, W | 1 |
Cornec, D; Le Nen, D; Saraux, A | 1 |
Bao, CF; Li, XH; Yang, LM | 1 |
Alberghini, M; Fabbri, N; Ferrari, C; Ferrari, S; Palmerini, E; Picci, P; Staals, E | 1 |
Cole, PD; Kamen, BA; Smith, AK | 1 |
Arbus, GS; Bash, RO; Hansch, E; Leavey, PJ; Quigley, R; Saland, JM | 1 |
Baldus, C; Blau, IW; Fietz, T; Knauf, WU; Stoltenburg, G; Thiel, E | 1 |
Ayala, A; Carrasco, H; Eftekhari, F; Jaffe, N; Raymond, K | 1 |
Cassoni, AM; Driver, D; Janinis, J; Kilby, A; McTiernan, A; Mitchell, C; Pringle, J; Whelan, JS | 1 |
Davis, KA; Walker, JC; Williams, P | 1 |
Bacci, G; Benini, S; Bertoni, F; Briccoli, A; Ferrari, S; Incaprera, M; Manara, MC; Mercuri, M; Picci, P; Reverter-Branchat, G; Scotlandi, K; Serra, M | 1 |
Bacci, G; Longhi, A; Macchiagodena, M; Vitali, G | 1 |
Ayala, AG; Devidas, M; Gebhardt, MC; Goorin, AM; Grier, HE; Harris, MB; Helman, LJ; Link, MP; Schwartzentruber, DJ | 1 |
Dechant, MJ; Ewerbeck, V; Fellenberg, J; Mau, H | 1 |
Bielack, SS; Branscheid, D; Flege, S; Gadner, H; Jundt, G; Jürgens, H; Kabisch, H; Kager, L; Kastner, U; Kempf-Bielack, B; Kotz, R; Pötschger, U; Reichardt, P; Salzer-Kuntschik, M; Winkelmann, W; Zoubek, A | 1 |
Alkallaf, S; Cornille, H; Delépine, G; Delépine, N; Markowska, B | 1 |
Alvegard, TA; Björk, O; Brosjö, O; Follerås, G; Holmström, T; Jonsson, K; Kivioja, A; Monge, O; Müller, C; Saeter, G; Smeland, S; Stenwig, AE; Wiebe, T; Wiklund, T; Willén, H | 1 |
Becton, DL; Saccente, S; Saylors, RL; Stine, KC | 1 |
Bacchini, P; Bacci, G; Bertoni, F; Briccoli, A; Donati, D; Ferrari, S; Forni, C; Galletti, S; Giacomini, S; Longhi, A; Manfrini, M; Rocca, M | 1 |
Ardito, R; De Santis, V; Falcone, G; Maccauro, G; Muratori, F; Rosa, MA; Sgambato, A | 1 |
Chang, TT; Chang, WH; Chen, RL; Hsiao, TC; Hung, IJ; Lin, DT; Lin, KH; Lin, KS; Lin, MT; Lu, MY; Shu, SG; Wu, CT; Yang, CP; Yang, RS | 1 |
DAWSON, EM | 1 |
MCGOVERN, EL; PERRIN, WE | 1 |
DIPAOLO, JA; DOWD, JE; WATNE, AL | 1 |
NAHUM, AM | 1 |
HALL, TC; NEVINNY, HB | 1 |
Benini, S; Castellani, GC; Hattinger, CM; Manara, MC; Pasello, M; Picci, P; Remondini, D; Reverter-Branchat, G; Scotlandi, K; Serra, M | 1 |
Assaraf, YG; Ifergan, I; Issakov, J; Meller, I | 1 |
Bacci, G; Briccoli, A; De Paolis, M; Ferrari, S; Forni, C; Longhi, A; Ruggieri, P; Setola, E | 1 |
Aldaz, A; Aquerreta, I; Giráldez, J; Sierrasesúmaga, L | 1 |
Blayac, JP; Cociglio, M; Hillaire-Buys, D; Margueritte, G; Peyriere, H; Vallat, C | 1 |
Fujita, K; Gotoh, M; Hirata, I; Hongo, H; Katsu, K; Kawabe, S; Ohta, S; Takiuchi, H | 1 |
Crews, KR; Daw, NC; Link, MP; Liu, T; Meyer, WH; Panetta, JC; Rodriguez-Galindo, C; Tan, M | 1 |
Adamson, PC; Bacci, G; Balis, FM; Bielack, S; Craft, AW; Ferrari, S; Kempf-Bielack, B; Pratt, CB; Widemann, BC | 1 |
Deguchi, T; Ehara, H; Ishihara, S; Masue, T; Mizutani, K; Seike, K; Sugawara, T; Takahashi, Y; Yokoi, S | 1 |
Itoi, E; Nagasawa, H; Okada, K; Sakamoto, H; Shimada, Y; Takahashi, S | 1 |
Bessis, D; Guilhou, JJ; Guillot, B; Legouffe, E | 1 |
Isobe, K; Nikaido, T; Shimizu, T; Takaoka, K | 1 |
Goto, T; Hozumi, T; Kobayashi, H; Kondo, T; Kosaku, H | 1 |
Bielack, S; Flege, S | 1 |
Berta, M; Bertoni, F; del Prever, AB; Fagioli, F; Ferrari, S; Mercuri, M | 1 |
Balcerska, A; Balwierz, W; Chełmecka-Hanuszewicz, L; Chybicka, A; Cwiklińska, M; Derwich, K; Jackowska, T; Kaczmarek-Kanold, M; Kowalczyk, JR; Kołtan, A; Matysiak, M; Odój, T; Płoszyńska, A; Sońta-Jakimczyk, D; Steczowicz, M; Wachowiak, J; Wojciechowska, V; Wójtowicz, A; Wysocki, M | 1 |
Gorlick, R; Healey, J; Huvos, AG; Kellick, M; Lo, S; Meyers, PA; Sankaran, M; Shi, W; Wexler, LH; Zelcer, S | 1 |
Antonescu, CR; Berens, ME; Brown, KM; Chen, W; Daluski, A; Gorlick, R; Healey, JH; Henry, MM; Hilmer, SC; Huvos, AG; Lafleur, B; Macdonald, TJ; Mazza, B; McDonough, WS; Meyers, PA; Mintz, MB; Ramsey, KE; Sowers, R; Stephan, DA | 1 |
Fukuda, H; Habuchi, T; Iinuma, M; Kato, T; Kumazawa, T; Minagawa, S; Mitsumori, K; Satoh, K; Satoh, S; Tadachi, K | 1 |
Bernstein, ML; Betcher, D; Conrad, E; Ferguson, W; Gebhardt, M; Goorin, AM; Grier, H; Harris, MB; Healey, J; Huvos, A; Kleinerman, ES; Krailo, M; Link, M; Meyers, PA; Montebello, J; Nadel, H; Nieder, M; Sato, J; Schwartz, CL; Siegal, G; Weiner, M; Wells, R; Wold, L; Womer, R | 1 |
Mekni, A; Mrad, K; Oubiche, F; Romdhane, KB; Sassi, S; Smida, M | 1 |
Ishikawa, T; Kamimura, T; Mizuno, K; Ohta, H; Seki, K; Togashi, T; Watanabe, K; Yoshida, T | 1 |
Ceylaner, B; Dervişoğlu, S; Dinçbaş, FO; Hiz, M; Koca, S; Mandel, NM; Oksüz, DC; Seçmezacar, H; Uzel, B | 1 |
Bacci, G; Cesari, M; Ferrari, S; Lamanna, G; Pieretti, F; Tolentinis, L; Verri, E; Versari, M; Zolezzi, C | 1 |
Hobson, R; Morland, B; Ng, A; Williams, D | 1 |
Boglione, A; Cattel, L; Comandone, A; Ferrari, S; Passera, R; Tagini, V | 1 |
Chintagumpala, M; Davino, N; Helman, L; Hicks, J; Johnson, M; Lau, CC; Man, TK; Meyer, W; Murray, J; Perlaky, L; Shen, J; Triche, T; Visvanathan, J; Wong, KK | 1 |
Brodsky, I; Rosenbluth, JZ; Styler, MJ; Zak, D | 1 |
Bielack, SS; Bürger, H; Eselgrim, M; Gosheger, G; Grunert, H; Jürgens, H; Kevric, M; Kühne, T; Mayer-Steinacker, R; Zoubek, A | 1 |
Alvegard, TA; Bacci, G; Bernini, G; Bertoni, F; Böhling, T; Brosjö, O; Capanna, R; Comandone, A; Del Prever, AB; Ferrari, S; Longhi, A; Mercuri, M; Müller, C; Picci, P; Ruggieri, P; Saeter, G; Smeland, S; Tienghi, A; Wiebe, T | 1 |
Arndt, CA; Doherty, DK; Gordon, N; Hawkins, DS; Inwards, CY; Kleinerman, ES; Koshkina, NV; Munsell, MF; Stewart, J | 1 |
Berger, M; Berta, L; Fagioli, F; Ferrero, I; Frairia, R; Madon, E; Palmero, A; Rustichelli, D; Venturi, C | 1 |
Billups, CA; Cain, AM; Daw, NC; Jenkins, JJ; McCarville, MB; Meyer, WH; Neel, MD; Rao, BN; Rodriguez-Galindo, C | 1 |
Alleva, R; Benassi, MS; Borghi, B; Gellert, N; Neuzil, J; Pazzaglia, L; Picci, P; Tomasetti, M | 1 |
Hioki, Y; Kusuzaki, K; Matsumine, A; Seto, M; Sonoda, J; Tomoda, R; Uchida, A | 1 |
Almeida, MT; Alves, MT; Borsato, ML; Brunetto, AL; Bruniera, P; Camargo, OP; Consentino, E; Davi, A; de Camargo, B; dos Santos, TM; Filho, VO; Jesus-Garcia, R; Macedo, CR; Mendes, WL; Oliveira, CR; Ortega, J; Pena, W; Péricles, P; Petrilli, AS; Prospero, JD | 1 |
Bacchini, P; Bacci, G; Bertoni, F; Longhi, A; Loro, L; Picci, P; Serra, M; Versari, M | 1 |
Bashir, H; Crom, D; Hudson, MM; Jones, D; Metzger, M; Mulcahey, J | 1 |
Affronti, ML; Broadwater, G; Coniglio, D; Edwards, J; Madan, B; Marks, L; McDonald, C; Niedzwiecki, D; Peters, WP; Ross, M; Vandemark, R; Vredenburgh, JJ | 1 |
Acha García, T; Camacho Alonso, J; Escobosa Sánchez, OM; Herrero Hernández, A; Milano Manso, G; Ortega Acosta, MJ | 1 |
Balduzzi, A; Cardillo, A; Colleoni, M; Ghisini, R; Goldhirsch, A; Orlando, L; Peruzzotti, G; Pietri, E; Rocca, A; Torrisi, R | 1 |
Fujioka, H; Hatano, K; Honda, M; Matsumiya, K; Satoh, M; Takada, T; Tsujimoto, Y | 1 |
Carrato Mena, A; Guillén Ponce, C; Maciá Escalante, S; Martínez Banaclocha, N; Pons Sanz, V; Rodríguez Lescure, A | 1 |
André, N; Bernard, JL; Coze, C; Devictor-Pierre, B; Estève, MA; Galy, G; Lacarelle, B; Monjanel-Mouterde, S | 1 |
Bacci, G; Balladelli, A; Barbieri, E; Briccoli, A; Fabbri, N; Ferrari, S; Forni, C; Longhi, A; Mercuri, M; Picci, P | 1 |
Brugières, L; Kalifa, C; Le Deley, MC | 1 |
Crassard, N; Frappaz, D; Marec-Bérard, P; Philip, T; Ranchin, B; Schell, M; Thiesse, P | 1 |
Brugières, L; Dupoüy, N; Entz-Werlé, N; Gentet, JC; Guinebretière, JM; Kalifa, C; Le Deley, MC; Marec-Bérard, P; Pacquement, H; Pichon, F; Schmitt, C; Tabone, MD; Vanel, D | 1 |
Chau, PY; Co, NN; Kwok, TT; Tsang, TY; Tsang, WP; Wong, RP | 1 |
Agarwal, M; Anchan, C; Pai, S; Puri, A; Shah, M | 1 |
Bazille, C; Entz-Werle, N; Fromigué, O; Levillain, P; Marie, PJ; Modrowski, D; Orosco, A | 1 |
Amaddeo, P; Barbaglio, A; Faldi, F; Fontana, S; Ghilardi, R; Pericotti, S | 1 |
Blay, JY | 1 |
Reichardt, P; Tunn, PU | 1 |
Chou, A; Gorlick, R; Healey, JH; Hoang, B; Huvos, AG; Kolb, EA; Meyers, PA; Qin, J; Sowers, R; Yang, R | 1 |
Bacci, G; Balladelli, A; Bertoni, F; Briccoli, A; Ferrari, S; Forni, C; Longhi, A; Mercuri, M; Picci, P; Serra, M | 1 |
Chen, L; Fan, Y; Fu, L; Guo, XJ; Lang, RG; Sun, YL | 1 |
Bacci, G; Bertoni, F; Ferrari, S; Palmerini, E | 1 |
Crews, KR; Daw, NC; Inaba, H; Khan, RB; Laningham, FH; Pui, CH | 1 |
Jeon, DG; Kim, DH; Kim, MS; Koh, JS; Lee, JA; Lee, SY; Lim, JS; Park, KD; Yoo, JY | 1 |
Anderson, P; Chang, EL; Herzog, CE; Hughes, D; Huh, W; Kornguth, DG; Mahajan, A; Pelloski, CE; Woo, SY | 1 |
Bernstein, ML; Betcher, D; Ferguson, WS; Gebhardt, MC; Goorin, AM; Grier, HE; Harris, M; Healey, JH; Kleinerman, E; Krailo, MD; Link, MP; Meyers, PA; Nadel, H; Nieder, M; Schwartz, CL; Siegal, GP; Weiner, MA; Wells, RJ; Womer, RB | 1 |
Gorlick, R; Kellick, M; Meyers, PA; Wexler, LH; Zelcer, S | 1 |
Alberghini, M; Bacci, G; Ferrari, S; Hattinger, CM; Manara, MC; Michelacci, F; Pasello, M; Picci, P; Scionti, I; Scotlandi, K; Serra, M | 1 |
Cheng, KK | 1 |
Andersen, J; Bergh, J; Bjerregaard, B; Cold, S; Edlund, P; Ejlertsen, B; Ewertz, M; Jensen, MB; Kamby, C; Kristensen, B; Lindman, H; Mouridsen, HT; Nordenskjöld, B | 1 |
Fukuma, H; Iribe, K; Masuda, M; Oe, H; Tookito, Y | 1 |
Blondet, R; Bouffet, E; Brunat-Mentigny, M; Chauvot, P; Moyen, B; Philip, T | 1 |
Akahoshi, Y; Kasai, C; Nishimoto, Y; Takeuchi, S | 1 |
Oliver, RT | 1 |
Cacavio, A; Caparros, B; Huvos, AG; Kosloff, C; Lane, JM; Marcove, RC; Mehta, B; Nirenberg, A; Rosen, G; Urban, C | 1 |
Horrig, C; Ribeiro-Ayeh, J; Walther, A | 1 |
Beck, J; Beck, W; Beron, G; Brandeis, W; Ebell, W; Erttmann, R; Göbel, U; Havers, W; Henze, G; Hinderfield, L; Höcker, P; Jobke, A; Jürgens, H; Kabisch, H; Kotz, R; Landbeck, G; Preusser, P; Prindull, G; Ramach, W; Ritter, J; Salzer-Kuntschik, M; Sekera, J; Treuner, J; Winkler, K; Wüst, G | 1 |
Sauer, H; Schalhorn, A; Stupp-Poutot, G; Wilmanns, W | 1 |
Beck, J; Beck, W; Beron, G; Brandeis, W; Ebell, W; Erttmann, R; Göbel, U; Kotz, R; Salzer-Kuntschik, M; Winkler, K | 1 |
Beaufort, F; Gölles, M | 1 |
Ajani, JA; Blumenschein, GR; Buzdar, AU; Hortobagyi, GN; Legha, SS | 1 |
Bunn, PA; Carney, DN; Cohen, MH; Ihde, DC; Makuch, RW; Matthews, MJ; Minna, JD | 1 |
Metz, O; Plenert, W; Stoll, W | 1 |
Brunat Mentigny, M; Dutou, L; Gérard, JP; Papillon, J | 1 |
Dick, HM; Johnston, AD; Sedlis, M; Weiner, M; Wolff, JA | 1 |
Cacavio, A; Caparros, B; Huvos, AG; Nirenberg, A; Rosen, G; Urban, C | 1 |
Alcalay, M; Bontoux, D; Daban, A; Vincent, D; Vincent-Joyeux, F | 1 |
Goto, M; Konishi, H; Tsuda, N; Yamashina, H | 1 |
Abel, U; Beyer, JH; Herrmann, R; Holzmann, K; Schmieder, A; Spehn, J; von Franqué, U | 1 |
Beron, G; Jürgens, H; Winkler, K | 1 |
Bartolucci, AA; Lowenbraun, S; Presant, CA | 1 |
Müller, J; Sitzman, FC; Wahlen, W; Windorfer, A; Winograd, B; Wündisch, G | 1 |
Creagan, ET; Dahlin, DC; Edmonson, JH; Gilchrist, GS; Green, SJ; Ivins, JC; Pritchard, DJ; Smithson, WA; Taylor, WF | 1 |
Breithaupt, H; Fischer, HP; Pralle, H; Schulz, A | 1 |
Caceres, E; de la Flor, J; Misad, O; Tejada, F; Valdivia, S; Zaharia, M; Zubrod, G | 1 |
Almanaseer, IY; Okuno, T; Taxy, JB; Trujillo, YP | 1 |
Al'tshtuller, IuB; Besova, NS; Kurkina, TV; Voznyĭ, EK | 1 |
Woźniak, W | 1 |
Gotou, M; Isu, K; Ubayama, Y; Yamaguti, H; Yamawaki, S | 1 |
Blumenschein, GR; Buzdar, AU; Distefano, A; Pinnamaneni, K; Yap, HY | 1 |
Cadman, EC; Cross, J; Glick, JH; Horton, J; Taylor, SG | 1 |
Aleksandrova, GI; Dymarskiĭ, LIu; Sanchakova, AV; Trishkina, EA | 1 |
Cserhati, MD; Groscurth, P; Hofmann, V; Honegger, HP; von Hochstetter, A | 1 |
Engel, A; Kotz, R; Kumpan, W; Lechner, G; Salzer-Kuntschik, M; Sekera, J | 1 |
Chia, KB; Chua, EJ; Khor, TH; Tan, BC | 1 |
Kofránek, I; Kraus, P; Matĕjovský, Z; Trnka, V | 1 |
Endoh, F; Hodaka, E; Ishii, T; Takada, N; Umeda, T | 1 |
Abelson, HT; Frei, E; Jaffe, N; Smith, E | 1 |
Fritsch, G; Urban, C | 1 |
Chan, KW; Duncan, CP; Knowling, MA; Morton, KS | 1 |
Burny, F; Klastersky, J; Lejeune, FJ; Otten, J | 1 |
Breithaupt, H; Küenzlen, E | 2 |
Cacavio, A; Caparros, BI; Groshen, S; Huvos, AG; Lane, JM; Marcove, RC; Nirenberg, A; Rosen, G | 1 |
Baker, L; Balcerzak, SP; Loh, K; McKelvey, E; Stephens, R; Vaughn, CB | 1 |
Bartolucci, A; Carpenter, J; Krauss, S; Lefante, J; Smalley, RV; Vogel, C | 1 |
Lange, B; Levine, AS | 1 |
Banfi, A; Bonadonna, G; Rossi, A; Tancini, G; Tess, JD; Valagussa, P | 1 |
Bacci, G; Campanacci, M; Giunti, A; Pagani, P | 1 |
Ghanta, VK; Hiramoto, RN | 1 |
Eilber, FR; Grant, TT; Mirra, JJ; Morton, DL; Weisenburger, T | 1 |
Gutjahr, P; Pontz, BF | 1 |
Kotz, R; Mutz, ID; Seewann, H; Urban, C | 1 |
Rathbun, SB; Rose-Williamson, K | 1 |
Eilber, FR | 1 |
Jentsch, E; Poppe, H; Prindull, G; Schauer, A | 1 |
Abelson, HT; Beardsley, GP; Fellows, KE; Frei, E; Goorin, A; Jaffe, N; Link, M; Vawter, G; Watts, H | 1 |
Bast, RC; Blum, RH; Canellos, GP; Frei, E; Garnick, MB; Henderson, IC; Kirkwood, JM; Mayer, RJ; Parker, LM; Pitman, SW; Skarin, AT | 1 |
Allen, JC; Horten, B; Mehta, BM; Rosen, G | 1 |
Gehan, EA; Sutow, WW | 1 |
Decker, DA; Edmonson, JH; Gilchrist, GS; Kovach, JS; Offord, JR; Taylor, WF | 1 |
Abelson, HT; Beardsley, GP; Cohen, D; Frei, E; Jaffe, N; Link, MP; Traggis, D; Watts, H | 1 |
Huvos, AG; Juergens, H; Kosloff, C; Mehta, BM; Nirenberg, A; Rosen, G | 1 |
Abelson, HT; Frei, E; Goorin, AM | 2 |
Cortes, EP; Holland, JF | 1 |
Pratt, CB | 1 |
Goto, M | 1 |
Bernstein, ID; Bleyer, WA; Chard, RL; Feigl, P; Greenlee, TK; Haas, JE; Hartmann, JR; Johnson, FL; Morgan, A; Pendergrass, TW; Schaller, RT | 1 |
Caparros, B; Caravelli, JF; Heelan, RT; Huvos, AG; Rosen, G; Smith, J; Urmacher, C | 1 |
Evans, AE; Gregg, JR; Kramer, S; Lange, B; Toledano, S; Wimmer, R | 1 |
Bang, G; Dahl, O; Engedal, H; Gøthlin, J; Lunde, OD; Mella, O | 1 |
Bertolone, SJ; Clark, LW; Hilton, MA; Kmetz, DR; Patel, CC | 1 |
Nirenberg, A; Rosen, G | 1 |
Rosen, G; Urban, C | 1 |
Lowe, J; Makin, M; Sulkes, A | 1 |
Am, YB; Brenner, HJ; Tichler, TE | 1 |
Amino, K | 1 |
Cantwell, BM; Fennelly, JJ; Jones, MP | 1 |
Brodie, GN; Fox, RM; Levi, JA; Tattersall, MH; Woods, RL | 1 |
Cregan, ET; Dahlin, DC; Edmonson, JH; Gilchrist, GS; Green, SJ; Ivins, JC; Pritchard, DJ; Smithson, WA; Taylor, WF | 1 |
Franchimont, C; Pierard, GE | 1 |
Chiari, K; Endler, T; Gabl, F; Kotz, R; Krisch, K; Leber, H; Salzer-Kuntschik, M | 1 |
Cortes, EP; Glidewell, O; Holland, JF | 1 |
Rosenberg, SA | 1 |
Gasparini, M; Lombardi, F | 1 |
Abe, M | 1 |
Brunner, KW; Gasser, AB; Tièche, M | 1 |
Brodkin, R; Cooper, MR; Howard, V; Jackson, DV; Muss, HB; Resnick, MI; Richards, F; Spurr, CL; Stuart, JJ; White, DR | 1 |
Bartolucci, AA; Lowenbraun, S; Presant, CA; Smalley, RV | 1 |
Turner, AG | 1 |
Hortobagyi, GN; Libshitz, HI | 1 |
Bekerman, C; Bitran, JD; Desser, RK | 1 |
Jones, MA; Williams, G | 1 |
Little, JB; Weichselbaum, R; West, GW | 1 |
Almasan, A; Banerjee, D; Bertino, JR; Fan, J; Hochhauser, D; Kelly, R; Li, W; Wahl, GM; Yin, Y; Zielinski, Z | 1 |
Benjamin, RS; Jaffe, N; Patel, SR | 1 |
Igawa, M; Kadena, H; Ueda, M; Usui, T | 1 |
Carpentier, AF; Chantelard, JV; Henin, D; Poisson, M | 1 |
Ho, KC; Ho, SK; Johnson, PJ; Kumta, SM; Leung, WT; Lin, J; Metreweli, C | 1 |
Bramwell, V; Mertens, WC | 1 |
Crank, S; Galasko, CS; Oliver, G; Wang, HM; Ward, CA | 1 |
Petrylak, D; Yagoda, A | 1 |
Link, MP | 1 |
Bielack, SS; Delling, G; Jürgens, H; Kotz, R; Salzer-Kuntschik, M; Winkler, K | 1 |
Krailo, M; Miser, JS | 1 |
Avella, M; Bacci, G; Casadei, R; Cazzola, A; Ferrari, S; Lari, S; Monti, C; Picci, P; Prever, BA; Ruggieri, P | 1 |
Heller, G; Meyers, PA; Vlamis, V | 1 |
Delepine, G; Delepine, N; Desbois, JC | 2 |
Contesso, G; Edeline, V; Kalifa, C; Lemerle, J; Razafindrakoto, H; Valteau, D; Vanel, D; Vassal, G | 1 |
Ekert, H; Tiedemann, K | 1 |
Göeken, LN; Kamps, WA; Molenaar, WM; Postma, A; Schraffordt Koops, H; Veth, RP | 1 |
Callans, LS; Jardines, L; Torosian, MH | 1 |
George, M; Goorin, A; Letvak, LA; Link, M; Poplack, D; Strother, D | 1 |
Kawaguchi, N; Kuroda, H; Manabe, J; Matsumoto, S; Shimoji, T | 1 |
Castiglione, M; Coates, AS; Collins, J; Gelber, RD; Goldhirsch, A; Hacking, A; Lindtner, J; Marini, G; Price, KN; Rudenstam, CM | 1 |
Hsi, SN; Kiu, MC; Lai, GM; Liaw, CC; Lu, CS; Yang, TS | 1 |
Kalifa, C; Lemerle, J; Raquin, M; Rodary, C; Tabone, MD; Valteau-Couanet, D | 1 |
al-Lamki, Z; el-Banna, N; Jaffe, N; Thomas, E | 1 |
Bacci, G; Fabbri, A; Ferrari, S; Figus, E; Longhi, C; Marchesini, G; Marchi, E; Motta, E | 1 |
Adachi, I; Fukami, A; Koyama, H; Nomura, Y; Tominaga, T | 1 |
Burgers, JM | 1 |
Higaki, S; Takeyama, S; Tateishi, A; Yamanashi, M | 1 |
Astier, A; Brun, B; Goutallier, D; Hernigou, P; le Bourgeois, JP | 1 |
Burgers, JM; Craft, AW | 1 |
Bauer, HC; Brosjö, O; Kreicbergs, A; Lindholm, J; Nilsonne, U; Silfverswärd, C; Strander, H; Szamosi, A | 1 |
Elomaa, I | 1 |
Arndt, CA; Edmonson, JH; Gilchrist, GS; Miser, JS; Pritchard, DJ; Rock, MG; Schaid, DJ; Shives, TC; Smithson, WA | 1 |
Ayass, M; Cassano, W; Dickson, N; Enneking, W; Graham-Pole, J; Heare, M; Heare, T; Marcus, R; Saleh, R; Spanier, S | 1 |
Advani, SH; Dinshaw, KA; Pande, SC; Suraiya, JN; Susnerwala, SS | 1 |
Rosen, G | 4 |
Fukaya, N; Katagiri, H; Nakanishi, K; Sato, K; Sugiura, H; Takahashi, M; Yamamura, S | 1 |
Greco, FA; Hainsworth, JD; Johnson, DH; Lamar, RE; Murphy, PB | 1 |
Chauveinc, L; Follezou, JY; Guerin, JM | 1 |
Cui, TH | 1 |
Bacci, G; Brach Del Prever, A; Casadei, R; Ferrari, S; Mancini, A; Picci, P; Tienghi, A | 1 |
Bacci, G; Brach del Prever, A; Casadei, R; Ferrari, S; Gherlinzoni, F; Mercuri, M; Monti, C; Picci, P; Ruggieri, P; Tienghi, A | 1 |
Borsi, J; Kálmánchey, R; Koós, R; Majtényi, K | 1 |
Zhou, JC | 1 |
Carlson, RW; Catolico, M; Reid, T; Yuen, A | 1 |
Borsi, JD; Koós, R; Kovács, GT; Paál, C; Schuler, D; Somló, P | 1 |
Anai, H; Furuyama, M; Ikejiri, K; Maekawa, S; Muranaka, T; Saku, M; Takeo, S; Yakabe, S | 1 |
Nakano, M; Norimatsu, H; Oka, S; Tsukamoto, T; Yoshioka, S | 1 |
Barrett, G; George, M; Jaffe, N; Jorgensen, K; Letvak, L; Robertson, R | 1 |
Liu, JQ; Wu, DW | 1 |
Filippi, C; Garbe, L; Garnier, G; Gratecos, N; Michiels, JF; Pesce, A; Poitou, G; Rosenthal, E; Taillan, B; Vinti, H | 1 |
Ehlinger, P; Fossion, E; Peeters, LC; Servais, J | 1 |
Cho, KJ; Jang, JJ; Jeon, DG; Kim, SS; Lee, SY | 1 |
Avidor, I; Cohen, IJ; Goshen, Y; Kaplinsky, C; Katz, K; Mor, C; Yaniv, Y; Yosipovitch, Z; Zaizov, R | 1 |
Kotz, R; Mader, RM; Proprentner, R; Rainer, H; Rizovski, B; Steger, GG | 1 |
Avella, M; Figus, E; Gnudi, S; Ripamonti, C | 1 |
Blumenstein, BA; Boileau, M; Crawford, ED; Fletcher, WS; Rivkin, SE; Wozniak, AJ | 1 |
Couthon, HM; Hosain, F; Spencer, RP; Sturtz, GL | 1 |
Beaufort-Krol, GC; Bink-Boelkens, MT; Elzenga, NJ; Kamps, WA; Kengen, RA; Postma, A; Schasfoort-van Leeuwen, MJ; Schraffordt koops, H | 1 |
Al-Lamki, Z; Jaffe, N; Pearson, P | 1 |
Bessis, D; Guilhou, JJ; Hellier, I; Margueritte, G; Sotto, A | 1 |
Ham, SJ; Hoekstra, HJ; Kamps, WA; Molenaar, WM; Schraffordt Koops, H; van der Graaf, WT | 2 |
Butenko, AK; Glukhovskaia, IIu; Konovalenko, VF; Tolstopiatov, BA | 1 |
Goorin, A; Hallowell, JA; Kharasch, VS; Lipsitz, S; Santis, W | 1 |
Maestri, A; Malacarne, P | 1 |
Cleary, ML; Davis, RE; Kamel, OW; Soslow, RA; Warnke, RA | 1 |
Marcove, RC | 2 |
DiPaola, RS; Kaufman, A; Mikhail, MM | 1 |
Aoki, M; Hino, M; Honoki, K; Kido, A; Mii, Y; Miura, S; Miyauchi, Y; Morishita, T; Nakanishi, E; Nomura, Y; Tamai, S | 1 |
Amaya, J; Aymerich, ML; Calvo, M; Maldonado, S; Muñoz Villa, A; Ocete, G; Otheo, E | 1 |
Bacci, G; Bertoni, F; Comandone, A; Ferrari, S; Ferraro, A; Mercuri, M; Picci, P; Ruggieri, P; Tella, G | 1 |
Purdy, MH | 1 |
Spencer, RP | 1 |
Body, JJ | 1 |
Crank, S; Galasko, CS; Oliver, G; Wang, HM | 1 |
Hetzel, DJ; Mortel, R; Olt, GJ; Podczaski, ES; Singapuri, K; Sorosky, JI | 1 |
Bacci, G; Delepine, G; Delepine, N; Desbois, JC; Rosen, G | 1 |
Barisone, E; Brach Del Prever, A; Leone, L; Miniero, R; Ridolfi, L; Vivalda, M; Vivenza, C | 1 |
Fujimoto, T | 1 |
Bacci, G; Cazzola, A; Ferrari, S; Gherlinzoni, F; Iantorno, D; Picci, P; Zolezzi, C | 1 |
Baum, ES; Betcher, DL; Ettinger, LJ; Huvos, AG; Kisker, CT; Krailo, MD; Makley, JT; Miser, JS; Nachman, JB; Provisor, AJ; Yunis, EJ | 1 |
Araki, N; Myoui, A; Shinto, Y; Uchida, A; Ueda, T; Yoshikawa, H | 1 |
Connolly, LP; Ecklund, K; Goorin, AM; Jaramillo, D; Laor, T | 1 |
al Mahr, M; Hughes, DO; Lee, DB; Leung, S; Marshall, GM; Tobias, V | 1 |
Alvegård, TA; Björk, O; Elomaa, I; Saeter, G; Solheim, OP; Strander, H; Wiebe, T | 1 |
Hamada, M; Inoue, H; Kawai, A; Kunisada, T; Sugihara, S | 1 |
Leo, E; Lindemann, A; Schlegel, PG | 1 |
Alexandre, J; Brain, E; Minozzi, C; Misset, JL | 1 |
Clifton-Bligh, P; Jackson, C; Laurent, MR; Mason, RS; Preston, SJ | 1 |
Beron, G; Bielack, SS; Winkler, K | 1 |
Dahrouge, S; Stewart, DJ | 1 |
Bacci, G; Bertoni, F; Campanacci, M; Cesari, M; Ferrari, S; Forni, C; Gasbarrini, A; Mercuri, M; Sottili, S; Tienghi, A | 1 |
Cefalo, G; Ferrari, A; Fossati-Bellani, F; Gianni, MC; Lombardi, F; Massimino, M; Tesoro-Tess, JD | 1 |
Andersen, A; Bruland, OS; Ekstrøm, PO; Giercksky, KE; Slørdal, L | 1 |
Glukhovskaia, IIu | 1 |
Bacci, G; Ferrari, S; Mercuri, M; Picci, P | 1 |
Kamei, M; Kawabata, H; Matsuda, K; Nishioka, M; Sasahara, K; Uchida, Y | 1 |
Bacchini, P; Bacci, G; Bertoni, F; Brach del Prever, A; Campanacci, M; Comandone, A; Delepine, N; Ferrari, S; Mercuri, M; Picci, P; Tienghi, A | 1 |
Bruland, OS; Pihl, A | 1 |
Itokazu, M; Katagiri, Y; Ohno, T; Sugiyama, T; Wada, E | 1 |
Bacci, G; Bernini, G; Brach del Prever, A; Capanna, R; Cesari, M; Comandone, A; Ferrari, S; Longhi, A; Mercuri, M; Picci, P; Tienghi, A | 1 |
Koshino, T; Saito, T; Takagi, T; Yoshida, K | 1 |
Abeloff, MD; Cummings, FJ; Falkson, G; Gelman, RS; Osborne, CK; Pandya, KJ; Sledge, GW; Tormey, D | 1 |
Constine, LS; Hicks, DG; O'Keefe, R; Packman, CH; Rapoport, AP; Rosier, RN; Rowe, JM; Rubin, SJ | 1 |
Gusta, A; Król, R | 1 |
Casper, E; Gorlick, R; Healey, JH; Heller, G; Huvos, AG; Lane, J; Meyers, PA | 1 |
Lyn, BE; Mahendra, P; McMillan, AM; Shaw, B; Somers, LJ | 1 |
Alvegård, TA; Elomaa, I; Monge, OR; Nilbert, M; Saeter, G; Wiebe, T | 1 |
Balme, B; Besançon, C; Devaux, Y; Pincemaille, B; Thomas, L | 1 |
Horiuchi, S; Negishi, T; Tsukamoto, T; Urushibara, M | 1 |
Aronson, J; Jarka, DE; Nicholas, RW | 1 |
Brunat-Mentigny, M; Cochat, P; Dubourg, L; Hadj-Aïssa, A; Koch Nogueira, PC; Schell, M | 1 |
Bielack, SS; Bieling, P; Delling, G; Epler, D; Fuchs, N; Graf, N; Heise, U; Jürgens, H; Körholz, D; Kotz, R; Salzer-Kuntschik, M; Weinel, P; Werner, M; Winkler, K | 1 |
Ayala, A; Ferguson, WS; Gieser, P; Goorin, AM; Harris, MB; Holbrook, T; Link, MP; Shochat, SJ | 1 |
Albino, AP; Devaney, K; Glantz, L; Healey, JH; Mak, S; Schwartz, GK; Terek, RM | 1 |
Enneking, WF; Lindner, NJ; Scarborough, MT; Spanier, SS | 1 |
Amigo-Ferreiro, ME; Bonnay, M; Grill, J; Hartmann, O; Schoepfer, C; Valteau-Couanet, D; Vassal, G | 1 |
Bailey, CC; Gattamaneni, HR; Lashford, LS; Lewis, IJ; Michelagnoli, MP | 1 |
Bacci, G; Cesari, M; Fasano, MC; Ferrari, S; Lamanna, G; Zolezzi, C | 1 |
Iqbal, MP | 1 |
Flombaum, CD; Meyers, PA | 1 |
Hoare, D; Leonard, P; Whelan, J | 1 |
Cohen, IJ; Katz, K; Kidron, D; Meller, I; Tomer, G; Yosipovitch, Z; Zaizov, R | 1 |
Alvegård, TA; Brosjö, O; Engström, K; Follerås, G; Forestier, E; Holmström, T; Monge, O; Saeter, G; Stenwig, AE; Strander, H; Wahlqvist, Y; Wiebe, T; Wiklund, T; Willén, H | 1 |
Ashihara, T; Hashiguchi, S; Hirasawa, Y; Hirata, M; Kusuzaki, K; Murata, H; Takeshita, H | 1 |
Fukuda, K; Kim, YH; Kitano, H; Kokufu, I; Taniguchi, H; Yamada, K; Yamamoto, M; Yano, T | 2 |
Nasu, K; Nishimura, M; Ohta, H; Shintaku, M; Takahashi, Y | 1 |
Babin-Boilletot, A; Brunat-Mentigny, M; Kalifa, C; Mahmoud, HH; Pacquement, H; Schmitt, C; Tabone, MD; Terrier, P | 1 |
Blay, JY; Brunat-Mentigny, M; Chauvin, F; Demaille, MC; Gentet, JC; Iliescu, C; Krakowski, I; Pacquement, H; Philip, T; Soler-Michel, P; Thiesse, P | 1 |
Aparicio, J; Garcerá, S; Montalar, J; Munárriz, B; Oltra, A; Pastor, M; Santaballa, A; Segura, A; Yuste, A | 1 |
Galloway, M; MacLeod, D; Sheaff, M; Wedzicha, J | 1 |
Horiuchi, R; Shinozaki, T; Takagishi, K; Tomidokoro, R; Watanabe, H; Yamamoto, K | 1 |
Ben Abdallah, M; Ben Ayed, F; Ben Ghachem, M; Ben Hamida, H; Ben Hassine, H; Ben Romdhane, K; Boussen, H; Daldoul, O; Douik, M; Gamoudi, A; Karray, S; Khalfallah, S; Mezlini, A; Mezzi, F; Saadi, A | 1 |
Debatin, KM; Ewerbeck, V; Fellenberg, J; Mau, H; Nedel, S | 1 |
Boruczkowski, D; Chybicka, A; Gołebiowski, W; Jaworski, W; Katski, K; Kazanowska, B; Kowalczyk, J; Kołecki, P; Leda, M; Liebhart, M; Wecławek-Tompol, J; Woźniak, W | 1 |
Król, R; Pankowski, J; Uciński, R; Waloszczyk, P | 1 |
Decker, S; Nies, B; van Valen, F; Winkelmann, W | 1 |
Hanioka, K; Hayashi, Y; Kizaki, T; Marui, T; Minami, R; Mizuno, K; Yamamoto, T | 1 |
Ben Arush, MW; Ben-Barak, A; Elhasid, R; Levin, K; Postovsky, S | 1 |
Bacci, G; Bertoni, F; Campanacci, M; Casadei, R; Fabbri, N; Ferrari, S; Forni, C; Longhi, A; Picci, P; Ruggieri, P; Versari, M | 1 |
Craft, AW; Lewis, IJ; Machin, D; Stark, D; Weeden, S | 1 |
Krege, S; Otto, T; Rübben, H; Suhr, J | 1 |
Bacci, G; Bertoni, F; Fabbri, N; Ferrari, S; Forni, C; Longhi, A; Versari, M; Zavatta, M | 1 |
Bacchini, P; Bacci, G; Bertoni, F; De Giorgi, U; Ferrari, S; Fiorentini, G; Forni, C; Longhi, A; Mercuri, M; Picci, P; Rimondini, S; Tienghi, A | 1 |
Gebski, V; Machin, D; Tai, BC; White, I | 1 |
Goto, E; Okamoto, I; Tanaka, K; Tomojiri, S | 1 |
Bacchini, P; Bacci, G; Bertoni, F; Campanacci, L; Campanacci, M; Donati, D; Ferrari, S; Forni, C; Longhi, A; Picci, P | 1 |
Bacci, G; Bernini, G; Biagini, R; Briccoli, A; Capanna, R; Donati, D; Fabbri, N; Ferrari, S; Longhi, A; Versari, M | 1 |
Abe, S; Ganev, GG; Nakano, H; Ogawa, K; Tateishi, A | 1 |
Auvrignon, A; Dalle, JH; Kalifa, C; Leverger, G; Vassal, G | 1 |
Hannequin, JR; Nonnenmacher, J; Offner, C; Simon, P | 1 |
Horie, H; Kinugawa, N; Okimoto, Y; Sakao, E; Teraoka, N | 1 |
Berend, KR; Dibernardo, L; Harrelson, JM; Moore, JO; Pietrobon, R; Scully, SP | 1 |
Chowbay, B; Siong, KK | 1 |
Kim, HS; Lee, SH; Oh, JH; Park, YB; Yoo, KH | 1 |
Hu, Y; Lei, S; Mao, Y; Pei, F; Wei, Y; Zeng, J | 1 |
Blum, R; Seymour, JF; Toner, G | 1 |
Takahashi, M; Yamada, K; Yoshida, M | 1 |
Hisada, T; Ito, T; Masuda, S; Mochida, A; Morinari, H; Nakahara, K; Nishi, K; Saito, K; Sasaki, S; Tahara, M; Yakumaru, K | 1 |
Auvrignon, A; Dalle, JH; Leverger, G; Vassal, G | 1 |
Day, M; Edwards, AO; Leavey, PJ; Weinberg, A | 1 |
Alvegard, TA; Bacci, G; Briccoli, A; Donati, D; Ferrari, S; Forni, C; Lari, S; Longhi, A; Manfrini, M; Mercuri, M; Picci, P; Saeter, G | 1 |
Boruczkowski, D; Chybicka, A; Gołebiowski, W; Jaworski, W; Katski, K; Kazanowska, B; Kijowski, J; Kowalczyk, J; Kołecki, P; Leda, M; Liebhart, M; Wecławek-Tompol, J; Woźniak, W | 1 |
Hauben, EI; Hogendoorn, PC; Pringle, J; Van Marck, EA; Weeden, S | 1 |
Douglass, HO; Friedman, M; Mindell, E; Takita, H; Wallace, HJ; Wang, J | 1 |
Bender, RA; Strayer, DR | 1 |
Arbes, H; Kotz, R; Leber, H; Ramach, W; Wolf, A | 1 |
Kubanek, B; Schreml, W | 1 |
Caparros, B; Huvos, AG; Kosloff, C; Marcove, RC; Nirenberg, A; Rosen, G | 1 |
Elias, K | 1 |
Becker, KL; Doppman, JL; Primack, A; Silva, OL; Snider, RH | 1 |
Billings, A; Bitran, JD; Colman, M; DeMeester, TR; Desser, RK; Evans, R; Golomb, HM; Griem, M; Rubenstein, L; Shapiro, C | 1 |
Eveloff, AR; Lascari, AD | 1 |
Kotz, D; Krisch, K; Mehta, BM | 1 |
Jenkin, RD | 2 |
Austin, EH; Drake, J; Goldberg, NH; Romolo, JL; Rosenberg, SA | 1 |
Etcubanas, E; Giritsky, AS; Mark, JB | 1 |
Janka, G | 1 |
Bohndorf, W | 1 |
Kotz, R | 1 |
Conkle, D; Flye, MW; Levine, AS; Rosenburg, SA; Seipp, CA; Simon, RM | 1 |
Breur, K; van der Schueren, E | 1 |
Huvos, AG; Marcove, RC; Rosen, G | 1 |
Frei, E; Jaffe, N; Traggis, D; Watts, H | 2 |
Hustu, O; Kumar, AP; Pratt, C; Rivera, G; Shanks, E; Smith, J | 1 |
Cassady, RJ; Filler, RM; Jaffe, N; Murray, J; Traggis, D; Watts, H; Weichselbaum, R; Weinstein, H | 1 |
Pratt, CB; Rivera, G; Shanks, E | 1 |
Arwidi, A; Lindholm, CE; Mattsson, W; von Eyben, F | 1 |
Miller, TR | 1 |
Goldberg, NH; Hande, KR; Romolo, JL; Rosenberg, SA | 1 |
Delling, G; Gaedicke, G; Grosch-Wörner, I; Landbeck, G; Marsmann, G; Winkler, K | 1 |
Huvos, AG; Marroum, MC; Rosen, G | 1 |
Bender, RA; Louie, AC; Muggia, FM; Rozencweig, M; Von Hoff, DD | 1 |
Sauer, H; Wilmanns, W | 1 |
Fink, U; Lindner, H; von Gumppenberg, S | 1 |
Mills, EE | 1 |
Allen, JC; Rosen, G | 1 |
Cotter, SM; Parker, LM | 1 |
Chabner, BA; Costa, J; Hanson, TA; Head, GC; Levine, AS; Rosenburg, SA; Seipp, CA; Simon, RM; Young, RC | 1 |
Bidlingmaier, F; Haas, RJ; Janka, GE; Wiesner, H | 1 |
Herson, J; Perez, C; Sutow, WW; Wang, YM | 1 |
Barker, LF; Crom, WR; Evans, WE; Pratt, CB; Taylor, RH | 1 |
Bartolucci, A; Carpenter, J; Krauss, S; Smalley, RV; Vogel, C | 1 |
Tashchiev, RK; Voinov, EA | 1 |
Meuret, G | 1 |
Eilber, FR; Grant, T; Morton, DL | 1 |
Fellows, KE; Jaffe, N; Vawter, G; Watts, H | 1 |
Appelbaum, FR; Graw, RG; Levine, AS; Magrath, IT; Pizzo, PA; Poplack, DG; Ziegler, JL | 1 |
George, S; Green, AA; Kumar, AP; Pratt, CB; Rivera, G; Shanks, E | 1 |
Etcubanas, E; Wilbur, JR | 1 |
Edmonson, JM; Gilchrist, GS; Ivins, JC; Pritchard, DJ; Ritts, RE; Taylor, WF | 1 |
Bacci, G; Campanacci, M; Pagani, P; Picci, P | 1 |
Chabora, BM; Rosen, G; Tefft, M | 1 |
Chang, P | 1 |
Jaffe, N; Strieder, DJ; Wall, MA; Wohl, ME | 1 |
Oster, MW | 1 |
Blumenschein, GR; Bodey, GP; Buzdar, AU; Freireich, EJ; Gehan, EA; Hortobagyi, GN; Legha, SS; Smith, TL; Swenerton, KD | 1 |
Biran, S; Brufman, G; Schächner, E | 1 |
Broggini, M; Colombo, T; Donelli, MG; Garattini, S | 1 |
Bloom, HJ; Hendry, WF; Turner, AG; Williams, GB | 1 |
Bainvel, JV; Brossel, E; Dumont, J; Durant, D; Fumoleau, P; Garetta, M; Gimenez, M; Guerrin, D; Hoerni, B; Jasmin, C; Kenesi, C; Le Mevel, BP; Liegey-Bagari, D; Mazabraud, A; Rogez, JM; Salle, M; Sancho-Garnier, H; Tomend, B; Trifaud, A | 1 |
Frei, E | 1 |
Fudenberg, HH | 1 |
Ivins, JC; Pritchard, DJ | 1 |
Israel, L | 1 |
Campbell, CJ; Cohen, J; Enneking, WF | 1 |
Bacci, G; Cagnano, R; Donati, U; Figus, E; Pagani, PA | 1 |
Mindell, ER; Sinks, LF | 1 |
Burchenal, J; D'angio, G; Exelby, P; Fang, S; Lieberman, P; Murphy, ML; Wollner, N | 1 |
Chabner, BA; Jacobs, SA; Johns, DG; Stoller, RG | 1 |
AKAHOSHI, Y; Chen, SH; Kikuike, A; Nishimoto, T; Takeuchi, S; Yamamuro, T; Yonezawa, H | 1 |
Green, AA; Pratt, C; Smith, K; Webster, RG | 1 |
Sweetnam, R | 1 |
Bacci, G; Donati, U; Pagani, PA | 1 |
Beattie, EJ; Marcove, R; Murphy, ML; Rosen, G; Sanmaneechai, A; Tan, C | 1 |
Price, CH | 1 |
Marcove, RC; Martini, N; Rosen, G | 1 |
Block, JB; Eiber, FR; Forster, T; Isacoff, WH; Morton, DL; Townsend, CM | 1 |
Bleehen, NM | 1 |
Cassady, JR; Filler, RM; Frei, E; Jaffe, N; Traggis, D; Watts, H | 1 |
Gilchrist, GS; Ivins, JC; Miller, GC; Pritchard, DJ; Ritts, RE; Taylor, WF | 1 |
Carter, SK; Handelsman, H | 1 |
Bergsagel, DE; Librach, SL; Ogawa, M | 1 |
Bruntsch, U; Gallmeier, WM; Schmidt, CG | 1 |
Alexander, JL; Edelstyn, GA; Gillespie, PJ | 1 |
Catalano, RB; Creech, RH; Engstrom, PF; Mastrangelo, MJ | 1 |
Bonadonna, G; Brambilla, C; De Lena, M; Morabito, A | 1 |
Johnson, RE; Pomeroy, TC | 1 |
Bacci, G; Cagnano, R; Figus, E; Orlandi, G; Pagani, PA | 1 |
Canellos, GP; Chabner, BA; DeVita, VT; Gold, GL; Schein, PS; Young, RC | 2 |
Bonadonna, G; Brambilla, C; De Lena, M; Rossi, A; Valagussa, P | 1 |
Ibuka, T; Imai, K; Ishiwata, J; Kobayashi, T; Monma, K; Ohno, T; Onozawa, Y; Sakaki, N; Sasaki, T; Tabata, I | 1 |
Hirano, T; Iwasaki, K; Kumashiro, T; Sadamatsu, T | 1 |
Applewhite, A; Healey, J; Heller, G; Huvos, A; Lane, J; Marcove, R; Meyers, PA; Rosen, G; Vlamis, V | 1 |
Baur, M; Chott, A; Fortelny, A; Hanak, H; Heinz, R; Kreiner, G; Marosi, C; Radaszkiewicz, T; Schwarzinger, I; Steger, G | 1 |
Charpentier, A; de Baere, T; di Paola, M; Shapeero, LG; Terrier, P; Vanel, D | 1 |
Gutjahr, P; Reitz, M | 1 |
Baba, H; Tomita, K; Tsuchiya, H; Ueda, Y; Yasutake, H; Yokogawa, A | 1 |
Avella, M; Bacci, G; Battistini, A; Brach del Prevert, A; Casadei, R; Ferrari, S; Mancini, A; Picci, P; Ruggieri, P; Tienghi, A | 1 |
Doz, F; Michon, J; Pacquement, H; Quintana, E; Zucker, JM | 1 |
Berthau, N; Courpied, JP; Coutant, M; Daugu, M; Dorval, T; Forest, M; Palangie, T; Pouillart, P; Tomeno, B | 1 |
Amar, D; Barst, SM; McDowall, RH; Scher, CS | 1 |
Dean, R; Lorenzana, AN; Nachman, J | 1 |
Fairclough, DL; Fletcher, BD; Hanna, SL; Le, AH; Meyer, WH; Parham, DM | 1 |
Avella, M; Bacci, G; Caldora, P; Ferrari, S; Ferraro, A; Orlandi, M; Ravazzolo, G | 1 |
Alvegård, TA; Elomaa, I; Saeter, G; Solheim, OP | 1 |
Blomqvist, C; Elomaa, I; Holmström, T; Karaharju, E; Laasonen, E; Ryöppy, S; Siimes, MA | 1 |
Atanacković, M; Barjaktarević, Z; Bekić, Z; Munjas, N; Sbutega, B | 1 |
Eldridge, RM; Fleming, RA; Johnson, CE; Stewart, CF | 1 |
Glasser, DB; Lane, JM | 1 |
Bielack, S; Bieling, P; Delling, G; Dose, C; Jürgens, H; Kotz, R; Ritter, J; Salzer-Kuntschik, M; Winkler, K | 1 |
Alvegård, TA; Elomaa, I; Holmström, T; Saeter, G; Solheim, OP; Stenwig, AE | 1 |
Kawada, Y; Kobayashi, S; Kuriyama, M; Nagatani, Y; Shinoda, I; Takahashi, Y; Takeuchi, T | 1 |
Jurczyk-Procyk, S; Perek, D | 1 |
Hovi, L; Saarinen, UM; Sariola, H | 1 |
Bissett, D; Kaye, SB; Kerr, DJ | 1 |
Dobroskok, LB; Korman, DB; Maslova, IA; Mikaélian, SG; Pines, EV; Snimshchikov, VA | 1 |
Ferrari, AM; Marsden, FW; McCarthy, SW; Stephens, FO | 1 |
Kotz, R; Kropej, D; Ritschl, P; Salzer-Kuntschik, M; Schiller, C | 1 |
Figueiredo, MT; Gentil, FC; Lopes, A; Penna, V; Petrilli, S | 1 |
Fujinami, S; Miura, T; Ogihara, Y; Sato, K; Sudo, A | 1 |
Avella, M; Bacci, G; Dallari, D; De Cristofaro, R; Ferruzzi, A; Manfrini, M; Marangolo, M; Mercuri, M; Picci, P; Pignatti, G | 1 |
Bacchini, P; Bacci, G; Bertoni, F; Capanna, R; Dallari, D; Picci, P; Pignatti, G | 1 |
Cserhati, MD; Exner, GU; Groscurth, P; Honegger, HP; von Hochstetter, A | 1 |
Camitta, B; Dunn, D; Murray, K; Segura, A; Unni, KK; Wells, R | 1 |
Affronti, ML; Bast, RC; Eggleston, S; Johnston, C; Jones, RB; Rosner, GL; Ross, M; Shpall, EJ; Tepperburg, M; Vandermark, R | 1 |
Geller, NL; Penenberg, D; Scher, H; Sternberg, CN; Yagoda, A | 1 |
Cornille, H; Delépine, G; Delépine, N; Desbois, JC; Jasmin, C | 1 |
Campanacci, M; Cascinelli, N; Picci, P; Santinami, M; Vaglini, M | 1 |
Fiorentini, G; Graziani, G; Molinari, M; Priori, T; Tienghi, A | 1 |
Bielack, S; Delling, G; Erttmann, R; Greenshaw, C; Jürgens, H; Kotz, R; Kusnierz-Glaz, C; Ritter, J; Salzer-Kuntschik, M; Winkler, K | 1 |
Chernichenko, VA; Konovalenko, VF; Monich, AIu; Palivets, AIu; Tolstopiatov, BA | 1 |
Avella, M; Bacci, G; Biagini, R; Caldora, P; Campanacci, M; Casadei, R; Ferruzzi, A; Picci, P; Ruggieri, P | 1 |
Kuzuya, T; Miura, T; Mizuno, M; Nakanishi, K; Sato, K; Sato, T; Takahashi, M | 1 |
Isii, S; Isu, K; Takeda, N; Ubayama, Y; Usui, M; Yagi, T; Yamawaki, S | 1 |
Sato, K; Watanabe, M; Yanagisawa, M | 1 |
Avella, M; Bacci, G; Brach Del Prever, A; Capanna, R; Gherlinzoni, F; Mancini, A; Mercuri, M; Padovani, G; Picci, P; Ruggieri, P | 1 |
Avella, M; Bacci, G; Caldora, P; Dallari, D; Di Scioscio, M; Ferrari, S; Malaguti, C; Picci, P; Prasad, R | 1 |
Eremina, LA; Fedenko, AN; Manziuk, LV; Moldovanova, LK; Perevodchikova, NI; Singin, AS; Siniukov, PA | 1 |
Igawa, M; Ohkuchi, T; Okada, K; Ueda, M; Ueki, T; Usui, T | 1 |
Delling, G; Hajek, P; Kotz, R; Kumpan, W; Lechner, G; Salzer-Kuntschik, M; Sekera, J; Wittich, GR | 1 |
Huvos, AG; Marcove, R; Nirenberg, A; Rosen, G | 1 |
Dawson, P; Dean, L; Nachman, J; Shermeta, D; Simon, MA; Vogelzang, NJ | 1 |
Bauters, F; Fenaux, P; Jouet, JP; Lai, JL; Lepelley, P | 1 |
Berger, J; Beron, G; Delling, G; Gerein, V; Heise, U; Jürgens, H; Kabisch, H; Purfürst, C; Ritter, J; Winkler, K | 1 |
Bachelot, C; Boitetot, A; Brunat-Mentigny, M; Demaille, MC; Gentet, JC; Noir, P; Olive, D; Quitana, E; Roche, H; Thyss, JP | 1 |
Contesso, G; Dubousset, J; Kalifa, C; Lumbroso, J; Mlika, N; Vanel, D | 1 |
Bielack, S; Delling, G; Knop, J; Winkler, K | 1 |
Beppu, Y; Chuman, H; Fukuma, H | 1 |
Baranzelli, MC; Bouretz, JC; Demaille, MC; Dusol, F; Gosselin, P | 1 |
Irie, G; Kamada, T; Matsuoka, Y; Takamura, A; Tsuji, H; Tsujii, H; Usubuchi, H | 1 |
Iqbal, MP; Khursheed, M; Mahboobali, N | 1 |
Chuman, H; Shinohara, N; Yokoyama, K | 1 |
Kramer, ED; Lewis, D; Packer, RJ; Raney, B; Womer, R | 1 |
Benoit, J; Delepine, G; Goutallier, D; Hagege, G; Hernigou, P; Leroux, P; Thiéry, JP; Voisin, MC | 1 |
Ciminari, R; Pelotti, P; Rimondi, E | 1 |
Alkallaf, S; Astier, A; Cornille, H; Delepine, G; Delepine, N; Desbois, JC | 1 |
Nomura, S; Tomita, K; Tsuchiya, H | 1 |
Amino, K; Kawaguchi, N; Machida, M; Manabe, J; Matsumoto, S; Tabata, D | 1 |
Bozdĕch, Z; Cerný, J; Janecek, M; Kiss, I; Sklenský, M | 1 |
Bertolone, S; Hilton, MA; Patel, CC | 1 |
Kickinger, W; Kotz, R; Ritschl, P | 1 |
Hoekstra, HJ; Hogeboom, WR; Mooyaart, EL; Oosterhuis, JW; Postma, A; Schraffordt Koops, H; Veth, RP | 1 |
Bander, N; Geller, N; Herr, HW; Morse, MJ; Scher, HI; Sogani, PC; Sternberg, CN; Vaughan, ED; Watson, RC; Yagoda, A | 1 |
Gill, M; McCarthy, M; Murrells, T; Silcocks, P | 1 |
Beauchamp, CP; Chan, KW; Knowling, M | 1 |
Tateishi, A | 1 |
Abe, K; Adachi, I; Suzuki, M; Tsuchihashi, T; Yamaguchi, K | 1 |
den Heeten, GJ; Kamps, WA; Oldhoff, J; Oosterhuis, JW; Schraffordt Koops, H; Sleijfer, DT | 1 |
Amino, K; Ishii, Y; Kawaguchi, N; Machida, M; Manabe, J; Matsumoto, S; Tabata, D | 1 |
Houghton, JA; Houghton, PJ; Meyer, WH | 1 |
Albisinni, U; Bacci, G; Biagini, R; Capanna, R; Galletti, S; Manfrini, M; Picci, P; Pignatti, G | 1 |
Baranzelli, MC; Bouretz, JC; Cazin, JL; Debeugny, P; Demaille, MC; Gosselin, P; Lecomte-Houcke, M | 1 |
Avella, M; Bacci, G; Brach Del Prevert, A; Campanacci, M; Capanna, R; Fiorentini, G; Malaguti, C; Picci, P; Rosito, P | 1 |
Cornille, H; Delepine, G; Delepine, N; Desbois, JC; Jasmin, C; Mathé, G | 1 |
Gotch, M; Isu, K; Matsuno, T; Nojima, T; Sasaki, T; Ubayama, Y; Yagi, T; Yamaguchi, H; Yamawaki, S | 1 |
Avella, M; Bacci, G; Butturini, L; Gnudi, S; Ripamonti, C | 1 |
Avella, M; Bacci, G; Boriani, S; Capanna, R; Dallari, D; Galletti, S; Giunti, A; Madon, E; Mancini, A; Mercuri, M | 1 |
Amiraslanov, AT; Eremina, LA; Fedenko, AN; Manziuk, LV; Trapeznikov, NN | 1 |
Barnes, L; Baum, E; Bleyer, WA; Ertel, I; Fryer, CJ; Hammond, GD; Krailo, M; Makley, J; Weetman, R; Yunis, E | 1 |
Adachi, N; Fukuma, H; Hanada, M; Ohira, M; Takayama, J | 1 |
Hijiya, N; Ise, T; Kanagawa, S; Kitabayashi, T; Matsushita, T; Yamaguchi, M | 1 |
Baum, ES; Bleyer, WA; Ertel, IJ; Fryer, CJ; Hammond, GD; Krailo, M; Makley, JT; Weetman, RM; Yunis, EJ | 1 |
Cortes Funes, H; Mouridsen, HT; Mulder, JH; Somers, R; Sylvester, R; Thomas, D; van Oosterom, AT; Wagener, DJ | 1 |
Bacci, G; Campanacci, M; Gherlinzoni, F; Manfrini, M; Normand, AR; Orlandi, M; Picci, P; Pignatti, G; Van Horn, JR | 1 |
Koczorek, GE; Schalhorn, A; Wilmanns, W | 1 |
Yamawaki, S | 1 |
Tomita, K; Yokogawa, A | 1 |
Brenes-Sáenz, A; García, I; Lobo-Sanahuja, F; Orlich, F; Vargas, G | 1 |
Feurer, EJ; Harris, MB; Johnson, J; Jones, R; Lahman, E; Lewis, M; Sherry, H; Weiner, MA | 1 |
Gasparini, M; Roncoroni, I; Rottoli, L; Tondini, C | 1 |
Furuse, K; Maeyama, I; Morimoto, K; Okuno, M; Orito, T | 1 |
Higaki, S; Takeyama, S; Tateishi, A | 1 |
Andersen, JW; Delorey, MJ; Frei, E; Gebhardt, M; Goorin, AM; Jaffe, N; Link, M; Perez-Atayde, A; Watts, H; Wilkinson, RH | 1 |
Enomoto, K; Fujimoto, K; Isobe, H; Kikuchi, M; Morioka, E; Niho, Y; Okamura, S; Shibuya, T; Yokota, E | 1 |
Delling, G; Dingeldein, E; Jungbluth, KH; Langendorff, HU; Senokowitsch, R; Wahlig, H | 1 |
Ariyoshi, H; Harushita, I; Kurita, S; Shinohara, N; Yokoyama, K | 1 |
Harnett, AN; Plowman, PN | 1 |
Bennett, CL; Bitran, JD; Kalokhe, U; Karesh, J; Putterman, A; Recant, W; Shapiro, CM | 1 |
Fujimoto, T; Hara, K; Matsuoka, H; Murakami, T; Niwa, J; Sasaki, K; Sawai, K; Takayanagi, F | 1 |
Tomita, K | 1 |
Ayala, A; Cangir, A; Carrasco, H; Eftekhari, F; Jaffe, N; Raymond, K; Robertson, R; Spears, R; Takaue, Y; Wallace, S | 1 |
Fujii, Y; Hongo, T; Horikoshi, Y; Ichimura, M; Igarashi, Y; Mizuno, Y; Sugie, H; Sugie, Y | 1 |
Bacci, G; Biagini, R; Capanna, R; Gherlinzoni, F; Guerra, A; Jaffe, N; Picci, P; Ruggieri, P; Toni, A; Van Horn, JR | 1 |
Goto, M; Ishii, S; Isu, K; Kobayash, M; Sasaki, T; Ubayama, Y; Usui, M; Yagi, T; Yamawaki, S | 1 |
Kelaridis, T; Pongracz, N; Ritschl, P | 1 |
Bruner, J; Fields, WS; Glass, JP; Lee, YY | 1 |
Flynn, BM; Treves, ST | 1 |
Aisner, J; Ginsberg, S; Holland, JF; Korzun, A; Perloff, M; Perry, M; Weinberg, V; Weiss, R | 1 |
Dabag, S; Rieche, K; Scharlau, L | 1 |
Aplevich, NN; Gritsaĭ, AA; Kondrat'eva, AP; Lichinitser, MR; Vyshinskaia, GV | 1 |
Biran, S; Catane, R; Gez, E; Isacson, R; Pfeffer, MR; Sulkes, A | 1 |
Cohen, SC; Gregory, EJ; Mims, CH; Oines, DW | 1 |
Cohen, MD; Mail, JT; Mirkin, LD; Provisor, AJ | 1 |
Ayala, A; Cangir, A; Carrasco, H; Eftekhari, F; Jaffe, N; Robertson, R; Takaue, Y; Wallace, S; Wang, A | 1 |
Anzai, T; Ayala, A; Cangir, A; Chen, T; Chuang, V; Jaffe, N; Robertson, R; Wallace, S; Wang, YM | 1 |
Anzai, T; Jaffe, N; Robertson, R; Takaue, Y | 1 |
Freiha, FS; Hannigan, J; Harker, EG; McWhirter, K; Meyers, FJ; Palmer, JM; Shortliffe, LD; Torti, FM | 1 |
Kalifa, C; Lemerle, J; Vanel, D | 1 |
Gritsaĭ, AA; Kondrat'eva, AP; Lichinitser, MR; Luk'ianchenko, AB; Vyshinskaia, GV | 1 |
Andreola, S; Attili, A; Belli, F; Cascinelli, N; Marolda, R; Nava, M; Prada, A; Santinami, M; Vaglini, M | 1 |
Furuse, K; Maeyama, I; Morimoto, K; Orito, T | 1 |
Case, D; Cooper, MR; Muss, HB; Nelson, EC; Pope, E; Puckett, JB; Resnick, MI; Richards, F; Spurr, CL; Zekan, P | 1 |
Brunat, M; Dargent, M; Pommatau, E | 1 |
Fromer, JL; Jaffe, N | 1 |
Cassady, JR; Das, L; Djerassi, I; Farber, S; Frauenberger, G; Geiser, C; Jaffe, N; Kim, BS; Paed, D; Traggis, D | 1 |
Beattie, EJ; Kwon, C; Murphy, ML; Rosen, G; Suwansirikul, S; Tan, C; Wu, SJ | 1 |
Carter, SK; Friedman, MA | 1 |
Bluming, AZ; Carbone, PP; Magrath, IT; Ziegler, JL | 1 |
Bozzetti, F; Doci, R | 1 |
Bishop, Y; Frei, E; Jaffe, N; Traggis, D | 1 |
Deutsch, M; Leen, RL; Mercado, R | 1 |
Borden, S; Toch, R; Wang, CC; Weber, AL | 1 |
Perlia, CP | 1 |
Eagan, RT; Forcier, RJ; Maurer, LH; Tulloh, M | 1 |
Scott, WP | 1 |
Hüther, W; Rickers, H | 1 |
Lanzkowsky, P; McGoldrick, KE | 1 |
Carbone, PP; Devita, VT; Serpick, AA | 1 |
Finklestein, JZ; Hastings, N; Hittle, R; Isaacs, H; Ortega, JA | 1 |
65 review(s) available for methotrexate and Bone Cancer
Article | Year |
---|---|
Resource-appropriate selection of osteosarcoma treatment protocols in low- and middle-income countries.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Developing Countries; Humans; Methotrexate; Osteosarcoma; Young Adult | 2022 |
Chemoresistance-Related Stem Cell Signaling in Osteosarcoma and Its Plausible Contribution to Poor Therapeutic Response: A Discussion That Still Matters.
Topics: Adolescent; Bone Neoplasms; Child; Cisplatin; Doxorubicin; Drug Resistance, Neoplasm; Humans; Methotrexate; Neoplasm Recurrence, Local; Osteosarcoma; Signal Transduction | 2022 |
A Comprehensive Review of Neuropsychologic Studies Supports the Concept That Adequate Folinic Acid Rescue Prevents Post Methotrexate Neurotoxicity.
Topics: Bone Neoplasms; Child; Humans; Leucovorin; Methotrexate; Neurotoxicity Syndromes; Osteosarcoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2023 |
The efficacy and safety comparison of first-line chemotherapeutic agents (high-dose methotrexate, doxorubicin, cisplatin, and ifosfamide) for osteosarcoma: a network meta-analysis.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Doxorubicin; Humans; Ifosfamide; Leukopenia; Methotrexate; Network Meta-Analysis; Osteosarcoma; Survival Rate; Thrombocytopenia; Treatment Outcome | 2020 |
Future Directions in the Treatment of Osteosarcoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Doxorubicin; Female; Humans; Immunotherapy; Male; Medical Oncology; Methotrexate; Neoadjuvant Therapy; Osteosarcoma; Precision Medicine; Prognosis; Quality of Life; Treatment Outcome | 2021 |
Concomitant Administration of High-dose Methotrexate and Low-dose Aspirin Without Any Delay in Methotrexate Clearance in a Patient With Osteosarcoma: A Case Report and Review of the Literature.
Topics: Aspirin; Bone Neoplasms; Child; Glomerular Filtration Rate; Humans; Male; Methotrexate; Osteosarcoma | 2018 |
Diffuse large B cell lymphoma (DLBCL): bilateral vanishing tibiae.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemoradiotherapy; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Prednisone; Rituximab; Sarcoidosis, Pulmonary; Tibia; Vincristine | 2018 |
Efficacy of methotrexate, doxorubicin, and cisplatin for osteosarcoma: Study protocol for a systematic review of randomized controlled trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Disease-Free Survival; Doxorubicin; Humans; Methotrexate; Osteosarcoma; Quality of Life; Randomized Controlled Trials as Topic; Research Design | 2019 |
Methotrexate, doxorubicin, and cisplatinum regimen is still the preferred option for osteosarcoma chemotherapy: A meta-analysis and clinical observation.
Topics: Antineoplastic Agents; Bone Neoplasms; Cisplatin; Doxorubicin; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Osteosarcoma; Retrospective Studies; Survival Analysis | 2019 |
Analysis of chemotherapy dosage and dosage intensity and survival outcomes of high-grade osteosarcoma patients younger than 40 years.
Topics: Adolescent; Adult; Analysis of Variance; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Disease-Free Survival; Doxorubicin; Female; Humans; Ifosfamide; Male; Methotrexate; Neoplasm Grading; Osteosarcoma; Treatment Outcome | 2014 |
Impaired testicular function after an ifosfamide-containing regimen for pediatric osteosarcoma: a case series and review of the literature.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Cohort Studies; Disorder of Sex Development, 46,XY; Doxorubicin; Follow-Up Studies; Humans; Ifosfamide; Luteinizing Hormone; Male; Methotrexate; Osteosarcoma; Prognosis; Review Literature as Topic; Spermatogenesis; Testis; Testosterone; Young Adult | 2014 |
Historical perspective on the introduction and use of chemotherapy for the treatment of osteosarcoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Administration Routes; Drug Administration Schedule; History, 20th Century; History, 21st Century; Humans; Ifosfamide; Lung Neoplasms; Methotrexate; Osteosarcoma; Treatment Outcome | 2014 |
The role of chemotherapy for metastatic, relapsed and refractory osteosarcoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Deoxycytidine; Docetaxel; Etoposide; Gemcitabine; Humans; Ifosfamide; Methotrexate; Neoplasm Recurrence, Local; Osteosarcoma; Taxoids | 2014 |
An update on chemotherapy for osteosarcoma.
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Doxorubicin; Etoposide; Humans; Ifosfamide; Methotrexate; Neoadjuvant Therapy; Neoplasm Metastasis; Osteosarcoma; Prognosis; Randomized Controlled Trials as Topic | 2015 |
Pharmacogenomics of genes involved in antifolate drug response and toxicity in osteosarcoma.
Topics: Antimetabolites, Antineoplastic; Bone Neoplasms; Folic Acid Antagonists; Humans; Methotrexate; Neoplasm Grading; Osteosarcoma; Pemetrexed; Pharmacogenetics; Trimetrexate | 2017 |
Methotrexate for high-grade osteosarcoma in children and young adults.
Topics: Adolescent; Antineoplastic Agents; Bone Neoplasms; Child; Cisplatin; Humans; Methotrexate; Osteosarcoma; Young Adult | 2009 |
Rare localizations of bone sarcoidosis: two case reports and review of the literature.
Topics: Alendronate; Bone Diseases; Bone Neoplasms; Diagnosis, Differential; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Methotrexate; Methylprednisolone; Middle Aged; Osteolysis; Radiography; Rare Diseases; Ribs; Sarcoidosis; Skull; Spine; Treatment Outcome | 2011 |
Osteosarcoma: review of the past, impact on the future. The American experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Cyclophosphamide; Doxorubicin; Humans; Leucovorin; Methotrexate; Osteosarcoma | 2009 |
Sequelae of osteosarcoma medical therapy: a review of rare acute toxicities and late effects.
Topics: Antidotes; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Doxorubicin; Hearing Loss; Heart Diseases; Humans; Ifosfamide; Infertility; Kidney Diseases; Methotrexate; Neoplasms, Second Primary; Neurotoxicity Syndromes; Osteosarcoma; Survivors | 2010 |
Primary malignant bone neoplasm: a case report of dedifferentiated chondrosarcoma in the rib and review of the literature.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chondrosarcoma; Cisplatin; Doxorubicin; Follow-Up Studies; Hemangioendothelioma; Humans; Immunohistochemistry; Lung Neoplasms; Male; Methotrexate; Multimodal Imaging; Positron-Emission Tomography; Ribs; Tomography, X-Ray Computed | 2010 |
Methotrexate for high-grade osteosarcoma in children and young adults.
Topics: Adolescent; Antineoplastic Agents; Bone Neoplasms; Child; Cisplatin; Humans; Methotrexate; Osteosarcoma; Quality of Life; Young Adult | 2011 |
Anaphylaxis during the first course of high-dose methotrexate: a case report and literature review.
Topics: Anaphylaxis; Antimetabolites, Antineoplastic; Bone Neoplasms; Child; Dose-Response Relationship, Drug; Drug Hypersensitivity; Humans; Male; Methotrexate; Osteosarcoma | 2012 |
Isolated subcutaneous metastasis of osteosarcoma 5 years after initial diagnosis.
Topics: Abdominal Wall; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Calcinosis; Cisplatin; Combined Modality Therapy; Doxorubicin; Female; Humans; Ifosfamide; Lung Neoplasms; Methotrexate; Neoadjuvant Therapy; Organ Sparing Treatments; Osteosarcoma; Radiography; Razoxane; Receptor, IGF Type 1; Skin Neoplasms; Subcutaneous Tissue; Tibia; Time Factors; Young Adult | 2011 |
The activity of the Bone and Soft Tissue Tumor Study Group of the Japan Clinical Oncology Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Disease-Free Survival; Doxorubicin; Extremities; Feasibility Studies; Gene Expression Profiling; Humans; Ifosfamide; Japan; Medical Oncology; Methotrexate; Multicenter Studies as Topic; Neoplasm Staging; Osteosarcoma; Perioperative Period; Practice Guidelines as Topic; Research Design; Societies, Medical; Soft Tissue Neoplasms; Survival Analysis; Treatment Outcome | 2012 |
[Progress and stagnation in chemotherapy protocols for primary osteosarcoma].
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Doxorubicin; Humans; Methotrexate; Multicenter Studies as Topic; Neoadjuvant Therapy; Osteosarcoma; Preoperative Care; Prognosis; Randomized Controlled Trials as Topic; Survival Analysis | 2003 |
High-dose methotrexate-induced nephrotoxicity in patients with osteosarcoma.
Topics: Acute Kidney Injury; Antimetabolites, Antineoplastic; Bone Neoplasms; gamma-Glutamyl Hydrolase; Humans; Kidney; Methotrexate; Osteosarcoma; Renal Dialysis | 2004 |
Osteosarcoma occurring in osteogenesis imperfecta.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Combined Modality Therapy; DNA Mutational Analysis; DNA, Neoplasm; Doxorubicin; Humans; Ifosfamide; Immunohistochemistry; Lung Neoplasms; Male; Methotrexate; Osteogenesis Imperfecta; Osteosarcoma; Radiography, Thoracic; Thigh; Tomography, X-Ray Computed; Treatment Outcome; Tumor Suppressor Protein p53 | 2004 |
[Soft tissue sarcoma: postoperative chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Dactinomycin; Doxorubicin; Drug Administration Schedule; Humans; Ifosfamide; Melphalan; Mesna; Methotrexate; Osteosarcoma; Rhabdomyosarcoma; Sarcoma; Sarcoma, Ewing; Soft Tissue Neoplasms; Vincristine | 2004 |
Osteosarcoma with rhabdomyosarcomatous component or so-called malignant mesenchymoma of bone.
Topics: Adolescent; Antimetabolites, Antineoplastic; Bone Neoplasms; Chondrosarcoma; Combined Modality Therapy; Desmin; Diagnosis, Differential; Fatal Outcome; Female; Fibrosarcoma; Humans; Humerus; Mesenchymoma; Methotrexate; Neoplasm Proteins; Neoplasms, Multiple Primary; Osteolysis; Osteosarcoma; Postoperative Complications; Pulmonary Embolism; Radiography; Rhabdomyosarcoma; Sarcoma, Ewing | 2004 |
Anaplastic large cell lymphoma of bone--is it a bad tumor?
Topics: Activin Receptors, Type II; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Neoplasms; Child; Child, Preschool; Cohort Studies; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Ki-1 Antigen; Lymphoma, Large-Cell, Anaplastic; Magnetic Resonance Imaging; Male; Methotrexate; Prognosis; Remission Induction; Scapula; Treatment Outcome; United Kingdom | 2007 |
Combination of gemcitabine and irinotecan for recurrent metastatic osteogenic sarcoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Camptothecin; Cisplatin; Combined Modality Therapy; Deoxycytidine; Doxorubicin; Etoposide; Femoral Neoplasms; Gemcitabine; Head and Neck Neoplasms; Humans; Ifosfamide; Irinotecan; Leucovorin; Liver Neoplasms; Lung Neoplasms; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Osteosarcoma; Palliative Care; Salvage Therapy; Scalp; Skin Neoplasms; Thoracotomy | 2005 |
[Neoadjuvant treatment in osteosarcomas].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Doxorubicin; Humans; Ifosfamide; Methotrexate; Neoadjuvant Therapy; Osteosarcoma | 2006 |
[Drug therapy of malignant tumors of the bone and soft tissues].
Topics: Adolescent; Bone Neoplasms; Child; Cisplatin; Doxorubicin; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Osteosarcoma; Rhabdomyosarcoma; Sarcoma, Ewing; Soft Tissue Neoplasms | 1981 |
Chemotherapy in osteosarcoma. Basis for application and antagonism to implementation; early controversies surrounding its implementation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Clinical Trials as Topic; Disease-Free Survival; Doxorubicin; Humans; Infusions, Intra-Arterial; Methotrexate; Multicenter Studies as Topic; Osteosarcoma; Randomized Controlled Trials as Topic; Remission Induction; Survival Rate; Treatment Outcome | 1995 |
Osteosarcoma and other tumors of bone.
Topics: Antineoplastic Agents; Bone Neoplasms; Cisplatin; Disease-Free Survival; Female; Humans; Male; Methotrexate; Mutation; Osteosarcoma; Prognosis; Tomography; Tumor Suppressor Protein p53 | 1995 |
Cytotoxic chemotherapy for advanced hormone-resistant prostate cancer.
Topics: Antibodies, Monoclonal; Antineoplastic Agents; Bone Neoplasms; Cisplatin; Clinical Trials as Topic; Coumarins; Doxorubicin; Drug Administration Schedule; Drug Resistance; Fluorouracil; Humans; Intercalating Agents; Male; Methotrexate; Neoplasm Staging; Polyamines; Prostate-Specific Antigen; Prostatic Neoplasms; Remission Induction; Somatostatin | 1993 |
Treatment of osteosarcoma: experience of the Cooperative Osteosarcoma Study Group (COSS).
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Clinical Protocols; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Germany; Humans; Ifosfamide; Immunologic Factors; Interferon-beta; Methotrexate; Multicenter Studies as Topic; Osteosarcoma; Prognosis; Randomized Controlled Trials as Topic; Treatment Outcome; Vincristine | 1993 |
Osteosarcoma of the extremities: chemotherapy experience at Memorial Sloan-Kettering.
Topics: Adolescent; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Humans; Male; Methotrexate; New York; Osteosarcoma; Prognosis; Proportional Hazards Models; Racial Groups; Retrospective Studies; Risk; Survival Rate; Treatment Outcome | 1993 |
Recurrent breast cancer: presentation, diagnosis, and treatment.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Bone Neoplasms; Breast Neoplasms; Central Nervous System Neoplasms; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Liver Neoplasms; Lung Neoplasms; Mastectomy; Methotrexate; Neoplasm Metastasis; Neoplasm Recurrence, Local; Palliative Care; Radiotherapy; Soft Tissue Neoplasms | 1993 |
Experience of the EORTC Radiotherapy/Chemotherapy Group in osteosarcoma trials.
Topics: Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Disarticulation; Doxorubicin; Europe; Humans; Leucovorin; Lung Neoplasms; Methotrexate; Neoplasm Recurrence, Local; Osteosarcoma; Survival Analysis; Treatment Outcome; Vincristine | 1993 |
The European Osteosarcoma Intergroup (E.O.I.) studies 1980-1991.
Topics: Adolescent; Adult; Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Cisplatin; Clinical Protocols; Combined Modality Therapy; Doxorubicin; Europe; Humans; Methotrexate; Osteosarcoma; Survival Rate; Treatment Outcome | 1993 |
An update of Scandinavian studies of osteosarcoma.
Topics: Adolescent; Adult; Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Cisplatin; Clinical Protocols; Combined Modality Therapy; Doxorubicin; Etoposide; Humans; Ifosfamide; Methotrexate; Osteosarcoma; Scandinavian and Nordic Countries; Survival Rate; Treatment Outcome | 1993 |
Osteosarcoma in adolescents and young adults: new developments and controversies. The Mayo Clinic studies.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Cisplatin; Clinical Protocols; Combined Modality Therapy; Doxorubicin; Feasibility Studies; Female; Humans; Ifosfamide; Life Tables; Male; Methotrexate; Minnesota; Necrosis; Osteosarcoma; Pilot Projects; Survival Analysis; Treatment Outcome; Vincristine | 1993 |
Neoadjuvant chemotherapy for patients with osteosarcoma: University of Florida studies.
Topics: Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Florida; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Life Tables; Lung Neoplasms; Methotrexate; Osteosarcoma; Survival Analysis; Treatment Outcome | 1993 |
Osteosarcoma: experience of the Tata Memorial Hospital, Bombay, India.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Developing Countries; Doxorubicin; Female; Humans; India; Lung Neoplasms; Male; Methotrexate; Middle Aged; Osteosarcoma; Retrospective Studies; Survival Rate; Treatment Outcome; Vinblastine | 1993 |
An opinion supporting the role of high-dose methotrexate in the treatment of osteosarcoma.
Topics: Acidosis, Renal Tubular; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Doxorubicin; Humans; Ifosfamide; Leucovorin; Mesna; Methotrexate; Osteosarcoma; Postoperative Care; Preoperative Care; Radionuclide Imaging; Retrospective Studies; Salvage Therapy; Thallium Radioisotopes; Treatment Outcome | 1993 |
Influence of methotrexate dose intensity on outcome of patients with high grade osteogenic osteosarcoma. Analysis of the literature.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Humans; Methotrexate; Osteosarcoma; Survival Rate | 1996 |
[Methotrexate-leucovorin rescue therapy: pharmacological characteristics and clinical effective use].
Topics: Antidotes; Antimetabolites, Antineoplastic; Bone Neoplasms; Drug Synergism; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Methotrexate; Neoplasms; Osteosarcoma | 1996 |
Chemotherapy for osteosarcoma and Ewing's sarcoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Dose-Response Relationship, Drug; Doxorubicin; Humans; Methotrexate; Osteosarcoma; Prognosis; Randomized Controlled Trials as Topic; Research Design; Sarcoma, Ewing | 1997 |
On the current management of osteosarcoma. A critical evaluation and a proposal for a modified treatment strategy.
Topics: Antimetabolites, Antineoplastic; Bone Neoplasms; Combined Modality Therapy; Decision Making; Humans; Methotrexate; Osteosarcoma; Treatment Outcome | 1997 |
[Therapy of sarcomas].
Topics: Adolescent; Adult; Bone Neoplasms; Child; Cyclophosphamide; Dacarbazine; Dactinomycin; Doxorubicin; Drug Therapy, Combination; Humans; Methotrexate; Middle Aged; Osteosarcoma; Remission, Spontaneous; Rhabdomyosarcoma; Sarcoma; Sarcoma, Ewing; Soft Tissue Neoplasms; Vincristine | 1978 |
Progress in the treatment of osteosarcoma.
Topics: Adolescent; Adult; Amputation, Surgical; Antineoplastic Agents; Bone Neoplasms; Cell Division; Child; Clinical Trials as Topic; Doxorubicin; Drug Therapy, Combination; Female; Humans; Leucovorin; Lung Neoplasms; Male; Methotrexate; Neoplasm Metastasis; Osteosarcoma; Prognosis; Radiotherapy, High-Energy; Time Factors | 1977 |
Methotrexate revisited.
Topics: Adolescent; Adult; Alkalies; Aminopterin; Animals; Bone Marrow; Bone Neoplasms; Drug Therapy, Combination; Female; Folic Acid Antagonists; Humans; Kidney; Kidney Failure, Chronic; Leucovorin; Leukemia L1210; Methotrexate; Neoplasm Metastasis; Osteosarcoma; Thymidine; Vincristine | 1976 |
Dialyzable transfer factor in the treatment of human osteosarcoma: an analytic review.
Topics: Animals; Antineoplastic Agents; Biological Assay; Bone Neoplasms; Cell Extracts; Chemical Fractionation; Chemical Phenomena; Chemistry; Cytotoxicity Tests, Immunologic; Dialysis; Doxorubicin; Humans; Immunity, Cellular; Methotrexate; Osteosarcoma; T-Lymphocytes; Transfer Factor; Tuberculin Test | 1976 |
Neoplasms of the shoulder girdle.
Topics: Adult; Amputation, Surgical; Bone Neoplasms; Child; Chondroblastoma; Chondrosarcoma; Cryosurgery; Curettage; Eosinophilic Granuloma; Humans; Humerus; Methotrexate; Neoplasm Metastasis; Osteosarcoma; Scapula; Shoulder | 1975 |
The potential of combined modality approaches for the treatment of malignant bone tumors in children.
Topics: Adolescent; Adult; Bone Neoplasms; Child; Child, Preschool; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Humans; Immunotherapy; Infant; Lung Neoplasms; Methotrexate; Neoplasm Metastasis; Osteosarcoma; Radiography; Sarcoma, Ewing | 1975 |
Current therapies in osteosarcoma.
Topics: Adjuvants, Pharmaceutic; Adult; Animals; Bone Neoplasms; Child; Doxorubicin; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Humans; Immunotherapy; Leucovorin; Methotrexate; Neoplasm Metastasis; Osteosarcoma | 1975 |
Local control and survival from the Cooperative Osteosarcoma Study Group studies of the German Society of Pediatric Oncology and the Vienna Bone Tumor Registry.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Austria; Bleomycin; Bone Neoplasms; Child; Child, Preschool; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Follow-Up Studies; Germany; Humans; Ifosfamide; Interferon Type I; Male; Methotrexate; Osteosarcoma; Registries; Societies, Medical; Survival Rate; Switzerland; Vincristine | 1991 |
Current management, local management, and survival statistics of high-grade osteosarcoma. Experience in Japan.
Topics: Adult; Aged; Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child, Preschool; Cisplatin; Combined Modality Therapy; Doxorubicin; Female; Follow-Up Studies; Humans; Japan; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Osteosarcoma; Osteotomy; Survival Analysis; Survival Rate | 1991 |
Osteogenic osteosarcoma: a model of curable disease by multidisciplinary approach of treatment.
Topics: Bone Neoplasms; Combined Modality Therapy; Drug Administration Schedule; Follow-Up Studies; Humans; Methotrexate; Osteosarcoma | 1990 |
Chemotherapy for the primary treatment of osteosarcoma: population effectiveness over 20 years.
Topics: Adolescent; Adult; Age Factors; Antineoplastic Agents; Bone Neoplasms; Child; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Male; Methotrexate; Middle Aged; Osteosarcoma; Registries; Regression Analysis; United Kingdom | 1988 |
Treatment-related leukoencephalopathy. A study of three cases and literature review.
Topics: Adolescent; Adult; Antineoplastic Agents; Bone Neoplasms; Brain; Brain Diseases; Brain Neoplasms; Cytarabine; Diagnosis, Differential; Humans; Leukemia, Lymphoid; Male; Methotrexate; Osteosarcoma; Tomography, X-Ray Computed | 1986 |
Osteosarcoma: fifteen years later.
Topics: Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Doxorubicin; Extremities; Humans; Leucovorin; Methods; Methotrexate; Neoplasm Metastasis; Osteosarcoma; Prognosis; Prostheses and Implants; Random Allocation | 1985 |
The therapy of osteogenic sarcoma: current status and thoughts for the future.
Topics: Age Factors; Aged; Bone Neoplasms; Doxorubicin; Female; Humans; Immunotherapy; Male; Methotrexate; Middle Aged; Osteosarcoma; Prognosis; Sex Factors; Time Factors | 1972 |
[Report of 11 cases of hemangiopericytoma and review of the most recent literature (author's transl)].
Topics: Adult; Bone Neoplasms; Cyclophosphamide; Electrocoagulation; Female; Hemangiopericytoma; Humans; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Rectal Neoplasms; Vincristine | 1974 |
138 trial(s) available for methotrexate and Bone Cancer
Article | Year |
---|---|
A phase II trial evaluating the feasibility of adding bevacizumab to standard osteosarcoma therapy.
Topics: Adolescent; Amputation, Surgical; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Bone Neoplasms; Child; Cisplatin; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Feasibility Studies; Female; Humans; Limb Salvage; Male; Methotrexate; Osteosarcoma; Postoperative Complications; Survival Rate; Time Factors; Vascular Endothelial Growth Factor A; Wound Healing; Young Adult | 2017 |
Results of methotrexate-etoposide-ifosfamide based regimen (M-EI) in osteosarcoma patients included in the French OS2006/sarcome-09 study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Diphosphonates; Doxorubicin; Etoposide; Female; France; Humans; Ifosfamide; Imidazoles; Kaplan-Meier Estimate; Male; Methotrexate; Neutropenia; Osteosarcoma; Young Adult; Zoledronic Acid | 2018 |
Pantoprazole, an Inhibitor of the Organic Cation Transporter 2, Does Not Ameliorate Cisplatin-Related Ototoxicity or Nephrotoxicity in Children and Adolescents with Newly Diagnosed Osteosarcoma Treated with Methotrexate, Doxorubicin, and Cisplatin.
Topics: Acute Kidney Injury; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cisplatin; Cross-Over Studies; Doxorubicin; Female; Hearing; Hearing Loss; Humans; Kidney; Male; Methotrexate; Organic Cation Transporter 2; Osteosarcoma; Pantoprazole; Young Adult | 2018 |
A Pharmacokinetic and Pharmacogenetic Analysis of Osteosarcoma Patients Treated With High-Dose Methotrexate: Data From the OS2006/Sarcoma-09 Trial.
Topics: Adolescent; Antimetabolites, Antineoplastic; Bone Neoplasms; Carrier Proteins; Child; Female; Gene Expression Regulation; Humans; Male; Methotrexate; Multidrug Resistance-Associated Protein 2; Osteosarcoma; Polymorphism, Single Nucleotide; Prospective Studies | 2018 |
Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cisplatin; Cohort Studies; Doxorubicin; Female; Follow-Up Studies; Humans; Male; Methotrexate; Neoplasm Metastasis; Osteosarcoma; Prognosis; Survival Rate | 2019 |
Addition of Zoledronate to Chemotherapy in Patients with Osteosarcoma Treated with Limb-Sparing Surgery: A Phase III Clinical Trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; China; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Doxorubicin; Female; Humans; Male; Methotrexate; Middle Aged; Osteosarcoma; Survival Rate; Zoledronic Acid | 2019 |
Results of API-AI based regimen in osteosarcoma adult patients included in the French OS2006/Sarcome-09 study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Feasibility Studies; Female; Follow-Up Studies; France; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Osteosarcoma; Prognosis; Survival Rate; Young Adult; Zoledronic Acid | 2020 |
Neoadjuvant and adjuvant chemotherapy with high-dose ifosfamide, doxorubicin, cisplatin and high-dose methotrexate in non-metastatic osteosarcoma of the extremities: a phase II trial in Japan.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Extremities; Female; Follow-Up Studies; Humans; Ifosfamide; Infant; Infant, Newborn; Japan; Limb Salvage; Male; Methotrexate; Neoadjuvant Therapy; Osteosarcoma; Survival Rate; Treatment Outcome; Young Adult | 2013 |
Combination of 18F-FDG PET/CT and diffusion-weighted MR imaging as a predictor of histologic response to neoadjuvant chemotherapy: preliminary results in osteosarcoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Diffusion Magnetic Resonance Imaging; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Male; Methotrexate; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Osteosarcoma; Pilot Projects; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2013 |
Treatment of large osteosarcoma in children: new approach.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cisplatin; Doxorubicin; Female; Humans; Ifosfamide; Male; Methotrexate; Osteosarcoma; Precision Medicine; Treatment Outcome; Ultrasonography, Doppler | 2013 |
High-dose chemotherapy with stem cell rescue in the primary treatment of metastatic and pelvic osteosarcoma: final results of the ISG/SSG II study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Doxorubicin; Feasibility Studies; Female; Follow-Up Studies; Humans; Ifosfamide; Male; Methotrexate; Neoplasm Grading; Neoplasm Metastasis; Osteosarcoma; Pelvic Neoplasms; Pilot Projects; Prognosis; Stem Cell Transplantation; Survival Rate; Young Adult | 2014 |
Experience of pediatric osteosarcoma of the extremity at a single institution in Taiwan: prognostic factors and impact on survival.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cisplatin; Doxorubicin; Extremities; Female; Follow-Up Studies; Humans; Ifosfamide; Lung Neoplasms; Lymphatic Metastasis; Male; Methotrexate; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Osteosarcoma; Prognosis; Retrospective Studies; Survival Rate; Taiwan | 2015 |
EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cisplatin; Combined Modality Therapy; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Interferon-alpha; Male; Methotrexate; Neoadjuvant Therapy; Osteosarcoma; Polyethylene Glycols; Quality of Life; Research Design; Young Adult | 2015 |
Comparative outcome of Thai pediatric osteosarcoma treated with two protocols: the role of high-dose methotrexate (HDMTX) in a single institute experience.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Dose-Response Relationship, Drug; Etoposide; Extremities; Feasibility Studies; Female; Follow-Up Studies; Humans; Ifosfamide; Male; Maximum Tolerated Dose; Methotrexate; Neoadjuvant Therapy; Neoplasm Metastasis; Neoplasm Staging; Osteosarcoma; Prognosis; Retrospective Studies; Survival Rate | 2014 |
Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Respons
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asia; Australia; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Disease Progression; Disease-Free Survival; Doxorubicin; Europe; Female; Humans; Interferon alpha-2; Interferon-alpha; Kaplan-Meier Estimate; Male; Methotrexate; Neoadjuvant Therapy; Neoplasm Grading; North America; Osteosarcoma; Osteotomy; Polyethylene Glycols; Proportional Hazards Models; Recombinant Proteins; Risk Factors; Time Factors; Treatment Outcome; Young Adult | 2015 |
A Prognostic Gene Expression Signature in the Molecular Classification of Chemotherapy-naïve Urothelial Cancer is Predictive of Clinical Outcomes from Neoadjuvant Chemotherapy: A Phase 2 Trial of Dose-dense Methotrexate, Vinblastine, Doxorubicin, and Cisp
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Bone Neoplasms; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Cystectomy; Doxorubicin; Female; Gene Expression Profiling; Humans; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Prognosis; Proportional Hazards Models; Survival Rate; Transcriptome; Treatment Outcome; Tumor Suppressor Protein p53; Urinary Bladder Neoplasms; Vinblastine | 2016 |
Developing a prognostic model for patients with localized osteosarcoma treated with uniform chemotherapy protocol without high dose methotrexate: A single-center experience of 237 patients.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Male; Methotrexate; Neoadjuvant Therapy; Neoplasm Staging; Osteosarcoma; Prognosis; Retrospective Studies; Survival Rate | 2015 |
Assessment of extent of surgical resection of primary high-grade osteosarcoma by treating institutions: A report from the Children's Oncology Group.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cisplatin; Cohort Studies; Doxorubicin; Humans; Methotrexate; Middle Aged; Neoplasm Grading; Osteosarcoma; Retrospective Studies; Young Adult | 2016 |
Evaluation of chemotherapy response in osteosarcoma with FDG-PET.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cisplatin; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Ifosfamide; Male; Methotrexate; Middle Aged; Osteosarcoma; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome; Young Adult | 2009 |
Sex- and age-related chemotherapy toxicity in patients with non-metastatic osteosarcoma.
Topics: Adolescent; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cisplatin; Doxorubicin; Female; Humans; Ifosfamide; Male; Methotrexate; Osteosarcoma; Sex Factors; Young Adult | 2009 |
Phase II trial of metronomic chemotherapy as salvage therapy for patients with metastatic breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Dose-Response Relationship, Drug; Female; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Maximum Tolerated Dose; Methotrexate; Middle Aged; Prognosis; Remission Induction; Salvage Therapy; Survival Rate; Treatment Outcome | 2008 |
Hyper-alkalinization without hyper-hydration for the prevention of high-dose methotrexate acute nephrotoxicity in patients with osteosarcoma.
Topics: Acute Kidney Injury; Adolescent; Adult; Alkalosis; Antimetabolites, Antineoplastic; Bone Neoplasms; Female; Humans; Kidney; Kidney Function Tests; Male; Methotrexate; Osmolar Concentration; Osteosarcoma; Water Intoxication; Young Adult | 2010 |
Addition of pamidronate to chemotherapy for the treatment of osteosarcoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Diphosphonates; Doxorubicin; Drug Administration Schedule; Feasibility Studies; Female; Humans; Male; Methotrexate; Osteosarcoma; Pamidronate | 2011 |
Neoadjuvant chemotherapy with methotrexate, cisplatin, and doxorubicin with or without ifosfamide in nonmetastatic osteosarcoma of the extremity: an Italian sarcoma group trial ISG/OS-1.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Disease-Free Survival; Doxorubicin; Female; Femur; Humans; Humerus; Ifosfamide; Male; Methotrexate; Osteosarcoma; Tibia | 2012 |
Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric Oncology Group Study POG-8651.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Cisplatin; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Female; Humans; Leucovorin; Male; Methotrexate; Neoadjuvant Therapy; Osteosarcoma; Survival Analysis; Treatment Outcome | 2003 |
Neoadjuvant chemotherapy for osteosarcoma of the extremities with metastases at presentation: recent experience at the Rizzoli Institute in 57 patients treated with cisplatin, doxorubicin, and a high dose of methotrexate and ifosfamide.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Arm; Bone Neoplasms; Child; Child, Preschool; Cisplatin; Disease-Free Survival; Doxorubicin; Female; Humans; Ifosfamide; Leg; Male; Methotrexate; Neoadjuvant Therapy; Neoplasm Metastasis; Neoplasm Recurrence, Local; Osteosarcoma; Prognosis; Treatment Outcome | 2003 |
Unstratified chemotherapy for non-metastatic osteosarcoma of the extremities in children.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Epirubicin; Etoposide; Extremities; Female; Humans; Male; Methotrexate; Osteosarcoma; Statistics, Nonparametric; Survival Analysis; Taiwan; Treatment Outcome | 2003 |
High-dose methotrexate pharmacokinetics and outcome of children and young adults with osteosarcoma.
Topics: Adolescent; Adult; Age Factors; Antimetabolites, Antineoplastic; Bone Neoplasms; Child; Child, Preschool; Cisplatin; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Ifosfamide; Kidney Diseases; Male; Methotrexate; Osteosarcoma; Treatment Outcome | 2004 |
Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cisplatin; Disease-Free Survival; Doxorubicin; Female; Humans; Ifosfamide; Infant; Male; Methotrexate; Osteosarcoma; Prospective Studies | 2005 |
Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cisplatin; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Extremities; Female; Follow-Up Studies; Heart Failure; Humans; Ifosfamide; Italy; Male; Methotrexate; Neoplasm Recurrence, Local; Osteosarcoma; Patient Compliance; Prospective Studies; Renal Insufficiency; Scandinavian and Nordic Countries; Treatment Outcome | 2005 |
Metastatic osteosarcoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Child; Cisplatin; Doxorubicin; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Methotrexate; Osteosarcoma; Treatment Outcome | 2006 |
Results of the Brazilian Osteosarcoma Treatment Group Studies III and IV: prognostic factors and impact on survival.
Topics: Adolescent; Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brazil; Carboplatin; Chemotherapy, Adjuvant; Child; Cisplatin; Disease-Free Survival; Doxorubicin; Epirubicin; Female; Humans; Ifosfamide; Limb Salvage; Lung Neoplasms; Male; Methotrexate; Multivariate Analysis; Orthopedic Procedures; Osteosarcoma; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Prospective Studies; Risk Factors; Survival Analysis; Treatment Outcome | 2006 |
A randomized phase III comparative trial of immediate consolidation with high-dose chemotherapy and autologous peripheral blood progenitor cell support compared to observation with delayed consolidation in women with metastatic breast cancer and only bone
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Combined Modality Therapy; Disease-Free Survival; Doxorubicin; Female; Fluorouracil; Humans; Methotrexate; Peripheral Blood Stem Cell Transplantation; Prognosis; Prospective Studies; Survival Rate; Time Factors; Transplantation, Autologous | 2006 |
Trastuzumab in combination with metronomic cyclophosphamide and methotrexate in patients with HER-2 positive metastatic breast cancer.
Topics: Adult; Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Drug Administration Schedule; Female; Gene Amplification; Genes, erbB-2; Humans; Immunization, Passive; Leukopenia; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Methotrexate; Middle Aged; Neoplasm Proteins; Neutropenia; Receptor, ErbB-2; Remission Induction; Trastuzumab; Treatment Outcome; Ventricular Dysfunction, Left | 2006 |
SFOP OS94: a randomised trial comparing preoperative high-dose methotrexate plus doxorubicin to high-dose methotrexate plus etoposide and ifosfamide in osteosarcoma patients.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Male; Methotrexate; Osteosarcoma; Preoperative Care | 2007 |
Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cisplatin; Disease-Free Survival; Doxorubicin; Female; Humans; Ifosfamide; Infant; Lung Neoplasms; Male; Methotrexate; Neoplasm Recurrence, Local; Osteosarcoma; Survival Rate | 2008 |
Bisphosphonate treatment in primary breast cancer: results from a randomised comparison of oral pamidronate versus no pamidronate in patients with primary breast cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Diphosphonates; Epirubicin; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Pamidronate | 2008 |
Adjuvant chemotherapy in osteosarcoma - effects of cisplatinum, BCD, and fibroblast interferon in sequential combination with HD-MTX and adriamycin. Preliminary results of the COSS 80 study.
Topics: Adult; Antineoplastic Agents; Bone Neoplasms; Cisplatin; Clinical Trials as Topic; Dactinomycin; Doxorubicin; Drug Therapy, Combination; Humans; Interferons; Methotrexate; Osteosarcoma; Preoperative Care; Random Allocation | 1983 |
Neoadjuvant chemotherapy for osteogenic sarcoma: results of a Cooperative German/Austrian study.
Topics: Adolescent; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Female; Humans; Interferon Type I; Male; Methotrexate; Osteosarcoma; Prognosis | 1984 |
[Calcitonin in bone-metastasizing breast carcinoma. Results of a pilot study].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Calcitonin; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Methotrexate; Middle Aged; Pain, Intractable; Palliative Care; Pilot Projects | 1984 |
Toxicity associated with combination chemotherapy for osteosarcoma: a report of the cooperative osteosarcoma study (COSS 80).
Topics: Acute Kidney Injury; Adolescent; Adult; Antineoplastic Agents; Body Weight; Bone Neoplasms; Child; Child, Preschool; Cisplatin; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Leucovorin; Leukopenia; Male; Methotrexate; Osteosarcoma | 1983 |
Effects of amphotericin B on combination chemotherapy of metastatic sarcomas.
Topics: Amphotericin B; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Random Allocation; Sarcoma | 1984 |
[Clinico-pharmacological studies on the course of high-dose methotrexate therapy in childhood. A retrospective comparison of centers].
Topics: Adolescent; Bone Marrow; Bone Neoplasms; Cancer Care Facilities; Child; Chondrosarcoma; Clinical Trials as Topic; Germany, West; Humans; Methotrexate; Osteosarcoma; Retrospective Studies | 1984 |
A controlled pilot study of high-dose methotrexate as postsurgical adjuvant treatment for primary osteosarcoma.
Topics: Adult; Amputation, Surgical; Bone Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Extremities; Female; Follow-Up Studies; Humans; Male; Methotrexate; Osteosarcoma; Pilot Projects; Prognosis; Random Allocation | 1984 |
A comparison of cyclophosphamide, adriamycin, and 5-fluorouracil (CAF) and cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, and prednisone (CMFVP) in patients with advanced breast cancer.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; Humans; Methotrexate; Neoplasm Staging; Prednisone; Vincristine | 1983 |
Is it ethical not to conduct a prospectively controlled trial of adjuvant chemotherapy in osteosarcoma?
Topics: Antineoplastic Agents; Bone Neoplasms; Cisplatin; Clinical Trials as Topic; Doxorubicin; Drug Therapy, Combination; Ethics, Medical; Humans; Lung Neoplasms; Methotrexate; Osteosarcoma; Prognosis; Prospective Studies; Random Allocation; Tomography, X-Ray Computed | 1982 |
[Aggressive cytostatic treatment of osteogenic sarcoma in childhood (author's transl)].
Topics: Adolescent; Age Factors; Antibiotics, Antineoplastic; Bone Neoplasms; Child; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Humans; Lung Neoplasms; Male; Methotrexate; Neoplasm Recurrence, Local; Osteosarcoma; Vincristine | 1981 |
Metastatic adenocarcinomas of unknown primary site: a randomized study of two combination-chemotherapy regimens.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Bone Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; Humans; Liver Neoplasms; Lung Neoplasms; Male; Methotrexate; Middle Aged; Mitomycins; Random Allocation | 1980 |
Methotrexate as adjuvant treatment for primary osteosarcoma.
Topics: Bone Neoplasms; Clinical Trials as Topic; Humans; Methotrexate; Osteosarcoma; Postoperative Care | 1980 |
Osteogenic sarcoma studies by the Cancer and Leukemia Group B.
Topics: Bone Neoplasms; Clinical Trials as Topic; Doxorubicin; Drug Therapy, Combination; Humans; Leucovorin; Lung Neoplasms; Methotrexate; Osteosarcoma | 1981 |
Treatment of soft tissue and bone sarcomas: review of studies at the National Cancer Institute.
Topics: Antineoplastic Agents; Bone Neoplasms; Cardiomyopathies; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Methotrexate; National Institutes of Health (U.S.); Osteosarcoma; Prospective Studies; Random Allocation; Sarcoma; Soft Tissue Neoplasms; United States | 1981 |
Adjuvant chemotherapy in Ewing's sarcoma patients.
Topics: Adolescent; Adult; Bone Neoplasms; Child; Child, Preschool; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Sarcoma, Ewing; Vincristine | 1982 |
Cyclophosphamide versus cyclophosphamide, methotrexate, and 5-fluorouracil in advanced prostatic cancer: a randomized trial.
Topics: Aged; Bone Neoplasms; Cyclophosphamide; Drug Evaluation; Drug Therapy, Combination; Fluorouracil; Humans; Male; Methotrexate; Middle Aged; Prognosis; Prospective Studies; Prostatic Neoplasms | 1981 |
Metastatic sarcomas: chemotherapy with adriamycin, cyclophosphamide, and methotrexate alternating with actinomycin D, DTIC, and vincristine.
Topics: Antineoplastic Agents; Bone Neoplasms; Cyclophosphamide; Dacarbazine; Dactinomycin; Doxorubicin; Drug Therapy, Combination; Humans; Methotrexate; Neoplasm Metastasis; Pilot Projects; Prognosis; Sarcoma; Soft Tissue Neoplasms; Vincristine | 1981 |
M-VEC (methotrexate, vinblastine, epirubicin, and cisplatin) with granulocyte colony-stimulating factor for the treatment of urothelial cancer: an effective and safe chemotherapy regimen.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Cisplatin; Epirubicin; Female; Granulocyte Colony-Stimulating Factor; Humans; Injections, Intravenous; Kidney Neoplasms; Kidney Pelvis; Lung Neoplasms; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Recombinant Proteins; Tomography, X-Ray Computed; Ureteral Neoplasms; Urinary Bladder Neoplasms; Vinblastine; World Health Organization | 1994 |
The multi-institutional osteosarcoma study: an update.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Cisplatin; Clinical Protocols; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Humans; Leucovorin; Life Tables; Methotrexate; Osteosarcoma; Survival Rate; Treatment Outcome; United States | 1993 |
Osteosarcoma in adolescents and young adults: new developments and controversies. The Childrens Cancer Group (CCG) studies.
Topics: Actuarial Analysis; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Humans; Leucovorin; Methotrexate; Osteosarcoma; Survival Rate; Treatment Outcome; United States; Vincristine | 1993 |
Neoadjuvant chemotherapy for nonmetastatic osteosarcoma of the extremities: the recent experience at the Rizzoli Institute.
Topics: Actuarial Analysis; Adolescent; Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Clinical Protocols; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Extremities; Female; Humans; Italy; Male; Methotrexate; Necrosis; Osteosarcoma; Prognosis; Salvage Therapy; Survival Analysis | 1993 |
Chemotherapy in osteogenic sarcoma: the experience of the Pediatric Department of the Gustave Roussy Institute.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Feasibility Studies; Female; France; Humans; Ifosfamide; Leucovorin; Male; Methotrexate; Osteosarcoma; Survival Rate; Treatment Outcome; Vincristine | 1993 |
Osteosarcoma of the limb: an institutional report of 10 years experience with neoadjuvant chemotherapy and delayed surgery.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Humans; Leucovorin; Life Tables; Methotrexate; Osteosarcoma; Treatment Outcome; Vincristine | 1993 |
Safety and efficacy of l-leucovorin rescue following high-dose methotrexate for osteosarcoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Female; Humans; Leucovorin; Male; Methotrexate; Osteosarcoma; Stereoisomerism | 1995 |
[Ifosfamide-induced hemorrhagic cystitis and its prevention by mesna].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cisplatin; Cystitis; Hemorrhage; Humans; Ifosfamide; Mesna; Methotrexate; Middle Aged; Soft Tissue Neoplasms | 1995 |
Effect of systemic adjuvant treatment on first sites of breast cancer relapse.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Female; Fluorouracil; Humans; Incidence; Methotrexate; Neoplasm Metastasis; Neoplasm Recurrence, Local; Prednisone; Proportional Hazards Models; Survival Analysis; Tamoxifen; Treatment Outcome | 1994 |
[Clinical evaluation of cyclophosphamide, methotrexate and 5-fluorouracil (CMF) on advanced and recurrent breast cancer. Clinical study group of CMF for breast cancer in Japan].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Drug Administration Schedule; Female; Fluorouracil; Humans; Infusions, Intravenous; Methotrexate; Middle Aged; Neoplasm Recurrence, Local | 1994 |
Experience of the EORTC Radiotherapy/Chemotherapy Group in osteosarcoma trials.
Topics: Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Disarticulation; Doxorubicin; Europe; Humans; Leucovorin; Lung Neoplasms; Methotrexate; Neoplasm Recurrence, Local; Osteosarcoma; Survival Analysis; Treatment Outcome; Vincristine | 1993 |
The European Osteosarcoma Intergroup (E.O.I.) studies 1980-1991.
Topics: Adolescent; Adult; Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Cisplatin; Clinical Protocols; Combined Modality Therapy; Doxorubicin; Europe; Humans; Methotrexate; Osteosarcoma; Survival Rate; Treatment Outcome | 1993 |
An update of Scandinavian studies of osteosarcoma.
Topics: Adolescent; Adult; Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Cisplatin; Clinical Protocols; Combined Modality Therapy; Doxorubicin; Etoposide; Humans; Ifosfamide; Methotrexate; Osteosarcoma; Scandinavian and Nordic Countries; Survival Rate; Treatment Outcome | 1993 |
Osteosarcoma in adolescents and young adults: new developments and controversies. The Mayo Clinic studies.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Cisplatin; Clinical Protocols; Combined Modality Therapy; Doxorubicin; Feasibility Studies; Female; Humans; Ifosfamide; Life Tables; Male; Methotrexate; Minnesota; Necrosis; Osteosarcoma; Pilot Projects; Survival Analysis; Treatment Outcome; Vincristine | 1993 |
Neoadjuvant chemotherapy for patients with osteosarcoma: University of Florida studies.
Topics: Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Florida; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Life Tables; Lung Neoplasms; Methotrexate; Osteosarcoma; Survival Analysis; Treatment Outcome | 1993 |
Influence of adriamycin dose in the outcome of patients with osteosarcoma treated with multidrug neoadjuvant chemotherapy: results of two sequential studies.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Extremities; Female; Humans; Male; Methotrexate; Osteosarcoma; Postoperative Complications | 1993 |
[High dose cisplatin combination chemotherapy for advanced breast cancer--a report on 50 cases].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cisplatin; Cyclophosphamide; Female; Fluorouracil; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Nausea; Soft Tissue Neoplasms | 1993 |
[Effect of high and low doses of methotrexate (MTX) on bone mass in subjects treated for osteosarcoma of the limbs].
Topics: Adolescent; Adult; Bone Density; Bone Neoplasms; Extremities; Female; Follow-Up Studies; Humans; Male; Methotrexate; Osteosarcoma | 1993 |
Cyclophosphamide, methotrexate, and 5-fluorouracil in the treatment of metastatic prostate cancer. A Southwest Oncology Group study.
Topics: Acid Phosphatase; Adenocarcinoma; Aged; Alkaline Phosphatase; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Neoplasms; Cyclophosphamide; Fluorouracil; Humans; Male; Methotrexate; Middle Aged; Prostatic Neoplasms; Remission Induction; Survival Rate | 1993 |
Intra-arterial versus intravenous cisplatinum (in addition to systemic Adriamycin and high dose methotrexate) in the neoadjuvant treatment of osteosarcoma of the extremities. results of a randomized study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Doxorubicin; Extremities; Female; Humans; Ifosfamide; Injections, Intra-Arterial; Injections, Intravenous; Male; Methotrexate; Osteosarcoma | 1996 |
Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: a report from the Children's Cancer Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Extremities; Humans; Methotrexate; Osteosarcoma; Vincristine | 1997 |
The importance of doxorubicin and methotrexate dose intensity in the chemotherapy of osteosarcoma.
Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Female; Humans; Infusions, Intravenous; Male; Methotrexate; Middle Aged; Osteosarcoma; Retrospective Studies; Survival Rate; Treatment Outcome | 1996 |
Neoadjuvant chemotherapy in malignant fibrous histiocytoma of bone and in osteosarcoma located in the extremities: analogies and differences between the two tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Arm; Bone Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Doxorubicin; Drug Administration Schedule; Female; Histiocytoma, Benign Fibrous; Humans; Ifosfamide; Infusions, Intra-Arterial; Infusions, Intravenous; Injections, Intravenous; Leg; Male; Methotrexate; Osteosarcoma; Prognosis; Surgical Procedures, Operative; Treatment Outcome | 1997 |
Eastern Cooperative Oncology Group randomized trials of observation versus maintenance therapy for patients with metastatic breast cancer in complete remission following induction treatment.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Female; Fluorouracil; Fluoxymesterone; Humans; Liver Neoplasms; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Prednisone; Remission Induction; Survival Rate; Tamoxifen | 1998 |
[Use of bone cements with added methotrexate for stabilization of pathologic fractures and filling of long bone defects in cases of neoplasm metastasis].
Topics: Activities of Daily Living; Adult; Aged; Antimetabolites, Antineoplastic; Bone Cements; Bone Neoplasms; Breast Neoplasms; Chemotherapy, Adjuvant; Drug Delivery Systems; Female; Femoral Fractures; Fractures, Spontaneous; Humans; Humeral Fractures; Kidney Neoplasms; Male; Methotrexate; Middle Aged; Ovarian Neoplasms; Pain Measurement; Survival Rate; Tibial Fractures; Treatment Outcome | 1998 |
Intensification of preoperative chemotherapy for osteogenic sarcoma: results of the Memorial Sloan-Kettering (T12) protocol.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Female; Humans; Male; Methotrexate; Necrosis; Osteosarcoma; Time Factors; Treatment Outcome | 1998 |
Long-term nephrotoxicity of cisplatin, ifosfamide, and methotrexate in osteosarcoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cisplatin; Creatinine; Female; Humans; Ifosfamide; Kidney Diseases; Kidney Function Tests; Male; Methotrexate; Osteosarcoma | 1998 |
Long-term results of the co-operative German-Austrian-Swiss osteosarcoma study group's protocol COSS-86 of intensive multidrug chemotherapy and surgery for osteosarcoma of the limbs.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Arm; Bone Neoplasms; Child, Preschool; Cisplatin; Doxorubicin; Female; Humans; Ifosfamide; Infusions, Intra-Arterial; Infusions, Intravenous; Leg; Male; Methotrexate; Neoadjuvant Therapy; Osteosarcoma; Risk Factors; Survival Analysis; Treatment Outcome | 1998 |
Treatment of metastatic osteosarcoma at diagnosis: a Pediatric Oncology Group Study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cisplatin; Combined Modality Therapy; Doxorubicin; Drug Administration Schedule; Female; Humans; Ifosfamide; Lung Neoplasms; Lymphatic Metastasis; Male; Methotrexate; Osteosarcoma; Time Factors | 1998 |
Local host response in osteosarcoma after chemotherapy referred to radiographs, CT, tumour necrosis and patient survival.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cisplatin; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Infant, Newborn; Male; Mesna; Methotrexate; Middle Aged; Necrosis; Neoadjuvant Therapy; Osteosarcoma; Predictive Value of Tests; Prognosis; Tomography, X-Ray Computed | 1998 |
Prospective evaluation of high-dose ifosfamide-related nephrotoxicity in young adult patients with recurrent osteosarcoma previously treated with cisplatin, methotrexate and standard-dose ifosfamide.
Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bicarbonates; Bone Neoplasms; Cisplatin; Creatinine; Dose-Response Relationship, Drug; Female; Humans; Ifosfamide; Kidney; Kidney Diseases; Male; Methotrexate; Neoplasm Recurrence, Local; Osteosarcoma; Prospective Studies | 1999 |
Chemotherapy in osteosarcoma. The Scandinavian Sarcoma Group experience.
Topics: Adolescent; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Cisplatin; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Humans; Male; Methotrexate; Osteosarcoma; Postoperative Care; Preoperative Care; Prognosis; Registries; Scandinavian and Nordic Countries | 1999 |
High dose chemotherapy for refractory urothelial carcinoma supported by peripheral blood stem cell transplantation.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Combined Modality Therapy; Doxorubicin; Female; Hematopoietic Stem Cell Transplantation; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Urologic Neoplasms; Vinblastine | 1999 |
High-dose methotrexate and HELP [Holoxan (ifosfamide), eldesine (vindesine), platinum]--doxorubicin in non-metastatic osteosarcoma of the extremity: a French multicentre pilot study. Fédération Nationale des Centres de Lutte contre le Cancer and Société F
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cisplatin; Disease-Free Survival; Doxorubicin; Female; France; Humans; Ifosfamide; Male; Methotrexate; Necrosis; Osteosarcoma; Pilot Projects; Prognosis; Survival Rate; Time Factors; Vindesine | 1999 |
Long-term results after combined modality treatment for non-metastatic osteosarcoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Methotrexate; Neoadjuvant Therapy; Neoplasm Staging; Osteosarcoma; Prognosis; Retrospective Studies; Treatment Outcome | 1999 |
Long-term outcome for patients with nonmetastatic osteosarcoma of the extremity treated at the istituto ortopedico rizzoli according to the istituto ortopedico rizzoli/osteosarcoma-2 protocol: an updated report.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cisplatin; Disease-Free Survival; Doxorubicin; Etoposide; Extremities; Female; Fertility; Follow-Up Studies; Humans; Ifosfamide; Male; Methotrexate; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Osteosarcoma; Patient Compliance; Plastic Surgery Procedures; Postoperative Complications; Radiography; Reoperation; Survival Rate | 2000 |
Received dose and dose-intensity of chemotherapy and outcome in nonmetastatic extremity osteosarcoma. European Osteosarcoma Intergroup.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cisplatin; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Extremities; Female; Humans; Male; Methotrexate; Neoadjuvant Therapy; Osteosarcoma; Survival Rate; Treatment Outcome | 2000 |
Impact of surgical resection of bladder cancer metastases refractory to systemic therapy on performance score: a phase II trial.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Transitional Cell; Cisplatin; Cystectomy; Doxorubicin; Female; Humans; Liver Neoplasms; Lung Neoplasms; Lymph Node Excision; Male; Methotrexate; Middle Aged; Prospective Studies; Skin Neoplasms; Urinary Bladder Neoplasms; Vinblastine | 2001 |
A comparison of methods of loco-regional chemotherapy combined with systemic chemotherapy as neo-adjuvant treatment of osteosarcoma of the extremity.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Doxorubicin; Extremities; Female; Humans; Ifosfamide; Infusions, Intra-Arterial; Infusions, Intravenous; Male; Methotrexate; Neoplasm Recurrence, Local; Osteosarcoma; Survival Rate | 2001 |
Competing risks analysis of patients with osteosarcoma: a comparison of four different approaches.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Cisplatin; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Female; Humans; Lung Neoplasms; Male; Methotrexate; Neoplasm Recurrence, Local; Osteosarcoma; Proportional Hazards Models; Risk Assessment | 2001 |
High dose ifosfamide in combination with high dose methotrexate, adriamycin and cisplatin in the neoadjuvant treatment of extremity osteosarcoma: preliminary results of an Italian Sarcoma Group/Scandinavian Sarcoma Group pilot study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chondrocytes; Cisplatin; Disease-Free Survival; Doxorubicin; Extremities; Female; Fibroblasts; Follow-Up Studies; Humans; Ifosfamide; Infusions, Intra-Arterial; Infusions, Intravenous; Male; Methotrexate; Neoadjuvant Therapy; Osteoblasts; Osteosarcoma; Pilot Projects; Preoperative Care; Prognosis; Survival Rate | 2002 |
Does the histological subtype of high-grade central osteosarcoma influence the response to treatment with chemotherapy and does it affect overall survival? A study on 570 patients of two consecutive trials of the European Osteosarcoma Intergroup.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cisplatin; Doxorubicin; Humans; Infant; Infant, Newborn; Methotrexate; Osteosarcoma; Risk Factors; Survival Analysis; Treatment Outcome | 2002 |
Treatment of osteogenic sarcoma. II. Aggressive resection of pulmonary metastases.
Topics: Antineoplastic Agents; Bone Neoplasms; Drug Therapy, Combination; Humans; Lung Neoplasms; Methotrexate; Neoplasm Metastasis; Osteosarcoma; Pneumonectomy; Thoracic Surgery; Thorax | 1979 |
Randomized trial of adjuvant chemotherapy in osteogenic osteosarcoma: comparison of altering sequential administrations of high doses of adriamycin, methotrexate, and cyclophosphamide with a 6-month administration of high-dose adriamycin followed by a low
Topics: Adolescent; Adult; Antineoplastic Agents; Bone Neoplasms; Child; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Middle Aged; Osteosarcoma; Random Allocation | 1978 |
Treatment of osteogenic sarcoma. I. Effect of adjuvant high-dose methotrexate after amputation.
Topics: Adolescent; Adult; Age Factors; BCG Vaccine; Bone Neoplasms; Child; Drug Therapy, Combination; Female; Humans; Leucovorin; Male; Methotrexate; Middle Aged; Osteosarcoma | 1979 |
A comparison of cyclophosphamide, adriamycin, 5-fluorouracil (CAF) and cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, prednisone (CMFVP) in patients with metastatic breast cancer: a Southeastern Cancer Study Group project.
Topics: Agranulocytosis; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; Humans; Methotrexate; Neoplasm Metastasis; Prednisone; Skin Neoplasms; Vincristine; Vomiting | 1977 |
Adjuvant therapy for osteosarcoma: preoperative and postoperative treatment.
Topics: Adolescent; Adult; Bone Neoplasms; Child; Child, Preschool; Clinical Trials as Topic; Doxorubicin; Female; Humans; Leucovorin; Male; Methotrexate; Neoplasm Recurrence, Local; Osteosarcoma; Postoperative Care; Preoperative Care; Time Factors | 1978 |
Local en bloc resection for limb preservation.
Topics: Adolescent; Bone Neoplasms; Clinical Trials as Topic; Doxorubicin; Drug Therapy, Combination; Extremities; Female; Humans; Joint Prosthesis; Leucovorin; Male; Methotrexate; Neoplasm Metastasis; Osteosarcoma; Vincristine | 1978 |
Sequential combination chemotherapy (containing high-dose cyclophosphamide) for metastic osteogenic sarcoma.
Topics: Adolescent; Bone Neoplasms; Child; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Neoplasm Metastasis; Osteosarcoma | 1978 |
Combination chemotherapy for osteosarcoma.
Topics: Adolescent; Adult; Bone Neoplasms; Child; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Humans; Leucovorin; Male; Methotrexate; Osteosarcoma; Time Factors | 1978 |
High-dose methotrexate in osteogenic sarcoma: a 5-year experience.
Topics: Adolescent; Adult; Bone Neoplasms; Child; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Leucovorin; Male; Methotrexate; Neoplasm Metastasis; Osteosarcoma; Time Factors; Vincristine | 1978 |
Adjuvant chemotherapy for osteogenic sarcoma.
Topics: Adolescent; Adult; Bone Neoplasms; Child; Child, Preschool; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Leucovorin; Male; Methotrexate; Neoplasm Metastasis; Osteosarcoma; Vincristine | 1978 |
Adjuvant therapy for nonmetastatic osteogenic sarcoma: an evaluation of transfer factor versus combination chemotherapy.
Topics: Bone Neoplasms; Clinical Trials as Topic; Doxorubicin; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Neoplasm Metastasis; Neoplasm Recurrence, Local; Osteosarcoma; Transfer Factor; Vincristine | 1978 |
Adjuvant multiple drug chemotherapy for osteosarcoma of the extremity: a 6 year report.
Topics: Adolescent; Adult; Antineoplastic Agents; Bone Neoplasms; Child; Clinical Trials as Topic; Doxorubicin; Drug Therapy, Combination; Extremities; Female; Humans; Male; Methotrexate; Middle Aged; Osteosarcoma; Recurrence; Vincristine | 1979 |
Progress in the treatment of osteosarcoma.
Topics: Adolescent; Adult; Amputation, Surgical; Antineoplastic Agents; Bone Neoplasms; Cell Division; Child; Clinical Trials as Topic; Doxorubicin; Drug Therapy, Combination; Female; Humans; Leucovorin; Lung Neoplasms; Male; Methotrexate; Neoplasm Metastasis; Osteosarcoma; Prognosis; Radiotherapy, High-Energy; Time Factors | 1977 |
Transfer factor versus combination chemotherapy: a preliminary report of a randomized postsurgical adjuvant treatment study in osteogenic sarcoma.
Topics: Antineoplastic Agents; B-Lymphocytes; Bone Neoplasms; Doxorubicin; Drug Therapy, Combination; Humans; Hypersensitivity, Delayed; Lymphocyte Activation; Methotrexate; Osteosarcoma; Skin Tests; T-Lymphocytes; Transfer Factor; Vincristine | 1976 |
Sequential therapy compared with combination therapy in multiple myeloma.
Topics: Autoradiography; Bence Jones Protein; Bone Neoplasms; Cell Count; Drug Therapy, Combination; Humans; Immunoglobulins; Kinetics; Melphalan; Methotrexate; Mitosis; Multiple Myeloma; Plasma Cells; Prednisone; Risk; Thymidine; Time Factors; Tritium; Vincristine | 1975 |
[Chemotherapy of metastasizing breast cancers. Indications and results].
Topics: Bone Neoplasms; Brain Neoplasms; Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Methotrexate; Neoplasm Metastasis; Prednisone; Remission, Spontaneous; Thoracic Neoplasms; Time Factors; Vincristine | 1975 |
Response and survival in advanced breast cancer after two non-cross-resistant combinations.
Topics: Antineoplastic Agents; Blood Cell Count; Blood Platelets; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; Humans; Leukocyte Count; Methotrexate; Middle Aged; Neoplasm Metastasis; Prospective Studies; Time Factors; Vincristine | 1976 |
MACOP-B treatment in patients with Ki-1-positive large-cell anaplastic lymphoma.
Topics: Adult; Aged; Antigens, CD; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Cyclophosphamide; Doxorubicin; Female; Humans; Ki-1 Antigen; Leucovorin; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Prednisone; Remission Induction; Vincristine | 1992 |
Effect of chemotherapy combined with caffeine for osteosarcoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Caffeine; Calcaneus; Chemotherapy, Adjuvant; Child; Cisplatin; Combined Modality Therapy; Doxorubicin; Etoposide; Female; Femoral Neoplasms; Humans; Ifosfamide; Infusions, Intra-Arterial; Male; Methotrexate; Osteosarcoma; Salvage Therapy; Tibia | 1992 |
Effect of intra-arterial versus intravenous cisplatin in addition to systemic adriamycin and high-dose methotrexate on histologic tumor response of osteosarcoma of the extremities.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Combined Modality Therapy; Dose-Response Relationship, Drug; Doxorubicin; Extremities; Female; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Male; Methotrexate; Osteosarcoma; Preoperative Care; Prospective Studies | 1992 |
[Effects of hydration on plasma concentrations of methotrexate in patients with osteosarcoma treated with high doses of methotrexate].
Topics: Adult; Bone Neoplasms; Child; Extremities; Female; Fluid Therapy; Glucose Solution, Hypertonic; Humans; Infusions, Intravenous; Kidney; Leucovorin; Male; Methotrexate; Osteosarcoma | 1992 |
The treatment of osteosarcoma: present trends. The Scandinavian Sarcoma Group experience.
Topics: Adolescent; Adult; Bone Neoplasms; Child; Combined Modality Therapy; Drug Therapy; Extremities; Female; Humans; Male; Methotrexate; Osteosarcoma; Preoperative Care; Retrospective Studies; Scandinavian and Nordic Countries; Survival Rate | 1992 |
Local control and survival from the Cooperative Osteosarcoma Study Group studies of the German Society of Pediatric Oncology and the Vienna Bone Tumor Registry.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Austria; Bleomycin; Bone Neoplasms; Child; Child, Preschool; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Follow-Up Studies; Germany; Humans; Ifosfamide; Interferon Type I; Male; Methotrexate; Osteosarcoma; Registries; Societies, Medical; Survival Rate; Switzerland; Vincristine | 1991 |
[Alternative chemotherapy of malignant bone neoplasms in children].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Child; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Humans; Leucovorin; Methotrexate; Organoplatinum Compounds; Osteosarcoma; Sarcoma, Ewing; Vincristine | 1990 |
[Comparative evaluation of 2 schedules of administration of anti- neoplastic drugs by the CMF protocol in disseminated breast cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cisplatin; Drug Administration Schedule; Female; Fluorouracil; Humans; Liver Neoplasms; Methotrexate; Prospective Studies; Remission Induction | 1991 |
Telangiectatic osteogenic sarcoma of the extremities. Results in 17 patients treated with neoadjuvant chemotherapy.
Topics: Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Clinical Protocols; Combined Modality Therapy; Doxorubicin; Follow-Up Studies; Humans; Infusions, Intravenous; Injections, Intra-Arterial; Italy; Methotrexate; Necrosis; Osteosarcoma; Osteotomy; Postoperative Care; Preoperative Care; Prostheses and Implants; Survival Rate; Telangiectasis | 1991 |
4-Hydroperoxycyclophosphamide purging of breast cancer from the mononuclear cell fraction of bone marrow in patients receiving high-dose chemotherapy and autologous marrow support: a phase I trial.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Transplantation; Bone Neoplasms; Brain Neoplasms; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Evaluation; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Neoplastic Stem Cells; Survival Rate | 1991 |
Late effects of adjuvant oophorectomy and chemotherapy upon premenopausal breast cancer patients.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Ovariectomy; Prednisone; Receptors, Estrogen | 1990 |
Effect of intraarterial versus intravenous cisplatin in addition to systemic doxorubicin, high-dose methotrexate, and ifosfamide on histologic tumor response in osteosarcoma (study COSS-86).
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Combined Modality Therapy; Doxorubicin; Female; Humans; Ifosfamide; Infusions, Intra-Arterial; Infusions, Intravenous; Male; Methotrexate; Osteosarcoma | 1990 |
[The combination treatment of malignant bone tumors using fast neutrons].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carubicin; Chondrosarcoma; Chordoma; Combined Modality Therapy; Fast Neutrons; Female; Humans; Male; Methotrexate; Middle Aged; Osteosarcoma; Survival Rate | 1990 |
Neoadjuvant chemotherapy of osteosarcoma: results of a randomized cooperative trial (COSS-82) with salvage chemotherapy based on histological tumor response.
Topics: Actuarial Analysis; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Child; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Humans; Male; Methotrexate; Osteosarcoma; Postoperative Period; Preoperative Care; Prognosis; Random Allocation | 1988 |
[Scintigraphic follow-up of osteosarcoma during neoadjuvant chemotherapy. Results of the cooperative osteosarcoma study of the Society for Pediatric Oncology].
Topics: Adolescent; Adult; Altretamine; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Child; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Follow-Up Studies; Humans; Methotrexate; Multicenter Studies as Topic; Osteosarcoma; Radionuclide Imaging; Technetium Tc 99m Medronate | 1988 |
A randomized study comparing high-dose methotrexate with moderate-dose methotrexate as components of adjuvant chemotherapy in childhood nonmetastatic osteosarcoma: a report from the Childrens Cancer Study Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Clinical Trials as Topic; Doxorubicin; Humans; Methotrexate; Osteosarcoma; Postoperative Care; Prognosis; Random Allocation; Time Factors; Vincristine | 1987 |
The relationship of various aspects of surgical management to outcome in childhood nonmetastatic osteosarcoma: a report from the Childrens Cancer Study Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Combined Modality Therapy; Doxorubicin; Female; Femoral Neoplasms; Humans; Humerus; Lung Neoplasms; Male; Methotrexate; Neoplasm Recurrence, Local; Osteosarcoma; Pelvic Neoplasms; Prognosis; Radius; Random Allocation; Tibia; Vincristine | 1988 |
Adriamycin-methotrexate high dose versus adriamycin-methotrexate moderate dose as adjuvant chemotherapy for osteosarcoma of the extremities: a randomized study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Combined Modality Therapy; Doxorubicin; Drug Evaluation; Extremities; Female; Humans; Leucovorin; Male; Methotrexate; Osteosarcoma; Random Allocation | 1986 |
Chemotherapy versus chemoimmunotherapy (CAF v CAFVP v CMF each +/- MER) for metastatic carcinoma of the breast: a CALGB study. Cancer and Leukemia Group B.
Topics: Antineoplastic Combined Chemotherapy Protocols; BCG Vaccine; Bone Neoplasms; Breast Neoplasms; Cisplatin; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Immunotherapy; Methotrexate; Middle Aged; Prednisone; Prognosis; Random Allocation; Vincristine | 1987 |
Comparison of intra-arterial cis-diamminedichloroplatinum II with high-dose methotrexate and citrovorum factor rescue in the treatment of primary osteosarcoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cisplatin; Humans; Infusions, Intra-Arterial; Leucovorin; Lung Neoplasms; Methotrexate; Osteosarcoma; Random Allocation | 1985 |
The fate of the bladder in patients with metastatic bladder cancer treated with cisplatin, methotrexate and vinblastine: a Northern California Oncology Group study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Transitional Cell; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Female; Humans; Liver Neoplasms; Male; Methotrexate; Middle Aged; Pelvic Neoplasms; Urinary Bladder Neoplasms; Vinblastine | 1985 |
Osteosarcoma: fifteen years later.
Topics: Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Doxorubicin; Extremities; Humans; Leucovorin; Methods; Methotrexate; Neoplasm Metastasis; Osteosarcoma; Prognosis; Prostheses and Implants; Random Allocation | 1985 |
[Chemotherapy of osteogenic sarcoma].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Doxorubicin; Follow-Up Studies; Humans; Methotrexate; Osteosarcoma | 1985 |
Intensive chemotherapy in patients with generalized Burkitt's lymphoma.
Topics: Abdominal Neoplasms; Adolescent; Adult; Bone Neoplasms; Burkitt Lymphoma; Child; Child, Preschool; Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Facial Neoplasms; Female; Humans; Male; Methotrexate; Neoplasm Metastasis; Neoplastic Cells, Circulating; Remission, Spontaneous; Thoracic Neoplasms; Vincristine | 1972 |
Adjuvant methotrexate and citrovorum-factor treatment of osteogenic sarcoma.
Topics: Amputation, Surgical; Bone Neoplasms; Clinical Trials as Topic; Drug Therapy, Combination; Femoral Neoplasms; Follow-Up Studies; Humans; Injections, Intramuscular; Injections, Intravenous; Leucovorin; Lung Neoplasms; Methotrexate; Neoplasm Metastasis; Osteosarcoma; Time Factors; Vincristine | 1974 |
629 other study(ies) available for methotrexate and Bone Cancer
Article | Year |
---|---|
TGF-β protects osteosarcoma cells from chemotherapeutic cytotoxicity in a SDH/HIF1α dependent manner.
Topics: Animals; Antineoplastic Agents; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Cisplatin; Down-Regulation; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Glucose; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Methotrexate; Mice; Osteosarcoma; Response Evaluation Criteria in Solid Tumors; STAT1 Transcription Factor; Succinate Dehydrogenase; Transforming Growth Factor beta; Up-Regulation; Warburg Effect, Oncologic; Xenograft Model Antitumor Assays | 2021 |
Oral-recombinant Methioninase Converts an Osteosarcoma from Methotrexate-resistant to -sensitive in a Patient-derived Orthotopic-xenograft (PDOX) Mouse Model.
Topics: Administration, Oral; Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carbon-Sulfur Lyases; Disease Models, Animal; Drug Resistance, Neoplasm; Humans; Methotrexate; Mice; Mice, Nude; Osteosarcoma; Treatment Outcome; Tumor Burden; Xenograft Model Antitumor Assays | 2022 |
Risk Factors for Hepatic Toxicity of High-dose Methotrexate in Patients With Osteosarcoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemical and Drug Induced Liver Injury; Child; Dose-Response Relationship, Drug; Female; History, 21st Century; Humans; Japan; Male; Methotrexate; Osteosarcoma; Retrospective Studies; Risk Factors; Young Adult | 2022 |
Unexpected severe hepatic and skin toxicities during high dose methotrexate course for osteosarcoma.
Topics: Adolescent; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Female; Humans; Liver-Specific Organic Anion Transporter 1; Methotrexate; Osteosarcoma; Renal Insufficiency; Stevens-Johnson Syndrome | 2022 |
Predictors and Treatment Outcomes of Pediatric Osteosarcoma in Diverse Socioeconomic Backgrounds in Southeast Asia: A Retrospective Multicenter Study.
Topics: Adolescent; Amputation, Surgical; Antineoplastic Agents; Asia, Southeastern; Bone Neoplasms; Child; Female; Humans; Limb Salvage; Male; Methotrexate; Neoplasm Staging; Osteosarcoma; Prognosis; Proportional Hazards Models; Retrospective Studies; Risk Factors; Socioeconomic Factors; Treatment Outcome | 2022 |
Quercetin and Methotrexate in Combination have Anticancer Activity in Osteosarcoma Cells and Repress Oncogenic MicroRNA-223.
Topics: Adolescent; Apoptosis; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Humans; Methotrexate; MicroRNAs; Osteosarcoma; Polycomb Repressive Complex 1; Proto-Oncogene Proteins c-bcl-2; Quercetin; Tumor Suppressor Protein p53 | 2022 |
Thymoquinone Augments Methotrexate-Induced Apoptosis on Osteosarcoma Cells.
Topics: Apoptosis; bcl-2-Associated X Protein; Benzoquinones; Bone Neoplasms; Caspase 9; Cell Line, Tumor; Cell Proliferation; Humans; Methotrexate; Osteosarcoma; Proto-Oncogene Proteins c-bcl-2 | 2022 |
Polydopamine-modified ZIF-8 nanoparticles as a drug carrier for combined chemo-photothermal osteosarcoma therapy.
Topics: Bone Neoplasms; Doxorubicin; Drug Carriers; Drug Liberation; Humans; Indoles; Methotrexate; Nanoparticles; Osteosarcoma; Phototherapy; Photothermal Therapy; Polymers | 2022 |
Prevalence and management of methotrexate-induced neurotoxicity in pediatric patients with osteosarcoma: a single-center experience.
Topics: Adolescent; Adult; Bone Neoplasms; Child; Child, Preschool; Humans; Male; Methotrexate; Neurotoxicity Syndromes; Osteosarcoma; Prevalence; Retrospective Studies; Young Adult | 2022 |
Nomogram predicting leukopenia in osteosarcoma after high-dose methotrexate chemotherapy.
Topics: Bone Neoplasms; Female; Humans; Ki-67 Antigen; Leukopenia; Methotrexate; Nomograms; Osteosarcoma | 2022 |
Thymoquinone Potentiates Methotrexate Mediated-Apoptosis in Saos-2 Osteosarcoma Cell Line.
Topics: Apoptosis; bcl-2-Associated X Protein; Benzoquinones; Bone Neoplasms; Caspase 3; Cell Line, Tumor; Cell Proliferation; Humans; Methotrexate; Osteosarcoma; Proto-Oncogene Proteins c-bcl-2 | 2022 |
Osteosarcoma and causes of death: A report of 1520 deceased patients from the Cooperative Osteosarcoma Study Group (COSS).
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cause of Death; Cisplatin; Doxorubicin; Female; Humans; Ifosfamide; Male; Methotrexate; Neoplasm Recurrence, Local; Osteosarcoma | 2022 |
Establishment and Characterization of Single and Triple-Agent Resistant Osteosarcoma Cell Lines.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Bone Neoplasms; Cell Line, Tumor; Cisplatin; Doxorubicin; Humans; Methotrexate; Osteosarcoma | 2023 |
LncRNA EBLN3P attributes methotrexate resistance in osteosarcoma cells through miR-200a-3p/O-GlcNAc transferase pathway.
Topics: Bone Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Methotrexate; MicroRNAs; Osteosarcoma; Pseudogenes; RNA, Long Noncoding | 2022 |
Peri-osteosarcoma adipose computed tomography attenuation and volume for predicting chemotherapy response in pediatric patients.
Topics: Bone Neoplasms; Child; Humans; Inflammation; Methotrexate; Osteosarcoma; Retrospective Studies; Tomography | 2023 |
Neurocognitive outcomes of children with osteosarcoma treated with methotrexate.
Topics: Antimetabolites, Antineoplastic; Bone Neoplasms; Child; Humans; Methotrexate; Osteosarcoma | 2023 |
Methotrexate Drug Monitoring From Central Access: Can Blood Sample Collection From Central Venous Access Replace Peripheral Venipuncture in Adults?
Topics: Adult; Blood Specimen Collection; Bone Neoplasms; Drug Monitoring; Female; Humans; Methotrexate; Middle Aged; Phlebotomy | 2023 |
Predicting chemosensitivity based on mini patient-derived xenografts in osteosarcoma patients: A retrospective study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Doxorubicin; Heterografts; Humans; Ifosfamide; Methotrexate; Osteosarcoma; Retrospective Studies | 2023 |
Effect of co-medications and potential risk factors of high-dose methotrexate-mediated acute hepatotoxicity in patients with osteosarcoma.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Bone Neoplasms; Chemical and Drug Induced Liver Injury; Child; Cohort Studies; Disease Progression; Female; Humans; Methotrexate; Osteosarcoma; Proton Pump Inhibitors; Risk Factors; Trimethoprim, Sulfamethoxazole Drug Combination | 2023 |
Outcomes and survival rates of childhood osteosarcoma in Iran, A report from MAHAK Pediatric Cancer Treatment and Research Center, from 2007 to 2020.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cisplatin; Disease-Free Survival; Doxorubicin; Female; Humans; Ifosfamide; Iran; Male; Methotrexate; Osteosarcoma; Retrospective Studies; Survival Rate | 2023 |
Risk factors associated with delayed methotrexate clearance and increased toxicity in pediatric patients with osteosarcoma.
Topics: Adolescent; Antimetabolites, Antineoplastic; Bone Neoplasms; Child; Child, Preschool; Female; Humans; Male; Methotrexate; Osteosarcoma; Retrospective Studies; Risk Factors | 2020 |
Decreasing Cost and Decreasing Length of Stay After Implementation of Updated High-Dose Methotrexate Discharge Criteria.
Topics: Bone Neoplasms; Humans; Length of Stay; Methotrexate; Patient Discharge; Retrospective Studies | 2020 |
Impact of chemotherapy-induced necrosis on event-free and overall survival after preoperative MAP chemotherapy in patients with primary high-grade localized osteosarcoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cisplatin; Correlation of Data; Disease-Free Survival; Doxorubicin; Female; Humans; Male; Methotrexate; Necrosis; Neoadjuvant Therapy; Osteosarcoma; Preoperative Period; Retrospective Studies; Survival Rate; Young Adult | 2020 |
Circular RNA hsa_circ_0000073 contributes to osteosarcoma cell proliferation, migration, invasion and methotrexate resistance by sponging miR-145-5p and miR-151-3p and upregulating NRAS.
Topics: Antimetabolites, Antineoplastic; Bone Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Drug Resistance, Neoplasm; GTP Phosphohydrolases; Humans; Membrane Proteins; Methotrexate; MicroRNAs; Neoplasm Invasiveness; Osteosarcoma; RNA, Circular | 2020 |
Methotrexate-induced epidermal necrosis in a child with osteosarcoma.
Topics: Adolescent; Antineoplastic Agents; Bone Neoplasms; Doxorubicin; Humans; Male; Methotrexate; Necrosis; Osteosarcoma | 2020 |
miR-192 enhances sensitivity of methotrexate drug to MG-63 osteosarcoma cancer cells.
Topics: Antimetabolites, Antineoplastic; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Down-Regulation; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Methotrexate; MicroRNAs; Osteosarcoma; Signal Transduction | 2020 |
Clinical factors affecting prognosis of limb osteosarcoma in China: a multicenter retrospective analysis.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; China; Cisplatin; Disease-Free Survival; Doxorubicin; Female; Humans; Ifosfamide; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Osteosarcoma; Prognosis; Retrospective Studies; Young Adult | 2020 |
Significant interaction between high-dose methotrexate and high-dose piperacillin-tazobactam causing reversible neurotoxicity and renal failure in an osteosarcoma patient.
Topics: Adolescent; Anti-Bacterial Agents; Antimetabolites, Antineoplastic; Bone Neoplasms; Drug Interactions; Humans; Male; Methotrexate; Neurotoxicity Syndromes; Osteosarcoma; Piperacillin; Renal Insufficiency | 2021 |
IAP Chemotherapy Regimen Is a Viable and Cost-effective Option in Children and Adolescents With Osteosarcoma: A Comparative Analysis With MAP Regimen on Toxicity and Survival.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cisplatin; Cost-Benefit Analysis; Disease-Free Survival; Doxorubicin; Female; Humans; Ifosfamide; Male; Methotrexate; Osteosarcoma; Retrospective Studies; Salvage Therapy | 2021 |
Standardized Supportive Care Documentation Improves Safety of High-Dose Methotrexate Treatment.
Topics: Bone Neoplasms; Documentation; Humans; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retrospective Studies | 2021 |
Clinical therapeutic effects of combined methotrexate and other chemotherapeutic agents in treating children and young patients with osteosarcoma: A protocol for systematic review and meta-analysis.
Topics: Adolescent; Antineoplastic Agents; Bone Neoplasms; Child; Drug Therapy, Combination; Female; Humans; Male; Meta-Analysis as Topic; Methotrexate; Osteosarcoma; Randomized Controlled Trials as Topic; Research Design; Systematic Reviews as Topic; Treatment Outcome; Young Adult | 2021 |
Effect assessment of methotrexate in combination with other chemotherapeutic agents for osteosarcoma in children: A protocol for systematic review and meta-analysis.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Disease-Free Survival; Humans; Meta-Analysis as Topic; Methotrexate; Neoplasm Recurrence, Local; Osteosarcoma; Randomized Controlled Trials as Topic; Survival Rate; Systematic Reviews as Topic; Time Factors | 2021 |
A possible interaction between favipiravir and methotrexate: Drug-induced hepatotoxicity in a patient with osteosarcoma.
Topics: Amides; Antiviral Agents; Bone Neoplasms; Chemical and Drug Induced Liver Injury; COVID-19; Humans; Methotrexate; Osteosarcoma; Pharmaceutical Preparations; Pyrazines; RNA, Viral; SARS-CoV-2 | 2022 |
Adjuvant and neoadjuvant chemotherapy for osteosarcoma: JCOG Bone and Soft Tissue Tumor Study Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Doxorubicin; Extremities; Humans; Ifosfamide; Methotrexate; Neoadjuvant Therapy; Osteosarcoma; Soft Tissue Neoplasms | 2021 |
High dose methotrexate containing regimen in pediatric non-metastatic extremity osteosarcoma patients: experience from a tertiary cancer center in India.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cisplatin; Doxorubicin; Extremities; Humans; Methotrexate; Osteosarcoma | 2022 |
Investigating Optimal Chemotherapy Options for Osteosarcoma Patients through a Mathematical Model.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Clinical Decision-Making; Cytotoxicity, Immunologic; Decision Support Techniques; Dendritic Cells; Doxorubicin; Drug Administration Schedule; HMGB1 Protein; Humans; Interferon-gamma; Lymphocytes, Tumor-Infiltrating; Methotrexate; Models, Theoretical; Osteosarcoma; Patient Selection; Precision Medicine; T-Lymphocytes, Helper-Inducer; Time Factors; Tumor Microenvironment | 2021 |
Diffuse Marrow Involvement in Metastatic Osteosarcoma: An Unusual Presentation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Neoplasms; Child; Cisplatin; Doxorubicin; Fatal Outcome; Female; Humans; Magnetic Resonance Imaging; Methotrexate; Osteosarcoma; Tomography, X-Ray Computed | 2017 |
Poloxamer surface modified trimethyl chitosan nanoparticles for the effective delivery of methotrexate in osteosarcoma.
Topics: Antineoplastic Agents; Bone Neoplasms; Cell Line, Tumor; Chitosan; Drug Carriers; Drug Delivery Systems; Endocytosis; Humans; Methotrexate; Nanoparticles; Osteosarcoma; Poloxamer | 2017 |
Fertility, Cardiac, and Orthopedic Challenges in Survivors of Adult and Childhood Sarcoma.
Topics: Adolescent; Adult; Bone Neoplasms; Cancer Survivors; Cardiotoxicity; Child; Cisplatin; Dexrazoxane; Doxorubicin; Female; Humans; Infertility; Male; Methotrexate; Osteosarcoma | 2017 |
Perioperative chemotherapy with and without high-dose methotrexate in adult osteosarcoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Doxorubicin; Female; Humans; Male; Methotrexate; Osteosarcoma; Perioperative Care; Retrospective Studies; Young Adult | 2017 |
Transition from Tumor Tissue to Bone Marrow in Patients with Appendicular Osteosarcoma after Neoadjuvant Chemotherapy.
Topics: Adolescent; Adult; Bone Marrow; Bone Neoplasms; Child; Cisplatin; Doxorubicin; Female; Humans; Ifosfamide; In Vitro Techniques; Limb Salvage; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Osteosarcoma; Treatment Outcome; Young Adult | 2017 |
Outcomes in non-metastatic treatment naive extremity osteosarcoma patients treated with a novel non-high dosemethotrexate-based, dose-dense combination chemotherapy regimen 'OGS-12'.
Topics: Adolescent; Adult; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Cisplatin; Developing Countries; Disease-Free Survival; Doxorubicin; Female; Humans; Ifosfamide; India; Intention to Treat Analysis; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Osteosarcoma; Proportional Hazards Models; Retrospective Studies; Time Factors; Treatment Outcome; Tumor Burden; Young Adult | 2017 |
Patient-derived osteosarcoma cells are resistant to methotrexate.
Topics: Adolescent; Animals; Antimetabolites, Antineoplastic; Biomarkers, Tumor; Bone Neoplasms; Cell Culture Techniques; Cells, Cultured; Child; Cisplatin; Doxorubicin; Drug Resistance, Neoplasm; Female; Humans; Male; Methotrexate; Mice, Inbred NOD; Mice, SCID; Middle Aged; Neoplasm Transplantation; Osteosarcoma; Young Adult | 2017 |
MicroRNA-375 as a potential serum biomarker for the diagnosis, prognosis, and chemosensitivity prediction of osteosarcoma.
Topics: Adolescent; Adult; Biomarkers, Tumor; Bone Neoplasms; Case-Control Studies; Child; Doxorubicin; Female; Humans; Male; Methotrexate; MicroRNAs; Neoadjuvant Therapy; Neoplasm Staging; Osteosarcoma; Prognosis; ROC Curve; Survival Analysis; Treatment Outcome; Tumor Burden | 2018 |
Ceramic core with polymer corona hybrid nanocarrier for the treatment of osteosarcoma with co-delivery of protein and anti-cancer drug.
Topics: Animals; Antineoplastic Agents; Bone Neoplasms; Cattle; Cell Line, Tumor; Drug Carriers; Drug Delivery Systems; Drug Liberation; Durapatite; Methotrexate; Nanoparticles; Osteosarcoma; Polyvinyl Alcohol; Serum Albumin, Bovine | 2018 |
Long non-coding RNA LUCAT1 modulates methotrexate resistance in osteosarcoma via miR-200c/ABCB1 axis.
Topics: Animals; Antimetabolites, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B; Bone Neoplasms; Cell Line, Tumor; Drug Resistance, Neoplasm; Humans; Male; Methotrexate; Mice; Mice, Inbred BALB C; Mice, Nude; MicroRNAs; Osteosarcoma; RNA, Long Noncoding; Signal Transduction; Treatment Outcome | 2018 |
Bone-targeting dendrimer for the delivery of methotrexate and treatment of bone metastasis.
Topics: Animals; Antimetabolites, Antineoplastic; Bone Neoplasms; Dendrimers; Female; Male; Methotrexate; Mice; Mice, Inbred C57BL; Tissue Distribution | 2018 |
Micrometastatic Drug Screening Platform Shows Heterogeneous Response to MAP Chemotherapy in Osteosarcoma Cell Lines.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cell Line, Tumor; Cisplatin; Doxorubicin; Drug Evaluation, Preclinical; Drug Resistance, Neoplasm; Humans; Methotrexate; Neoplasm Micrometastasis; Osteosarcoma | 2018 |
S-phase kinase-associated protein 2 is involved in epithelial-mesenchymal transition in methotrexate-resistant osteosarcoma cells.
Topics: Antineoplastic Agents; Bone Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Humans; Methotrexate; Osteosarcoma; S-Phase Kinase-Associated Proteins; Signal Transduction | 2018 |
Successful Treatment of Osteosarcoma Without Methotrexate in a 13-Year-Old Boy With Down Syndrome.
Topics: Adolescent; Bone Neoplasms; Down Syndrome; Humans; Male; Methotrexate; Osteosarcoma | 2019 |
The outcomes and prognostic factors in patients with osteosarcoma according to age: a Japanese nationwide study with focusing on the age differences.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Female; Humans; Japan; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Osteosarcoma; Prognosis; Proportional Hazards Models; Registries; Retrospective Studies; Risk Factors; Survival Rate; Treatment Outcome; Young Adult | 2018 |
The Efficiency and Toxicity of Mifamurtide in Childhood Osteosarcoma.
Topics: Acetaminophen; Acetylmuramyl-Alanyl-Isoglutamine; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Disease-Free Survival; Female; Follow-Up Studies; Humans; Male; Methotrexate; Osteosarcoma; Phosphatidylethanolamines; Retrospective Studies; Survival Rate; Turkey | 2018 |
Outpatient High-dose Methotrexate for Osteosarcoma: It's Safe and Feasible, If You Want It.
Topics: Adolescent; Bone Neoplasms; Hospitalization; Humans; Methotrexate; Osteosarcoma; Outpatients; Patient Satisfaction; Prospective Studies; Treatment Outcome | 2019 |
Bone sarcoma during pregnancy: an example of personalized multidisciplinary care.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Doxorubicin; Female; Humans; Methotrexate; Patient-Centered Care; Pregnancy; Pregnancy Complications, Neoplastic; Sarcoma | 2019 |
miR-29 Family Inhibits Resistance to Methotrexate and Promotes Cell Apoptosis by Targeting COL3A1 and MCL1 in Osteosarcoma.
Topics: Apoptosis; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Collagen Type III; Down-Regulation; Drug Resistance, Neoplasm; Humans; Methotrexate; MicroRNAs; Myeloid Cell Leukemia Sequence 1 Protein; Osteosarcoma; Up-Regulation | 2018 |
Population Pharmacokinetic Study and Individual Dose Adjustments of High-Dose Methotrexate in Chinese Pediatric Patients With Acute Lymphoblastic Leukemia or Osteosarcoma.
Topics: Adolescent; Antimetabolites, Antineoplastic; Asian People; Bone Neoplasms; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; Humans; Infant; Male; Methotrexate; Osteosarcoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retrospective Studies; Young Adult | 2019 |
Safety and efficacy of high-dose methotrexate for osteosarcoma in adolescents compared with young adults.
Topics: Adolescent; Adult; Antimetabolites, Antineoplastic; Bone Neoplasms; Child; Female; Humans; Male; Methotrexate; Neoplasm Recurrence, Local; Osteosarcoma; Treatment Outcome; Young Adult | 2019 |
Bone Sarcoma With
Topics: 12E7 Antigen; Adult; Amputation, Surgical; Biopsy; Bone Neoplasms; Chemotherapy, Adjuvant; Diagnosis, Differential; Femur; Gene Amplification; Humans; Male; Methotrexate; Oncogene Proteins, Fusion; Osteosarcoma; Sarcoma, Ewing; Treatment Outcome | 2019 |
Clinical Prognostic Factors and Outcome in Pediatric Osteosarcoma: Effect of Delay in Local Control and Degree of Necrosis in a Multidisciplinary Setting in Lebanon.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cisplatin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Infant; Lebanon; Male; Methotrexate; Neoadjuvant Therapy; Neoplasm Metastasis; Osteosarcoma; Prognosis; Retrospective Studies; Risk Assessment; Treatment Outcome | 2019 |
Primary angiosarcoma of bone: a retrospective analysis of 60 patients from 2 institutions.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cisplatin; Cohort Studies; Disease-Free Survival; Doxorubicin; Female; Femoral Neoplasms; Femur; Hemangiosarcoma; Humans; Humerus; Ifosfamide; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Paclitaxel; Pelvic Bones; Radiotherapy; Radiotherapy, Adjuvant; Radius; Retrospective Studies; Skull Neoplasms; Spinal Neoplasms; Treatment Outcome; Ulna; Young Adult | 2014 |
Osteosarcoma around the knee treated with neoadjuvant chemotherapy and a custom-designed prosthesis.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Arthroplasty, Replacement, Knee; Bone Neoplasms; Child; Doxorubicin; Female; Humans; Ifosfamide; Knee; Knee Joint; Knee Prosthesis; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Osteosarcoma; Prosthesis Design; Retrospective Studies; Young Adult | 2013 |
The correlation between dose of folinic acid and neurotoxicity in children and adolescents treated for osteosarcoma with high-dose methotrexate (HDMTX): a neuropsychological and psychosocial study.
Topics: Adolescent; Adult; Antimetabolites, Antineoplastic; Bone Neoplasms; Dose-Response Relationship, Drug; Female; Humans; Leucovorin; Male; Methotrexate; Neuropsychological Tests; Neurotoxicity Syndromes; Osteosarcoma; Young Adult | 2013 |
Carboplatin and doxorubicin in treatment of pediatric osteosarcoma: a 9-year single institute experience in the Northern Region of Thailand.
Topics: Adolescent; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Child; Child, Preschool; Disease-Free Survival; Doxorubicin; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Methotrexate; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Osteosarcoma; Retrospective Studies; Risk Factors; Survival; Survival Rate; Thailand; Treatment Outcome | 2013 |
Single nucleotide polymorphisms in the NER pathway and clinical outcome of patients with bone malignant tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Neoplasms; Child; Cisplatin; Cyclin H; DNA Helicases; DNA Repair; DNA Repair Enzymes; DNA-Binding Proteins; Endonucleases; Female; Follow-Up Studies; Genotype; Humans; Male; Methotrexate; Neoplasm Metastasis; Nuclear Proteins; Osteosarcoma; Poly-ADP-Ribose Binding Proteins; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Polymorphism, Single Nucleotide; Prognosis; Survival Rate; Transcription Factors; Young Adult | 2013 |
Predictive impact of common variations in DNA repair genes on clinical outcome of osteosarcoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Neoplasms; Child; Cisplatin; DNA Repair; DNA-Binding Proteins; Doxorubicin; Endonucleases; Female; Follow-Up Studies; Humans; Male; Methotrexate; Neoplasm Staging; Nuclear Proteins; Osteosarcoma; Polymorphism, Genetic; Prognosis; Transcription Factors; Young Adult | 2013 |
Targeted expression of human folylpolyglutamate synthase for selective enhancement of methotrexate chemotherapy in osteosarcoma cells.
Topics: Antimetabolites, Antineoplastic; Bone Neoplasms; Cell Line, Tumor; Cloning, Molecular; Gene Expression; Gene Order; Genes, Reporter; Genetic Vectors; Humans; Lentivirus; Methotrexate; Organ Specificity; Osteocalcin; Osteosarcoma; Peptide Synthases; Promoter Regions, Genetic; Transduction, Genetic; Transfection; Tumor Cells, Cultured | 2013 |
Hypersensitivity reaction to high-dose methotrexate and successful rechallenge in a pediatric patient with osteosarcoma.
Topics: Anaphylaxis; Antimetabolites, Antineoplastic; Bone Neoplasms; Child; Desensitization, Immunologic; Dose-Response Relationship, Drug; Drug Hypersensitivity; Female; Humans; Infusions, Intravenous; Methotrexate; Osteosarcoma; Prognosis | 2014 |
Effect of variation of ABCB1 and ABCC3 genotypes on the survival of bone tumor cases after chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Cisplatin; Dactinomycin; Doxorubicin; Female; Follow-Up Studies; Genotype; Humans; Male; Methotrexate; Middle Aged; Multidrug Resistance-Associated Proteins; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Osteosarcoma; Polymorphism, Single Nucleotide; Prognosis; Survival Rate; Vincristine; Young Adult | 2013 |
Efficacy of glucarpidase (carboxypeptidase g2) in patients with acute kidney injury after high-dose methotrexate therapy.
Topics: Acute Kidney Injury; Antimetabolites, Antineoplastic; Bone Neoplasms; Compassionate Use Trials; Drug Administration Schedule; gamma-Glutamyl Hydrolase; Humans; Leucovorin; Methotrexate; Osteosarcoma; Treatment Outcome | 2014 |
Drug-drug interaction between methotrexate and levetiracetam resulting in delayed methotrexate elimination.
Topics: Anticonvulsants; Antimetabolites, Antineoplastic; Bone Neoplasms; Drug Interactions; Humans; Levetiracetam; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Osteosarcoma; Piracetam | 2014 |
Can high dose methotrexate be continued after severe hypersensitivity reaction?
Topics: Anaphylaxis; Antimetabolites, Antineoplastic; Bone Neoplasms; Desensitization, Immunologic; Drug Hypersensitivity; Female; Humans; Methotrexate; Osteosarcoma | 2014 |
Hearing loss during osteosarcoma chemotherapy: when acute ifosfamide toxicity revealed unnoticed methotrexate encephalopathy.
Topics: Adolescent; Antineoplastic Agents; Bone Neoplasms; Brain; Brain Diseases; Female; Hearing Loss; Humans; Ifosfamide; Magnetic Resonance Imaging; Methotrexate; Osteosarcoma | 2014 |
[Value of ifosfamide in neoadjuvant therapy for osteosarcoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Doxorubicin; Female; Humans; Ifosfamide; Male; Methotrexate; Osteosarcoma | 2013 |
Is it important to maintain high-dose intensity chemotherapy in the treatment of adults with osteosarcoma?
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Dose-Response Relationship, Drug; Doxorubicin; Female; Follow-Up Studies; Humans; Ifosfamide; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Osteosarcoma; Prognosis; Retrospective Studies; Survival Rate; Time Factors; Young Adult | 2014 |
Developing population pharmacokinetic parameters for high-dose methotrexate therapy: implication of correlations among developed parameters for individual parameter estimation using the Bayesian least-squares method.
Topics: Adolescent; Adult; Aged; Bayes Theorem; Bone Neoplasms; Child; Dose-Response Relationship, Drug; Humans; Least-Squares Analysis; Lymphoma; Methotrexate; Middle Aged; Models, Statistical; Osteosarcoma; Patient-Specific Modeling; Retrospective Studies; Young Adult | 2014 |
Estrogen-related receptor alpha confers methotrexate resistance via attenuation of reactive oxygen species production and P53 mediated apoptosis in osteosarcoma cells.
Topics: Adaptor Proteins, Signal Transducing; Adolescent; Antimetabolites, Antineoplastic; Apoptosis; Apoptosis Regulatory Proteins; Bone Neoplasms; Cell Line, Tumor; Cell Survival; Child; Child, Preschool; Drug Resistance, Neoplasm; ERRalpha Estrogen-Related Receptor; Humans; Intracellular Signaling Peptides and Proteins; Methotrexate; Neoplasm Proteins; Osteosarcoma; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Receptors, Estrogen; Signal Transduction; Tumor Suppressor Protein p53 | 2014 |
Targeted antiosteosarcoma methotrexate-bisphosphonate conjugate induces apoptosis of osteosarcoma cells in vitro.
Topics: Apoptosis; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Diphosphonates; Humans; Methotrexate; Osteosarcoma; Survival Rate | 2014 |
Influence of the folate pathway and transporter polymorphisms on methotrexate treatment outcome in osteosarcoma.
Topics: Adolescent; Adult; Antimetabolites, Antineoplastic; Bone Neoplasms; Child; Female; Folic Acid; Humans; Liver-Specific Organic Anion Transporter 1; Male; Methotrexate; Organic Anion Transporters; Osteosarcoma; Polymorphism, Single Nucleotide; Survival Analysis; Treatment Outcome; Young Adult | 2014 |
Osteopontin upregulates the expression of glucose transporters in osteosarcoma cells.
Topics: Antineoplastic Agents; Bone Neoplasms; Cell Line, Tumor; Daunorubicin; Etoposide; Fluorouracil; Glucose Transport Proteins, Facilitative; Glucose Transporter Type 1; Glucose Transporter Type 3; Humans; Integrin alphaVbeta3; Membrane Transport Modulators; Methotrexate; Osteopontin; Osteosarcoma; Phloretin; Up-Regulation | 2014 |
Marginal resection for osteosarcoma with effective neoadjuvant chemotherapy: long-term outcomes.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Doxorubicin; Female; Follow-Up Studies; Humans; Ifosfamide; Lung Neoplasms; Lymphatic Metastasis; Male; Methotrexate; Neoadjuvant Therapy; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Osteosarcoma; Prognosis; Survival Rate; Time Factors | 2014 |
Pirarubicin versus doxorubicin in neoadjuvant/adjuvant chemotherapy for stage IIB limb high-grade osteosarcoma: does the analog matter?
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Cisplatin; Disease-Free Survival; Doxorubicin; Extremities; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Grading; Neoplasm Staging; Osteosarcoma; Retrospective Studies; Young Adult | 2015 |
Halloysite nanotube-based drug delivery system for treating osteosarcoma.
Topics: Aluminum Silicates; Antineoplastic Agents; Apoptosis; Bone Neoplasms; Cell Line, Tumor; Clay; Drug Carriers; Humans; Methotrexate; Nanotubes; Osteosarcoma | 2014 |
Excision repair cross-complementation group 1 protein expression predicts survival in patients with high-grade, non-metastatic osteosarcoma treated with neoadjuvant chemotherapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B; Biomarkers, Tumor; Bone Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; DNA-Binding Proteins; Doxorubicin; Endonucleases; Female; Humans; Ifosfamide; Immunohistochemistry; Kaplan-Meier Estimate; Male; Methotrexate; Neoadjuvant Therapy; Osteosarcoma; Prognosis; Retrospective Studies | 2015 |
Comparable efficacy with varying dosages of glucarpidase in pediatric oncology patients.
Topics: Acute Kidney Injury; Adolescent; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Creatinine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Costs; Drug Evaluation; Female; gamma-Glutamyl Hydrolase; Hematologic Neoplasms; Humans; Inactivation, Metabolic; Infusions, Intravenous; Injections, Intravenous; Leucovorin; Male; Methotrexate; Osteosarcoma; Recombinant Proteins; Recovery of Function; Retrospective Studies; Young Adult | 2015 |
DHFR-mediated effects of methotrexate in medulloblastoma and osteosarcoma cells: the same outcome of treatment with different doses in sensitive cell lines.
Topics: Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Cerebellar Neoplasms; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Flow Cytometry; Folic Acid Antagonists; Humans; Medulloblastoma; Methotrexate; Osteosarcoma; Reverse Transcriptase Polymerase Chain Reaction; Tetrahydrofolate Dehydrogenase | 2015 |
Benefit of consolidative radiation therapy for primary bone diffuse large B-cell lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cause of Death; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Prednisone; Proportional Hazards Models; Radiotherapy Dosage; Rituximab; Treatment Failure; Tumor Burden; Vincristine; Young Adult | 2015 |
Effects of melatonin combined with Cis-platinum or methotrexate on the proliferation of osteosarcoma cell line SaOS-2.
Topics: Apoptosis; Bone Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cisplatin; Flow Cytometry; Humans; Melatonin; Methotrexate; Osteosarcoma | 2015 |
The comparison of oncologic outcomes between metastatic upper tract urothelial carcinoma and urothelial carcinoma of the bladder after cisplatin-based chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Deoxycytidine; Doxorubicin; Female; Follow-Up Studies; Gemcitabine; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prognosis; Retrospective Studies; Survival Rate; Urologic Neoplasms; Vinblastine | 2015 |
Identification of genes associated with methotrexate resistance in methotrexate-resistant osteosarcoma cell lines.
Topics: Bone Neoplasms; Cell Line, Tumor; Databases, Genetic; Drug Resistance, Neoplasm; Humans; Methotrexate; Osteosarcoma; Protein Interaction Maps | 2015 |
Highly effective reduced toxicity dose-intensive pilot protocol for non-metastatic limb osteogenic sarcoma (SCOS 89).
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Doxorubicin; Drug Substitution; Etoposide; Female; Follow-Up Studies; Hearing Loss; Humans; Ifosfamide; Kidney Diseases; Leucovorin; Male; Methotrexate; Osteosarcoma; Pilot Projects; Stroke Volume; Survival Rate; Treatment Outcome; Young Adult | 2015 |
Intensified Chemotherapy With Dexrazoxane Cardioprotection in Newly Diagnosed Nonmetastatic Osteosarcoma: A Report From the Children's Oncology Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cardiotonic Agents; Child; Child, Preschool; Cisplatin; Dexrazoxane; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Infant, Newborn; Male; Methotrexate; Osteosarcoma; Treatment Outcome; Ventricular Dysfunction | 2016 |
Effect of ceftriaxone and cefepime on high-dose methotrexate clearance.
Topics: Administration, Intravenous; Animals; Anti-Bacterial Agents; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cefepime; Ceftriaxone; Cephalosporins; Drug Interactions; Humans; Kidney Tubules, Proximal; Male; Methotrexate; Young Adult | 2016 |
Risk-Based Therapy for Localized Osteosarcoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Doxorubicin; Female; Femoral Neoplasms; Humans; Male; Melphalan; Methotrexate; Osteosarcoma; Stem Cell Transplantation; Treatment Outcome | 2016 |
Neurocognitive and Patient-Reported Outcomes in Adult Survivors of Childhood Osteosarcoma.
Topics: Adult; Antimetabolites, Antineoplastic; Attention; Bone Neoplasms; Case-Control Studies; Cognition; Cognition Disorders; Cross-Sectional Studies; Emotions; Executive Function; Female; Humans; Male; Memory; Methotrexate; Middle Aged; Neurotoxicity Syndromes; Osteosarcoma; Quality of Life; Risk Assessment; Risk Factors; Survivors; Time Factors; Treatment Outcome; United States | 2016 |
For Patients With Cancer, Cure Is Not Enough.
Topics: Antimetabolites, Antineoplastic; Bone Neoplasms; Cognition; Cognition Disorders; Female; Hospitalization; Humans; Male; Methotrexate; Neoplasms; Neurotoxicity Syndromes; Osteosarcoma; Survivors | 2016 |
Effects of Incorporating Carboxymethyl Chitosan into PMMA Bone Cement Containing Methotrexate.
Topics: Animals; Biocompatible Materials; Bone Cements; Bone Neoplasms; Cell Line, Tumor; Chitosan; Compressive Strength; Femur; Guinea Pigs; Humans; Imaging, Three-Dimensional; Lab-On-A-Chip Devices; Materials Testing; Methotrexate; Microscopy, Electron, Scanning; Polymethyl Methacrylate; Tomography, Spiral Computed | 2015 |
Krüppel-like factor 4 promotes high-mobility group box 1-induced chemotherapy resistance in osteosarcoma cells.
Topics: Antineoplastic Agents; Binding Sites; Bone Neoplasms; Cell Line, Tumor; Cisplatin; Doxorubicin; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; HMGB1 Protein; Humans; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Methotrexate; Osteosarcoma; Promoter Regions, Genetic; Protein Binding; Transcription, Genetic | 2016 |
Singapore Cancer Network (SCAN) Guidelines for the Initial Evaluation, Diagnosis, and Management of Extremity Soft Tissue Sarcoma and Osteosarcoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Cisplatin; Disease Management; Doxorubicin; Extremities; Humans; Ifosfamide; Magnetic Resonance Imaging; Methotrexate; Neoadjuvant Therapy; Osteosarcoma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiotherapy; Radiotherapy, Adjuvant; Sarcoma; Singapore; Soft Tissue Neoplasms; Surgical Procedures, Operative; Tomography, X-Ray Computed | 2015 |
Combined Treatment of MCF-7 Cells with AICAR and Methotrexate, Arrests Cell Cycle and Reverses Warburg Metabolism through AMP-Activated Protein Kinase (AMPK) and FOXO1.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cell Cycle; Cell Division; Cell Line, Tumor; Cytostatic Agents; Drug Screening Assays, Antitumor; Drug Synergism; Energy Metabolism; Enzyme Induction; Female; Forkhead Box Protein O1; Forkhead Transcription Factors; Gene Expression Regulation, Neoplastic; Glycolysis; Humans; Lactates; MCF-7 Cells; Membrane Potential, Mitochondrial; Methotrexate; Molecular Targeted Therapy; Neoplasm Proteins; Osteosarcoma; Ribonucleotides; RNA Interference; Transcription Factors | 2016 |
Sirolimus induces apoptosis and reverses multidrug resistance in human osteosarcoma cells in vitro via increasing microRNA-34b expression.
Topics: Antineoplastic Agents; Apoptosis; Bone Neoplasms; Deoxycytidine; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Gemcitabine; HEK293 Cells; Humans; Methotrexate; MicroRNAs; Osteosarcoma; Sirolimus | 2016 |
Anti-VEGF-related thrombotic microangiopathy in a child presenting with nephrotic syndrome.
Topics: Adolescent; Angiogenesis Inhibitors; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Bone Neoplasms; Cisplatin; Doxorubicin; Humans; Ifosfamide; Male; Methotrexate; Nephrotic Syndrome; Niacinamide; Osteosarcoma; Phenylurea Compounds; Proteinuria; Remission, Spontaneous; Sorafenib; Thrombotic Microangiopathies; Vascular Endothelial Growth Factor A; Withholding Treatment | 2016 |
Analytical interference in the therapeutic drug monitoring of methotrexate.
Topics: Adolescent; Bone Neoplasms; Contraindications; Cross Reactions; Drug Monitoring; Drug Substitution; Fluorescence Polarization Immunoassay; Humans; Kidney Diseases; Male; Methotrexate; Osteosarcoma | 2016 |
A Pediatric Case of Metastatic Conventional Parosteal Osteosarcoma Treated With Multidrug Chemotherapy.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cisplatin; Disease-Free Survival; Doxorubicin; Humans; Ifosfamide; Lung Neoplasms; Male; Methotrexate; Osteosarcoma, Juxtacortical; Periosteum; Tomography, X-Ray Computed | 2016 |
Hippo/YAP signaling pathway is involved in osteosarcoma chemoresistance.
Topics: Adaptor Proteins, Signal Transducing; Antineoplastic Agents; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Doxorubicin; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Hippo Signaling Pathway; Humans; Methotrexate; Osteosarcoma; Phosphoproteins; Protein Serine-Threonine Kinases; Signal Transduction; Transcription Factors; YAP-Signaling Proteins | 2016 |
Candidate germline polymorphisms of genes belonging to the pathways of four drugs used in osteosarcoma standard chemotherapy associated with risk, survival and toxicity in non-metastatic high-grade osteosarcoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Neoplasms; Case-Control Studies; Child; Cisplatin; Cohort Studies; Disease-Free Survival; Doxorubicin; Female; gamma-Glutamyl Hydrolase; Genotype; Humans; Ifosfamide; Italy; Male; Methotrexate; Middle Aged; Multidrug Resistance-Associated Protein 2; Neoadjuvant Therapy; Neoplasm Metastasis; Osteosarcoma; Polymorphism, Genetic; Treatment Outcome; Young Adult | 2016 |
Pharmacogenetic analysis of high-dose methotrexate treatment in children with osteosarcoma.
Topics: Adolescent; Age Factors; Antimetabolites, Antineoplastic; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B; Bayes Theorem; Bone Neoplasms; Chi-Square Distribution; Child; Female; gamma-Glutamyl Hydrolase; Genotype; Half-Life; Humans; Male; Metabolic Clearance Rate; Methotrexate; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Multivariate Analysis; Odds Ratio; Osteosarcoma; Pharmacogenetics; Pharmacogenomic Variants; Phenotype; Polymorphism, Single Nucleotide; Pregnane X Receptor; Receptors, Steroid; Risk Factors; Treatment Outcome | 2017 |
Shock wave-induced ATP release from osteosarcoma U2OS cells promotes cellular uptake and cytotoxicity of methotrexate.
Topics: Adenosine Triphosphate; Antimetabolites, Antineoplastic; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Extracorporeal Shockwave Therapy; Fluoresceins; Humans; Methotrexate; Osteosarcoma; Receptors, Purinergic P2X7 | 2016 |
Simultaneous reconstruction of the bone and vessels for complex femoral defect.
Topics: Antineoplastic Agents; Autografts; Bone Neoplasms; Child; Cisplatin; Doxorubicin; Female; Femur; Fibula; Humans; Limb Salvage; Magnetic Resonance Imaging; Methotrexate; Neoadjuvant Therapy; Osteosarcoma; Saphenous Vein; Surgical Flaps; Transplantation, Autologous | 2016 |
Calcium phosphate nanoparticles functionalized with alendronate-conjugated polyethylene glycol (PEG) for the treatment of bone metastasis.
Topics: Alendronate; Animals; Antimetabolites, Antineoplastic; Bone Neoplasms; Calcium Phosphates; Cell Line; Cell Line, Tumor; Cell Survival; Drug Carriers; Drug Delivery Systems; Durapatite; Female; Humans; Methotrexate; Mice; Nanoparticles; Photoelectron Spectroscopy; Polyethylene Glycols; Rats; Rats, Sprague-Dawley; Tissue Distribution | 2017 |
In vivo pharmacological evaluation and efficacy study of methotrexate-encapsulated polymer-coated layered double hydroxide nanoparticles for possible application in the treatment of osteosarcoma.
Topics: Aluminum; Animals; Antimetabolites, Antineoplastic; Bone Neoplasms; Cell Line, Tumor; Female; Humans; Hydroxides; Kidney; Lactic Acid; Liver; Magnesium; Male; Methotrexate; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Osteosarcoma; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Tumor Burden | 2017 |
Osteosarcoma: the same old drugs or more?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Doxorubicin; Humans; Ifosfamide; Methotrexate; Osteosarcoma; Randomized Controlled Trials as Topic | 2008 |
Gastric phenotype signet-ring cell carcinoma of the stomach with multiple bone metastases effectively treated with sequential methotrexate and 5-fluorouracil.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Signet Ring Cell; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Stomach Neoplasms | 2008 |
Methotrexate-loaded polymethylmethacrylate bone cement for local bone metastasis therapy: pilot animal study in the rabbit patellar groove.
Topics: Animals; Bone Cements; Bone Neoplasms; Disease Models, Animal; Methotrexate; Patella; Pilot Projects; Polymethyl Methacrylate; Prostheses and Implants; Rabbits | 2008 |
COX-2 expression correlates with survival in patients with osteosarcoma lung metastases.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Biomarkers, Tumor; Bone Neoplasms; Child; Cisplatin; Combined Modality Therapy; Cyclooxygenase 2; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Proteins; Neoplasm Recurrence, Local; Osteosarcoma; Pneumonectomy; Prognosis; Retrospective Studies; Salvage Therapy; Survival Analysis | 2008 |
High-dose methotrexate in osteosarcoma: let the questions surcease--time for final acceptance.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cell Cycle; Child; Drug Administration Schedule; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Lung Neoplasms; Methotrexate; Oliguria; Osteosarcoma; Prognosis | 2008 |
Neoadjuvant chemotherapy with high-dose methotrexate in osteosarcoma.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Drug Administration Schedule; History, 20th Century; Humans; Methotrexate; Neoadjuvant Therapy; Osteosarcoma; Survival Rate; Treatment Outcome | 2008 |
Population pharmacokinetics of high-dose methotrexate after intravenous administration in pediatric patients with osteosarcoma.
Topics: Adolescent; Antidotes; Antimetabolites, Antineoplastic; Bone Neoplasms; Child; Female; Fluorescence Polarization Immunoassay; Humans; Infusions, Intravenous; Leucovorin; Male; Methotrexate; Models, Statistical; Osteosarcoma; Reproducibility of Results | 2009 |
Early recognition of renal toxicity of high-dose methotrexate therapy: a case report.
Topics: Acute Kidney Injury; Antimetabolites, Antineoplastic; Bone Neoplasms; Child; Drug Monitoring; gamma-Glutamyl Hydrolase; Humans; Leucovorin; Male; Methotrexate; Osteosarcoma | 2008 |
Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression.
Topics: Adolescent; Antimetabolites, Antineoplastic; Bone Neoplasms; Carrier Proteins; Case-Control Studies; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Female; Folate Receptors, GPI-Anchored; Folic Acid; Gastrointestinal Diseases; Genotype; Hematologic Diseases; Humans; Kidney Diseases; Male; Methotrexate; Osteosarcoma; Polymerase Chain Reaction; Polymorphism, Genetic; Receptors, Cell Surface; RNA, Messenger; Tetrahydrofolate Dehydrogenase | 2009 |
Treatment of non-metastatic high-grade osteosarcoma (study of 30 cases treated with Scandinavian osteosarcoma protocol XIV and surgery).
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cisplatin; Combined Modality Therapy; Doxorubicin; Extremities; Female; Humans; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Osteosarcoma; Young Adult | 2008 |
High-dose methotrexate: the rationale...
Topics: Antimetabolites, Antineoplastic; Bone Neoplasms; Child; Dose-Response Relationship, Drug; Humans; Methotrexate; Osteosarcoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2009 |
Delayed renal excretion of methotrexate after a severe anaphylactic reaction to methotrexate in a child with osteosarcoma.
Topics: Adolescent; Anaphylaxis; Antimetabolites, Antineoplastic; Bone Neoplasms; Female; Humans; Methotrexate; Osteosarcoma; Severity of Illness Index | 2009 |
Pulmonary toxocariasis masquerading as metastatic tumor nodules in a child with osteosarcoma.
Topics: Adolescent; Animals; Antibodies, Helminth; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cattle; Cattle Diseases; Cisplatin; Diagnosis, Differential; Doxorubicin; Food Parasitology; Humans; Humerus; Immunoglobulin G; Larva Migrans, Visceral; Liver; Lung Diseases, Parasitic; Lung Neoplasms; Male; Meat; Methotrexate; Osteosarcoma; Pulmonary Eosinophilia; Toxocariasis | 2009 |
An osteoporotic hip fracture in a 14-year-old girl undergoing chemotherapy and operated for knee osteosarcoma.
Topics: Adolescent; Antineoplastic Agents; Arthroplasty, Replacement, Knee; Bone Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Doxorubicin; Female; Femur; Fracture Fixation, Internal; Hip Fractures; Humans; Ifosfamide; Immobilization; Magnetic Resonance Imaging; Methotrexate; Osteoporosis; Osteosarcoma; Postoperative Care; Radiography | 2009 |
Sequential chemotherapy with methotrexate and 5-fluorouracil for chemotherapy-naive advanced gastric cancer with disseminated intravascular coagulation at initial diagnosis.
Topics: Adenocarcinoma; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Disseminated Intravascular Coagulation; Female; Fluorouracil; Humans; Male; Methotrexate; Middle Aged; Retrospective Studies; Stomach Neoplasms; Survival Analysis; Treatment Failure; Treatment Outcome | 2010 |
Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells.
Topics: Antimetabolites, Antineoplastic; Bone Neoplasms; Cell Cycle; Cell Proliferation; Colonic Neoplasms; Drug Resistance, Neoplasm; Fluorouracil; Gene Expression Regulation, Neoplastic; Genes, p53; HCT116 Cells; Humans; Methotrexate; MicroRNAs; Osteosarcoma; Transfection; Tumor Cells, Cultured; Up-Regulation | 2009 |
High-dose methotrexate is effective in osteosarcoma so what is the problem?
Topics: Antimetabolites, Antineoplastic; Bone Neoplasms; Humans; Methotrexate; Osteosarcoma; Treatment Outcome | 2009 |
Anaplastic large cell Ki-1 lymphoma arising in bone.
Topics: Adolescent; Anti-Inflammatory Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Humans; Hydrocortisone; Lymphoma, Large-Cell, Anaplastic; Magnetic Resonance Imaging; Male; Methotrexate; Prednisolone; Radiography; Thoracic Vertebrae; Treatment Outcome; Vincristine | 1993 |
Neoadjuvant multidrug chemotherapy including high-dose methotrexate modifies VEGF expression in osteosarcoma: an immunohistochemical analysis.
Topics: Adolescent; Adult; Antimetabolites, Antineoplastic; Biomarkers; Bone Neoplasms; Disease-Free Survival; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunohistochemistry; Male; Methotrexate; Neoadjuvant Therapy; Neovascularization, Pathologic; Osteosarcoma; Platelet Endothelial Cell Adhesion Molecule-1; Predictive Value of Tests; Prognosis; Retrospective Studies; Vascular Endothelial Growth Factor A; Young Adult | 2010 |
[A case of multidrug-resistant breast cancer associated with multiple hepatic and bone metastases for which cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy proved effective].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Drug Resistance, Neoplasm; Female; Fluorouracil; Humans; Liver Neoplasms; Methotrexate; Middle Aged | 2010 |
Severe intoxication with methotrexate possibly associated with concomitant use of proton pump inhibitors.
Topics: Adolescent; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Bone Neoplasms; Child; Child, Preschool; Drug Interactions; gamma-Glutamyl Hydrolase; Humans; Lymphoma; Methotrexate; Middle Aged; Neuroblastoma; Osteosarcoma; Proton Pump Inhibitors; Retrospective Studies; Young Adult | 2010 |
Anaphylactoid reaction to high-dose methotrexate and successful desensitization.
Topics: Anaphylaxis; Antimetabolites, Antineoplastic; Bone Neoplasms; Child; Desensitization, Immunologic; Female; Humans; Methotrexate; Osteosarcoma; Tibia | 2010 |
Moyamoya in a child treated with interferon for recurrent osteosarcoma.
Topics: Antineoplastic Agents; Bone Neoplasms; Carotid Artery Diseases; Cerebral Arterial Diseases; Cerebral Infarction; Chemotherapy, Adjuvant; Child; Cisplatin; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Interferon-alpha; Lung Neoplasms; Magnetic Resonance Angiography; Methotrexate; Moyamoya Disease; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Osteosarcoma; Thyroiditis, Autoimmune | 2010 |
Pharmacokinetic individualization of high-dose methotrexate chemotherapy for the treatment of localized osteosarcoma.
Topics: Adolescent; Adult; Antimetabolites, Antineoplastic; Bone Neoplasms; Child; Dose-Response Relationship, Drug; Female; Humans; Infusions, Intravenous; Male; Methotrexate; Osteosarcoma; Survival Rate; Tissue Distribution; Treatment Outcome; Young Adult | 2010 |
Reduced methotrexate clearance and renal impairment in a boy with osteosarcoma and earlier undetected autosomal dominant polycystic kidney disease (ADPKD).
Topics: Antimetabolites, Antineoplastic; Bone Neoplasms; Child; Humans; Incidental Findings; Kidney; Male; Methotrexate; Osteosarcoma; Polycystic Kidney, Autosomal Dominant | 2010 |
Ambulatory high-dose methotrexate administration among pediatric osteosarcoma patients in an urban, underserved setting is feasible, safe, and cost-effective.
Topics: Adolescent; Adult; Ambulatory Care; Antimetabolites, Antineoplastic; Bone Neoplasms; Child; Cost-Benefit Analysis; Costs and Cost Analysis; Female; Home Infusion Therapy; Hospital Charges; Humans; Infusions, Intravenous; Leucovorin; Male; Medically Underserved Area; Methotrexate; Osteosarcoma; Urban Population; Young Adult | 2010 |
Outpatient high-dose methotrexate: proceed with extreme caution, if at all.
Topics: Ambulatory Care; Antimetabolites, Antineoplastic; Bone Neoplasms; Child; Humans; Methotrexate; Osteosarcoma | 2010 |
Skeletal imaging effects of pamidronate therapy in osteosarcoma patients.
Topics: Adolescent; Adult; Antineoplastic Agents; Bone Neoplasms; Child; Cisplatin; Diphosphonates; Doxorubicin; Female; Humans; Magnetic Resonance Imaging; Male; Methotrexate; Osteosarcoma; Pamidronate; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
Difficulty measuring methotrexate in a patient with high-dose methotrexate-induced nephrotoxicity.
Topics: Acute Kidney Injury; Adolescent; Antimetabolites, Antineoplastic; Bone Neoplasms; gamma-Glutamyl Hydrolase; Humans; Immunoassay; Methotrexate; Osteosarcoma | 2010 |
Commentary.
Topics: Acute Kidney Injury; Adolescent; Antimetabolites, Antineoplastic; Bone Neoplasms; gamma-Glutamyl Hydrolase; Humans; Immunoassay; Methotrexate; Osteosarcoma | 2010 |
Commentary.
Topics: Acute Kidney Injury; Adolescent; Antimetabolites, Antineoplastic; Bias; Bone Neoplasms; gamma-Glutamyl Hydrolase; Humans; Immunoassay; Methotrexate; Osteosarcoma | 2010 |
[Bufalin induces apoptosis in osteosarcoma U-2OS and U-2OS methotrexate 300-resistant cell lines in vitro].
Topics: Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Bone Neoplasms; Bufanolides; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Humans; Methotrexate; Osteosarcoma; Proto-Oncogene Proteins c-bcl-2; Tetrahydrofolate Dehydrogenase; Tumor Suppressor Protein p53 | 2010 |
Tumor volume increase during preoperative chemotherapy as a novel predictor of local recurrence in extremity osteosarcoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cisplatin; Doxorubicin; Extremities; Female; Humans; Male; Methotrexate; Neoplasm Recurrence, Local; Osteosarcoma; Preoperative Care; Survival Rate; Treatment Outcome; Tumor Burden; Young Adult | 2011 |
Magnetic resonance imaging is appropriate for determining the osteotomy plane for appendicular osteosarcoma after neoadjuvant chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Cisplatin; Combined Modality Therapy; Epirubicin; Female; Follow-Up Studies; Humans; Ifosfamide; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Osteosarcoma; Osteotomy; Preoperative Care; Prognosis; Prospective Studies; Surgery, Computer-Assisted; Survival Rate; Young Adult | 2012 |
Long-term survivals of stage IIb osteosarcoma: a 20-year experience in a single institution.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Humans; Infant; Kaplan-Meier Estimate; Leucovorin; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Osteosarcoma; Survival Rate; Vincristine; Young Adult | 2011 |
Treatment outcome of Korean patients with localized Ewing sarcoma family of tumors: a single institution experience.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Confounding Factors, Epidemiologic; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Odds Ratio; Prognosis; Republic of Korea; Retrospective Studies; Risk Factors; Sarcoma, Ewing; Time Factors; Treatment Outcome; Vincristine; Young Adult | 2011 |
Results of the Scandinavian Sarcoma Group XIV protocol for classical osteosarcoma: 63 patients with a minimum follow-up of 4 years.
Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Cisplatin; Doxorubicin; Female; Finland; Follow-Up Studies; Humans; Ifosfamide; Male; Methotrexate; Norway; Osteosarcoma; Sweden; Treatment Outcome; Young Adult | 2011 |
Synergistic effect of low-dose cucurbitacin B and low-dose methotrexate for treatment of human osteosarcoma.
Topics: Animals; Antimetabolites, Antineoplastic; Apoptosis; Blotting, Western; Bone Neoplasms; Cell Cycle; Cell Proliferation; Dose-Response Relationship, Drug; Drug Synergism; Female; Humans; Immunoenzyme Techniques; Methotrexate; Mice; Mice, Nude; Mitogen-Activated Protein Kinases; Osteosarcoma; Phosphatidylinositol 3-Kinase; Phosphorylation; Proto-Oncogene Proteins c-akt; TOR Serine-Threonine Kinases; Triterpenes; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2011 |
Successful treatment of relapsed and refractory extramedullary acute promyelocytic leukemia with tamibarotene.
Topics: Adult; Aminoglycosides; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Benzoates; Bone Marrow; Bone Neoplasms; Combined Modality Therapy; Doxorubicin; Drug Resistance, Neoplasm; Gemtuzumab; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Leukemia, Promyelocytic, Acute; Leukemic Infiltration; Male; Mercaptopurine; Methotrexate; Oxides; Radionuclide Imaging; Remission Induction; Salvage Therapy; Sarcoma, Myeloid; Soft Tissue Neoplasms; Tetrahydronaphthalenes; Tretinoin | 2011 |
[Successful withdrawal from disseminated intravascular coagulation caused by disseminated carcinomatosis of bone marrow originated from gastric cancer treated by sequential therapy consisting of MTX and 5-FU and palliative radiotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Disseminated Intravascular Coagulation; Fatal Outcome; Fluorouracil; Humans; Male; Methotrexate; Middle Aged; Palliative Care; Stomach Neoplasms | 2011 |
Enrichment of osteosarcoma stem cells by chemotherapy.
Topics: Animals; Antigens, Surface; Antimetabolites, Antineoplastic; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Humans; Methotrexate; Mice; Mice, Nude; Neoplasm Transplantation; Neoplastic Stem Cells; Osteosarcoma; Phenotype; Proto-Oncogene Proteins c-kit | 2011 |
Targeting glutathione-S transferase enzymes in musculoskeletal sarcomas: a promising therapeutic strategy.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bone Neoplasms; Cell Cycle; Cell Line, Tumor; Cisplatin; Dose-Response Relationship, Drug; Doxorubicin; Drug Interactions; Drug Resistance, Neoplasm; Enzyme Inhibitors; Glutathione Transferase; Humans; Isoenzymes; Methotrexate; Mice; Mice, Nude; Muscle Neoplasms; Muscle, Skeletal; Oxadiazoles; Sarcoma; Time Factors; Tumor Burden; Vincristine; Xenograft Model Antitumor Assays | 2011 |
High dose methotrexate chemotherapy: pharmacokinetics, folate and toxicity in osteosarcoma patients.
Topics: Adolescent; Adult; Age Factors; Antimetabolites, Antineoplastic; Area Under Curve; Bone Neoplasms; Child; Dose-Response Relationship, Drug; Female; Folic Acid; Humans; Male; Methotrexate; Middle Aged; Osteosarcoma; Reduced Folate Carrier Protein; Sex Factors; Treatment Outcome; Young Adult | 2012 |
Clinical analysis of Chinese limb osteosarcoma patients treated by two combinations of methotrexate, cisplatin, doxorubicin and ifosfamide.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; China; Cisplatin; Disease-Free Survival; Doxorubicin; Female; Humans; Ifosfamide; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Osteosarcoma; Retrospective Studies; Young Adult | 2011 |
The influence of 7-OH methotrexate metabolite on clinical relevance of methotrexate determination.
Topics: Adolescent; Antimetabolites, Antineoplastic; Biotransformation; Bone Neoplasms; Child; Chromatography, High Pressure Liquid; Drug Monitoring; Fluorescence Polarization Immunoassay; Humans; Methotrexate; Osteosarcoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Young Adult | 2011 |
The effects of chemotherapeutic agents on differentiated chordoma cells.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Benzamides; Bone Neoplasms; Cell Differentiation; Cell Line, Tumor; Cell Lineage; Chordoma; Cisplatin; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Humans; Imatinib Mesylate; Methotrexate; Piperazines; Pyrimidines; Vidarabine; Vincristine | 2011 |
A population pharmacokinetic/pharmacodynamic model of methotrexate and mucositis scores in osteosarcoma.
Topics: Adolescent; Adult; Antimetabolites, Antineoplastic; Bone Neoplasms; Child; Child, Preschool; Drug Monitoring; Female; Humans; Male; Metabolic Clearance Rate; Methotrexate; Middle Aged; Models, Biological; Mucositis; Osteosarcoma; Prospective Studies; Severity of Illness Index; Young Adult | 2011 |
Immunotherapy targeting HER2 with genetically modified T cells eliminates tumor-initiating cells in osteosarcoma.
Topics: Animals; Bone Neoplasms; Cell Line, Tumor; Drug Resistance, Neoplasm; Epitopes, T-Lymphocyte; Humans; Immunotherapy, Adoptive; Male; Methotrexate; Mice; Mice, Inbred NOD; Mice, SCID; Osteosarcoma; Receptor, ErbB-2; T-Lymphocytes; Xenograft Model Antitumor Assays | 2012 |
Extraskeletal osteosarcoma of the breast in an adolescent girl.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Chemotherapy, Adjuvant; Chondroblastoma; Cisplatin; Doxorubicin; Female; Humans; Ifosfamide; Methotrexate; Neoplasm Grading; Osteosarcoma; Treatment Outcome | 2012 |
Inhibition of nuclear factor-κB by dehydroxymethylepoxyquinomicin induces schedule-dependent chemosensitivity to anticancer drugs and enhances chemoinduced apoptosis in osteosarcoma cells.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzamides; Bone Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cisplatin; Cyclohexanones; Doxorubicin; Drug Administration Schedule; Drug Screening Assays, Antitumor; Drug Synergism; Humans; Methotrexate; Mitotic Index; NF-kappa B; Osteosarcoma; Protein Transport | 2012 |
Small cell osteosarcoma successfully treated by high-dose ifosfamide and methotrexate, combined with carboplatin and pirarubicin.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Child; Combined Modality Therapy; Doxorubicin; Humans; Ifosfamide; Male; Methotrexate; Osteosarcoma | 2012 |
Ifosfamide in the neoadjuvant treatment of osteogenic sarcoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Doxorubicin; Female; Humans; Ifosfamide; Male; Methotrexate; Osteosarcoma | 2012 |
Clinical relations of methotrexate pharmacokinetics in the treatment for pediatric osteosarcoma.
Topics: Adolescent; Antimetabolites, Antineoplastic; Bone Marrow; Bone Neoplasms; Disease-Free Survival; Dose-Response Relationship, Drug; Female; Humans; Liver; Methotrexate; Osteosarcoma; Retrospective Studies; Treatment Outcome | 2012 |
Clinical monitoring in a patient with Friedreich ataxia and osteogenic sarcoma.
Topics: Analysis of Variance; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Blood Cells; Bone Neoplasms; Cisplatin; Cohort Studies; Doxorubicin; Female; Frataxin; Friedreich Ataxia; Humans; Immunosuppressive Agents; Iron-Binding Proteins; Male; Methotrexate; Osteosarcoma; Time Factors; Young Adult | 2012 |
[Organ-preserving interventions in combined therapy of children and adolescents with osteosarcoma].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Bone Transplantation; Chemotherapy, Cancer, Regional Perfusion; Child; Cisplatin; Cohort Studies; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Methotrexate; Neoadjuvant Therapy; Orthopedic Procedures; Osteosarcoma; Transplantation, Autologous; Treatment Outcome | 2012 |
Relationship between antimetabolite toxicity and pharmacogenetics in Turkish cancer patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alanine Transaminase; Alleles; Antimetabolites, Antineoplastic; Bone Neoplasms; Breast Neoplasms; Capecitabine; Deoxycytidine; Dihydrouracil Dehydrogenase (NADP); DNA; DNA-Binding Proteins; Drug Eruptions; Female; Fluorouracil; Gastrointestinal Neoplasms; Gene Frequency; Humans; Male; Methotrexate; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Minisatellite Repeats; Mucositis; Osteosarcoma; Polymorphism, Genetic; Thymidylate Synthase; Turkey; X-ray Repair Cross Complementing Protein 1; Xeroderma Pigmentosum Group D Protein; Young Adult | 2012 |
Osteoporosis in children and young adults: a late effect after chemotherapy for bone sarcoma.
Topics: Adolescent; Adult; Antimetabolites, Antineoplastic; Bone Density; Bone Neoplasms; Child; Female; Humans; Male; Methotrexate; Osteoporosis; Osteosarcoma; Retrospective Studies; Time Factors; Young Adult | 2012 |
Analysis of prognostic factors in 333 Chinese patients with high-grade osteosarcoma treated by multidisciplinary combined therapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asian People; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Doxorubicin; Extremities; Female; Follow-Up Studies; Humans; Ifosfamide; Leucovorin; Limb Salvage; Male; Methotrexate; Middle Aged; Neoplasm Grading; Neoplasm Staging; Osteosarcoma; Prognosis; Retrospective Studies; Risk Factors; Survival Rate; Young Adult | 2013 |
Targeting hedgehog-GLI-2 pathway in osteosarcoma.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Apoptosis; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Doxorubicin; Drug Resistance, Neoplasm; Genetic Therapy; Hedgehog Proteins; Humans; Kruppel-Like Transcription Factors; Methotrexate; Nuclear Proteins; Osteoblasts; Osteosarcoma; RNA, Small Interfering; Zinc Finger Protein Gli2 | 2013 |
Fibro-osseous pseudotumour of the digit in a patient with rheumatoid arthritis.
Topics: Amputation, Surgical; Arthritis, Rheumatoid; Biopsy, Needle; Bone Neoplasms; Disease Progression; Female; Fibroma, Ossifying; Fingers; Follow-Up Studies; Granuloma, Plasma Cell; Humans; Immunohistochemistry; Magnetic Resonance Imaging; Methotrexate; Middle Aged; Rare Diseases; Treatment Outcome | 2013 |
Glutathione S-transferase P1 and DNA polymorphisms influence response to chemotherapy and prognosis of bone tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cisplatin; Cyclophosphamide; Dactinomycin; DNA-Binding Proteins; DNA, Neoplasm; Doxorubicin; Endonucleases; Female; Glutathione S-Transferase pi; Humans; Male; Methotrexate; Neoplasm Staging; Osteosarcoma; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Prognosis; Survival Rate; Vincristine; Xeroderma Pigmentosum Group D Protein; Young Adult | 2012 |
Osteosarcoma of the pelvis: a monoinstitutional experience in patients younger than 41 years.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cisplatin; Doxorubicin; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Methotrexate; Osteosarcoma; Pelvic Bones; Prospective Studies; Radiography; Remission Induction; Treatment Outcome | 2012 |
Osteosarcoma cells, resistant to methotrexate due to nucleoside and nucleobase salvage, are sensitive to nucleoside analogs.
Topics: Animals; Antimetabolites, Antineoplastic; Biological Transport; Bone Neoplasms; Cattle; Culture Media; Cytarabine; Dialysis; Dipyridamole; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Synergism; Fetal Blood; Humans; Hypoxanthine; Methotrexate; Neoplasm Proteins; Nucleotides; Osteosarcoma; Tetrahydrofolate Dehydrogenase; Thymidine; Tumor Cells, Cultured; Vidarabine | 2002 |
Effective removal of methotrexate by high-flux hemodialysis.
Topics: Adolescent; Antimetabolites, Antineoplastic; Bone Neoplasms; Female; Fluorescence Polarization Immunoassay; gamma-Glutamyl Hydrolase; Half-Life; Humans; Hypokalemia; Hypophosphatemia; Infusions, Intravenous; Kidney Diseases; Male; Methotrexate; Osteosarcoma; Renal Dialysis; Rhabdomyosarcoma | 2002 |
Successful treatment of extracranially metastasized pineal gland germinoma with high-dose methotrexate.
Topics: Adult; Antimetabolites, Antineoplastic; Bone Neoplasms; Disease-Free Survival; Female; Germinoma; Humans; Infusions, Intravenous; Meningeal Neoplasms; Methotrexate; Neoplasm Staging; Pinealoma; Treatment Outcome | 2002 |
Can cure in patients with osteosarcoma be achieved exclusively with chemotherapy and abrogation of surgery?
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cisplatin; Disease-Free Survival; Follow-Up Studies; Humans; Leucovorin; Methotrexate; Neoplasm Recurrence, Local; Osteosarcoma; Survival Analysis; Treatment Outcome | 2002 |
A pilot study of short-course intensive multiagent chemotherapy in metastatic and axial skeletal osteosarcoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Bone Neoplasms; Child; Cisplatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Ifosfamide; Infusions, Intravenous; Lung Neoplasms; Male; Maximum Tolerated Dose; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Osteosarcoma; Pilot Projects; Prognosis; Risk Assessment; Sampling Studies; Survival Analysis; Treatment Outcome | 2002 |
Successful desensitization to high-dose methotrexate after systemic anaphylaxis.
Topics: Adult; Anaphylaxis; Bone Neoplasms; Desensitization, Immunologic; Dose-Response Relationship, Drug; Folic Acid Antagonists; Humans; Male; Methotrexate; Osteosarcoma | 2003 |
Value of P-glycoprotein and clinicopathologic factors as the basis for new treatment strategies in high-grade osteosarcoma of the extremities.
Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Arm; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biomarkers, Tumor; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Cisplatin; Doxorubicin; Female; Humans; Ifosfamide; Immunohistochemistry; Leg; Male; Methotrexate; Neoplasm Recurrence, Local; Neoplasm Staging; Osteosarcoma; Prognosis; Risk Factors | 2003 |
Fertility in male patients treated with neoadjuvant chemotherapy for osteosarcoma.
Topics: Abnormalities, Drug-Induced; Adolescent; Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Cisplatin; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Incidence; Infant, Newborn; Italy; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Oligospermia; Osteosarcoma; Puberty; Semen Preservation; Sperm Count; Surveys and Questionnaires | 2003 |
Identification of drug-regulated genes in osteosarcoma cells.
Topics: Actinin; Antineoplastic Agents; Apoptosis; Blotting, Northern; Bone Neoplasms; Cisplatin; Doxorubicin; Drug Resistance, Neoplasm; Ferritins; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; IMP Dehydrogenase; Isoenzymes; Methotrexate; Neoplasm Proteins; Nucleic Acid Hybridization; Osteosarcoma; Prohibitins; Protein Biosynthesis; Proteins; Repressor Proteins; rhoA GTP-Binding Protein; Ribonucleotide Reductases; Subtraction Technique; Transfection; Tumor Cells, Cultured | 2003 |
Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Disease-Free Survival; Doxorubicin; Europe; Female; Humans; Ifosfamide; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Metastasis; Osteosarcoma; Prognosis; Proportional Hazards Models; Survival Analysis; Treatment Outcome | 2003 |
Scandinavian Sarcoma Group Osteosarcoma Study SSG VIII: prognostic factors for outcome and the role of replacement salvage chemotherapy for poor histological responders.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Doxorubicin; Female; Humans; Infant; Infant, Newborn; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Osteosarcoma; Patient Compliance; Prognosis; Salvage Therapy; Survival Analysis | 2003 |
Long-term survival in osteosarcoma patients following retinoblastoma using doxorubicin, cisplatin, and methotrexate.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child, Preschool; Cisplatin; Doxorubicin; Humans; Humerus; Infant; Male; Methotrexate; Neoplasms, Second Primary; Osteosarcoma; Retinal Neoplasms; Retinoblastoma; Survivors; Tibia | 2003 |
Acrylic cement added with antiblastics in the treatment of bone metastases. Ultrastructural and in vitro analysis.
Topics: Antineoplastic Agents; Bone Cements; Bone Neoplasms; Cell Division; Cell Survival; Cisplatin; Coloring Agents; Doxorubicin; Drug Carriers; Humans; Methotrexate; Methylmethacrylate; Microscopy, Electron, Scanning; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 2003 |
OSTEOGENIC SARCOMA IN CHILDHOOD.
Topics: Adolescent; Bone Neoplasms; Child; Humans; Infant; Methotrexate; Mitomycin; Mitomycins; Neoplasms; Osteosarcoma; Radiography; Sarcoma; Surgical Procedures, Operative | 1963 |
TREATMENT OF INOPERABLE CARCINOMA WITH NEWER CHEMOTHERAPEUTIC AGENTS: REPORT OF THREE CASES.
Topics: Bone Neoplasms; Breast Neoplasms; Humans; Methotrexate; Neoplasm Metastasis; Prednisone; Retroperitoneal Neoplasms; Testosterone; Vinblastine | 1963 |
INDIVIDUALIZED CHEMOTHERAPY BY IN VITRO DRUG SELECTION.
Topics: Antineoplastic Agents; Bone Neoplasms; Dactinomycin; Female; Floxuridine; Fluorouracil; Genital Neoplasms, Female; Humans; In Vitro Techniques; Intestinal Neoplasms; Leukemia; Mechlorethamine; Melanoma; Mercaptopurine; Methotrexate; Neoplasms; Pharyngeal Neoplasms; Respiratory Tract Neoplasms; Stomach Neoplasms; Thiotepa | 1964 |
OSTEOGENIC SARCOMA OF THE MANDIBLE. REPORT OF CASE TREATED BY RADIATION AND CHEMOTHERAPY.
Topics: Bone Neoplasms; Cobalt Isotopes; Dactinomycin; Drug Therapy; Humans; Mandible; Mandibular Neoplasms; Melphalan; Methotrexate; Neoplasms; Osteomyelitis; Osteosarcoma; Pathology; Radiography; Radium; Sarcoma | 1964 |
Prevention of hormone-induced hypercalcemia by use of methotrexate.
Topics: Bone and Bones; Bone Neoplasms; Breast; Breast Neoplasms; Calcium; Folic Acid Antagonists; Gonadal Steroid Hormones; Humans; Hypercalcemia; Methotrexate; Neoplasms | 1962 |
Progression of osteosarcoma after high-dose methotrexate: over-rescue by folinic acid.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Female; Femur; Humans; Ifosfamide; Leucovorin; Methotrexate; Osteosarcoma | 2003 |
Genomic imbalances associated with methotrexate resistance in human osteosarcoma cell lines detected by comparative genomic hybridization-based techniques.
Topics: Antineoplastic Agents; Bone Neoplasms; Chromosome Aberrations; Chromosomes, Human; Drug Resistance, Neoplasm; Humans; Karyotyping; Membrane Transport Proteins; Methotrexate; Nucleic Acid Hybridization; Oligonucleotide Array Sequence Analysis; Osteosarcoma; Ploidies; Reduced Folate Carrier Protein; Tetrahydrofolate Dehydrogenase; Tumor Cells, Cultured | 2003 |
Reduced folate carrier protein expression in osteosarcoma: implications for the prediction of tumor chemosensitivity.
Topics: Actins; Adolescent; Adult; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bone Neoplasms; Carrier Proteins; Child; Drug Resistance, Neoplasm; Humans; Male; Membrane Proteins; Membrane Transport Proteins; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Osteosarcoma; Reduced Folate Carrier Protein; Tumor Cells, Cultured | 2003 |
Preoperative therapy versus immediate surgery in nonmetastatic osteosarcoma.
Topics: Amputation, Surgical; Bone Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Doxorubicin; Humans; Ifosfamide; Methotrexate; Neoadjuvant Therapy; Osteosarcoma | 2003 |
Methotrexate pharmacokinetics and survival in osteosarcoma.
Topics: Adolescent; Adult; Antimetabolites, Antineoplastic; Area Under Curve; Bone Neoplasms; Child; Child, Preschool; Disease-Free Survival; Female; Humans; Infusions, Intravenous; Male; Methotrexate; Osteosarcoma; Survival Rate | 2004 |
Optimal management of methotrexate intoxication in a child with osteosarcoma.
Topics: Acute Kidney Injury; Adolescent; Bone Neoplasms; Chemical and Drug Induced Liver Injury; Humans; Male; Methotrexate; Mouth Mucosa; Osteosarcoma; Stomatitis | 2004 |
[A case of advanced gastric cancer with DIC treated by sequential MTX and 5-FU].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Disseminated Intravascular Coagulation; Drug Administration Schedule; Fluorouracil; Humans; Male; Methotrexate; Remission Induction; Stomach Neoplasms | 2004 |
[Multiple metastases of the penile cancer: an experience of combination chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Humans; Liver Neoplasms; Lung Neoplasms; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplastic Cells, Circulating; Penile Neoplasms; Penis | 2004 |
Gemcitabine-associated scleroderma-like changes of the lower extremities.
Topics: Acetaminophen; Amitriptyline; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Neoplasms; Carcinoma, Transitional Cell; Cisplatin; Clonazepam; Deoxycytidine; Dermis; Doxorubicin; Edema; Gemcitabine; Humans; Infusions, Intravenous; Leg; Lung Neoplasms; Male; Methotrexate; Middle Aged; Morphine; Scleroderma, Diffuse; Vinblastine | 2004 |
Low-voltage electrochemotherapy with low-dose methotrexate enhances survival in mice with osteosarcoma.
Topics: Animals; Antimetabolites, Antineoplastic; Bone Neoplasms; Electroporation; Methotrexate; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Osteosarcoma; Survival Rate | 2004 |
[Goal and results of the COSS study].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Arm; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Germany; Hand; Humans; Ifosfamide; Methotrexate; Multicenter Studies as Topic; Neoadjuvant Therapy; Neoplasm Staging; Osteosarcoma; Patient Care Team; Prognosis; Survival Rate | 2004 |
Long-term survival in high-grade axial osteosarcoma with bone and lung metastases treated with chemotherapy only.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Child, Preschool; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Ifosfamide; Lumbar Vertebrae; Lung Neoplasms; Male; Methotrexate; Osteosarcoma; Thoracic Vertebrae; Time Factors; Tomography, X-Ray Computed | 2005 |
[Treatment results in children with standard-risk acute lymphoblastic leukemia. Report of the Polish Pediatric Leukemia/Lymphoma Study Group].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow; Bone Neoplasms; Central Nervous System Neoplasms; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Humans; Infant; Infant, Newborn; Male; Mercaptopurine; Methotrexate; Poland; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Remission Induction; Retrospective Studies; Risk Factors; Secondary Prevention; Survival Analysis; Testicular Neoplasms; Time Factors; Treatment Outcome; Vincristine | 2004 |
Methotrexate levels and outcome in osteosarcoma.
Topics: Adolescent; Antimetabolites, Antineoplastic; Bone Neoplasms; Female; Humans; Male; Methotrexate; Necrosis; Osteosarcoma; Prognosis; Prospective Studies; Treatment Outcome | 2005 |
An expression signature classifies chemotherapy-resistant pediatric osteosarcoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; Bone Neoplasms; Child; Cisplatin; Doxorubicin; Drug Resistance, Neoplasm; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Methotrexate; Mice; Mice, SCID; Necrosis; Oligonucleotide Array Sequence Analysis; Osteosarcoma; Prognosis; RNA, Messenger; RNA, Neoplasm; Signal Transduction; Survival Rate; Transplantation, Heterologous; Treatment Outcome | 2005 |
[Two cases of urothelial cancer responsive to high-dose-intensity methotrexate vinblastine doxorubicin and cisplatin (M-VAC) therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Doxorubicin; Female; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Methotrexate; Neoplasm Staging; Pulse Therapy, Drug; Treatment Outcome; Ureteral Neoplasms; Urinary Bladder Neoplasms; Vinblastine | 2005 |
[A case of advanced gastric cancer with bone metastasis and severe DIC responding to hypertensive subselective chemotherapy with pharmacokinetic modulating chemotherapy].
Topics: Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Signet Ring Cell; Disseminated Intravascular Coagulation; Drug Administration Schedule; Drug Combinations; Female; Fluorouracil; Humans; Infusion Pumps, Implantable; Methotrexate; Middle Aged; Paclitaxel; Quality of Life; Stomach Neoplasms; Tegafur; Uracil | 2005 |
The role of preoperative radiotherapy in nonmetastatic high-grade osteosarcoma of the extremities for limb-sparing surgery.
Topics: Adolescent; Adult; Aged; Amputation, Surgical; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Epirubicin; Extremities; Humans; Ifosfamide; Limb Salvage; Male; Mesna; Methotrexate; Middle Aged; Osteosarcoma; Prognosis; Radiotherapy Dosage; Retrospective Studies; Survival Rate | 2005 |
Prospective evaluation of renal function in pediatric and adult patients treated with high-dose ifosfamide, cisplatin and high-dose methotrexate.
Topics: Acute Kidney Injury; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cisplatin; Dose-Response Relationship, Drug; Female; Humans; Ifosfamide; Kidney Function Tests; Male; Methotrexate; Osteosarcoma; Prospective Studies | 2005 |
High dose methotrexate in adult patients with osteosarcoma: clinical and pharmacokinetic results.
Topics: Adolescent; Adult; Area Under Curve; Bone Neoplasms; Dose-Response Relationship, Drug; Female; Humans; Infusions, Intravenous; Male; Maximum Tolerated Dose; Methotrexate; Neoadjuvant Therapy; Osteosarcoma; Prognosis; Survival Rate | 2005 |
The classic: recent advances in chemotherapy of metastatic osteogenic sarcoma. 1972.
Topics: Antimetabolites, Antineoplastic; Bone Neoplasms; History, 20th Century; Humans; Leucovorin; Methotrexate; Orthopedics; Osteosarcoma; Vitamin B Complex | 2005 |
Expression profiles of osteosarcoma that can predict response to chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Neoplasms; Child; Cisplatin; Combined Modality Therapy; Doxorubicin; Drug Resistance, Neoplasm; Female; Gene Expression Profiling; Humans; Male; Methotrexate; Neoplasm Recurrence, Local; Nuclear Proteins; Osteosarcoma; Predictive Value of Tests; Prognosis; Razoxane; Reverse Transcriptase Polymerase Chain Reaction; Survival Rate; Twist-Related Protein 1 | 2005 |
Dose intensity of chemotherapy for osteosarcoma and outcome in the Cooperative Osteosarcoma Study Group (COSS) trials.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cisplatin; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Female; Humans; Ifosfamide; Infant; Male; Methotrexate; Multivariate Analysis; Osteosarcoma; Proportional Hazards Models; Retrospective Studies; Survival Analysis | 2006 |
Fas expression in lung metastasis from osteosarcoma patients.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cisplatin; Dendritic Cells; Doxorubicin; fas Receptor; Humans; Ifosfamide; Lung Neoplasms; Methotrexate; Neoplasm Staging; Osteosarcoma; Paraffin Embedding; Preoperative Care | 2005 |
High energy shock waves enhance the cytotoxic effect of doxorubicin and methotrexate to human osteosarcoma cell lines.
Topics: Antineoplastic Agents; Apoptosis; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Doxorubicin; High-Energy Shock Waves; Humans; Methotrexate; Osteosarcoma | 2006 |
Alpha-tocopheryl succinate alters cell cycle distribution sensitising human osteosarcoma cells to methotrexate-induced apoptosis.
Topics: Apoptosis; Bone Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Humans; Methotrexate; Osteosarcoma; Tocopherols; Vitamin E | 2006 |
Low-dose methotrexate inhibits lung metastasis and lengthens survival in rat osteosarcoma.
Topics: Animals; Antimetabolites, Antineoplastic; Bone Neoplasms; Cell Division; Cell Line, Tumor; Disease Models, Animal; Dose-Response Relationship, Drug; Lung Neoplasms; Male; Methotrexate; Neoplasm Metastasis; Osteosarcoma; Rats; Rats, Inbred F344; Survival Analysis | 2005 |
No correlation between methotrexate serum level and histologic response in the pre-operative treatment of extremity osteosarcoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Dose-Response Relationship, Drug; Doxorubicin; Extremities; Female; Humans; Male; Methotrexate; Neoadjuvant Therapy; Osteosarcoma; Preoperative Care | 2006 |
Cisplatin-induced hypomagnesemia and cardiac dysrhythmia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Cisplatin; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Gastroenteritis; Heart Arrest; Humans; Magnesium; Methotrexate; Osteosarcoma; Water-Electrolyte Imbalance | 2007 |
Clearance of methotrexate by means of hemofiltration in a patient with osteosarcoma.
Topics: Acute Kidney Injury; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cisplatin; Doxorubicin; gamma-Glutamyl Hydrolase; Hemofiltration; Humans; Ifosfamide; Male; Methotrexate; Osteosarcoma; Tibia | 2006 |
[Second-line chemotherapy with gemcitabine and cisplatin for urothelial cancer previously treated with or resistant to M-VAC therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Deoxycytidine; Doxorubicin; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Gemcitabine; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Prognosis; Remission Induction; Urologic Neoplasms; Vinblastine | 2006 |
A patient with breast cancer with hepatic metastases and a complete response to herceptin as monotherapy.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Neoplasms; Breast; Breast Neoplasms; Carcinoma, Ductal, Breast; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Female; Fluorouracil; Follow-Up Studies; Humans; Karnofsky Performance Status; Liver Neoplasms; Lymphatic Metastasis; Mastectomy, Modified Radical; Methotrexate; Radiotherapy Dosage; Receptor, ErbB-2; Tamoxifen; Time Factors; Tomography, X-Ray Computed; Trastuzumab; Treatment Outcome | 2006 |
Severe acute toxicity associated with high-dose methotrexate (MTX) therapy: use of therapeutic drug monitoring and test-dose to guide carboxypeptidase G2 rescue and MTX continuation.
Topics: Adolescent; Antidotes; Antimetabolites, Antineoplastic; Bone Neoplasms; Drug Monitoring; Female; gamma-Glutamyl Hydrolase; Humans; Methotrexate; Osteosarcoma | 2007 |
Neoadjuvant chemotherapy for radioinduced osteosarcoma of the extremity: The Rizzoli experience in 20 cases.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Female; Follow-Up Studies; Humans; Ifosfamide; Male; Methotrexate; Neoadjuvant Therapy; Neoplasms, Radiation-Induced; Osteosarcoma; Retrospective Studies | 2007 |
Osteosarcoma metastatic to the kidney and iatrogenic hemorrhage.
Topics: Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Fine-Needle; Bone Neoplasms; Calcinosis; Camptothecin; Child; Combined Modality Therapy; Doxorubicin; Fatal Outcome; Female; Hematuria; Hemorrhage; Humans; Iatrogenic Disease; Ilium; Irinotecan; Kidney Neoplasms; Lung Neoplasms; Methotrexate; Osteosarcoma; Radiography; Tibia; Ultrasonography, Interventional | 2008 |
p53-R273H gains new function in induction of drug resistance through down-regulation of procaspase-3.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Apoptosis; Bone Neoplasms; Carcinoma, Squamous Cell; Caspase 3; Down-Regulation; Doxorubicin; Drug Resistance, Neoplasm; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Methotrexate; Mutation; Osteosarcoma; RNA, Small Interfering; Transfection; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2007 |
Limb salvage surgery for osteosarcoma: effective low-cost treatment.
Topics: Adolescent; Adult; Antineoplastic Agents; Arm Bones; Bone Neoplasms; Child; Cohort Studies; Disease-Free Survival; Female; Humans; India; Internal Fixators; Leg Bones; Limb Salvage; Male; Methotrexate; Osteosarcoma; Retrospective Studies; Treatment Outcome | 2007 |
Syndecan-2 affects the basal and chemotherapy-induced apoptosis in osteosarcoma.
Topics: Antineoplastic Agents; Apoptosis; Bone Neoplasms; Cell Line, Tumor; Cell Movement; Cisplatin; Doxorubicin; Humans; Immunohistochemistry; Methotrexate; Osteoblasts; Osteosarcoma; RNA, Messenger; Syndecan-2 | 2007 |
Male breast cancer with mandibular metastasis. A case report.
Topics: Aged; Androstadienes; Antimetabolites, Antineoplastic; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone Density Conservation Agents; Bone Neoplasms; Brain Neoplasms; Breast Neoplasms, Male; Carcinoma, Ductal, Breast; Cortisone; Cyclophosphamide; Diphosphonates; Docetaxel; Fatal Outcome; Fluorouracil; Furosemide; Humans; Imidazoles; Liver Neoplasms; Male; Mandibular Neoplasms; Mastectomy, Modified Radical; Methotrexate; Omeprazole; Osteolysis; Phenobarbital; Taxoids; Toremifene; Vinblastine; Vinorelbine; Zoledronic Acid | 2007 |
Chemotherapy for osteosarcoma without high-dose methotrexate: another piece in the puzzle.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Dose-Response Relationship, Drug; Follow-Up Studies; Humans; Methotrexate; Neoadjuvant Therapy; Osteosarcoma; Survival Rate | 2007 |
Chemotherapy for osteosarcoma without high-dose methotrexate: a 12-year follow-up on 53 patients.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Limb Salvage; Male; Methotrexate; Neoadjuvant Therapy; Neoplasm Staging; Osteosarcoma; Survival Rate | 2007 |
The folate receptor alpha is frequently overexpressed in osteosarcoma samples and plays a role in the uptake of the physiologic substrate 5-methyltetrahydrofolate.
Topics: Animals; Antimetabolites, Antineoplastic; Bone Neoplasms; Carrier Proteins; Cell Line, Tumor; Drug Resistance, Neoplasm; Folate Receptors, GPI-Anchored; Folic Acid; Folic Acid Antagonists; Humans; Methotrexate; Osteosarcoma; Receptors, Cell Surface; RNA, Messenger; Tetrahydrofolates; Xenograft Model Antitumor Assays | 2007 |
Local recurrence and local control of non-metastatic osteosarcoma of the extremities: a 27-year experience in a single institution.
Topics: Adolescent; Adult; Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Contraindications; Cyclophosphamide; Dactinomycin; Drug Administration Schedule; Extremities; Female; Humans; Limb Salvage; Male; Methotrexate; Neoplasm Recurrence, Local; Osteosarcoma; Treatment Outcome | 2007 |
[Diagnosis and prognosis study of breast carcinoma with micropapillary component].
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Papillary; Chemotherapy, Adjuvant; Cyclophosphamide; Female; Fluorouracil; Follow-Up Studies; Genetic Predisposition to Disease; Humans; Liver Neoplasms; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Proportional Hazards Models; Radiotherapy, Adjuvant; Retrospective Studies; Survival Rate; Tamoxifen | 2007 |
Prognosis of radiation-induced bone sarcoma is similar to primary osteosarcoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Doxorubicin; Humans; Ifosfamide; Methotrexate; Middle Aged; Neoplasms, Radiation-Induced; Osteosarcoma; Radionuclide Imaging; Sarcoma; Survival Rate | 2007 |
Clinical and radiological characteristics of methotrexate-induced acute encephalopathy in pediatric patients with cancer.
Topics: Acute Disease; Adolescent; Aminophylline; Antimetabolites, Antineoplastic; Bone Neoplasms; Brain; Child; Diffusion Magnetic Resonance Imaging; Female; Histiocytoma, Malignant Fibrous; Humans; Injections, Intravenous; Injections, Spinal; Leukemia; Male; Metabolic Clearance Rate; Methotrexate; Neurotoxicity Syndromes; Osteosarcoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retrospective Studies | 2008 |
Relative tumor burden predicts metastasis-free survival in pediatric osteosarcoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Disease-Free Survival; Doxorubicin; Female; Humans; Kaplan-Meier Estimate; Magnetic Resonance Imaging; Male; Methotrexate; Neoadjuvant Therapy; Neoplasm Metastasis; Neoplasm Staging; Osteosarcoma; Prognosis; Radionuclide Imaging; Retrospective Studies | 2008 |
Multimodality treatment of osteosarcoma: radiation in a high-risk cohort.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cisplatin; Cohort Studies; Combined Modality Therapy; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Male; Medical Records; Methotrexate; Neoplasm Recurrence, Local; Osteosarcoma; Radiotherapy Dosage; Retrospective Studies; Risk Factors; Survival Rate | 2008 |
The Memorial Sloan Kettering Cancer Center experience with outpatient administration of high dose methotrexate with leucovorin rescue.
Topics: Adolescent; Adult; Ambulatory Care; Antimetabolites, Antineoplastic; Bone Neoplasms; Child; Drug Monitoring; Female; Humans; Infusions, Intravenous; Kidney; Leucovorin; Male; Methotrexate; Neutropenia; Osteosarcoma | 2008 |
Clinical impact of the methotrexate resistance-associated genes C-MYC and dihydrofolate reductase (DHFR) in high-grade osteosarcoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bone Neoplasms; Cell Line, Tumor; Drug Resistance, Neoplasm; Gene Expression; Genes, myc; Humans; Immunohistochemistry; Methotrexate; Oligonucleotides, Antisense; Osteosarcoma; Proto-Oncogene Proteins c-myc; Tetrahydrofolate Dehydrogenase | 2008 |
Association of plasma methotrexate, neutropenia, hepatic dysfunction, nausea/vomiting and oral mucositis in children with cancer.
Topics: Adolescent; Antimetabolites, Antineoplastic; Bone Neoplasms; Chemical and Drug Induced Liver Injury; Child; Epidemiologic Methods; Female; Humans; Male; Methotrexate; Nausea; Neutropenia; Osteosarcoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Stomatitis; Vomiting | 2008 |
[Results of intra-arterial infusion therapy with carcinostatics in malignant tumors of the extremities].
Topics: Adolescent; Adult; Antineoplastic Agents; Bone Neoplasms; Cyclophosphamide; Extremities; Female; Fibrosarcoma; Humans; Injections, Intra-Arterial; Male; Methotrexate; Middle Aged | 1966 |
[Initial chemotherapy and conservative surgery in the current treatment of osteosarcoma. Apropos of 24 cases].
Topics: Adolescent; Adult; Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Child; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Follow-Up Studies; Humans; Leucovorin; Male; Methods; Methotrexate; Osteosarcoma; Vincristine | 1984 |
[Clinical evaluation on the sensitivity test for anti-cancer agents in malignant bone and soft-tissue tumors].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Resistance; Fluorouracil; Histiocytoma, Benign Fibrous; Humans; Ifosfamide; Lymphoma; Male; Methotrexate; Middle Aged; Mitomycin; Mitomycins; Osteosarcoma; Sarcoma, Ewing; Soft Tissue Neoplasms; Succinate Dehydrogenase; Vincristine | 1984 |
Methotrexate as salvage or adjunctive therapy for primary invasive carcinoma of the bladder.
Topics: Bone Neoplasms; Carcinoma, Transitional Cell; Drug Evaluation; Humans; Methotrexate; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Palliative Care; Pilot Projects; Urinary Bladder Neoplasms | 1981 |
Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy.
Topics: Antineoplastic Agents; Bleomycin; Bone Neoplasms; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Therapy, Combination; Humans; Leucovorin; Methotrexate; Osteosarcoma; Prognosis; Time Factors | 1982 |
[Ewing's sarcoma: therapeutic experience (author's transl)].
Topics: Adolescent; Bleomycin; Bone Neoplasms; Cyclophosphamide; Dactinomycin; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Preoperative Care; Sarcoma, Ewing; Vincristine | 1982 |
Methotrexate and methotrexate polyglutamates in human sarcoma metastases after high-dose methotrexate therapy.
Topics: Biotransformation; Bone Neoplasms; Dose-Response Relationship, Drug; Humans; Leiomyosarcoma; Lung; Lung Neoplasms; Methotrexate; Osteosarcoma; Peptides; Polyglutamic Acid; Skin; Skin Neoplasms | 1983 |
Combination chemotherapy of metastatic breast carcinoma with cyclophosphamide, adriamycin, and peptichemio.
Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Drug Eruptions; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Nausea; Peptichemio; Phlebitis; Thiotepa; Time Factors; Vomiting | 1984 |
Prognostic implications of stage of disease and sites of metastases in patients with small cell carcinoma of the lung treated with intensive combination chemotherapy.
Topics: Aged; Bone Neoplasms; Carcinoma, Small Cell; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Liver Neoplasms; Lung Diseases; Lung Neoplasms; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prognosis; Soft Tissue Neoplasms | 1981 |
Meningosis prophylaxis with intrathecal 198Au-colloid and methotrexate in childhood acute lymphocytic leukemia.
Topics: Bone Neoplasms; Child; Drug Administration Schedule; Drug Therapy, Combination; Female; Gold Colloid, Radioactive; Humans; Injections, Spinal; Leukemia, Lymphoid; Male; Meningeal Neoplasms; Methotrexate; Prognosis | 1982 |
[Changes in the management of osteosarcomas of long bones in the Léon Bérard Center, in the last twenty years ].
Topics: Adolescent; Adult; Amputation, Surgical; Bone Neoplasms; Extremities; France; Humans; Lung Neoplasms; Methotrexate; Osteosarcoma | 1982 |
Adjuvant chemotherapy of malignant fibrous histiocytoma of bone.
Topics: Adolescent; Antineoplastic Agents; Bone Neoplasms; Doxorubicin; Drug Therapy, Combination; Female; Follow-Up Studies; Histiocytoma, Benign Fibrous; Humans; Infant; Leucovorin; Methotrexate; Prognosis; Vincristine | 1983 |
Chemotherapy of malignant fibrous histiocytoma of bone. A report of five cases.
Topics: Adolescent; Adult; Bone Neoplasms; Drug Therapy, Combination; Female; Follow-Up Studies; Histiocytoma, Benign Fibrous; Humans; Leucovorin; Male; Methotrexate; Neoplasm Metastasis | 1983 |
[Bone metastasis of breast cancer. Apropos of a series of 50 cases].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; France; Humans; Methotrexate; Vincristine | 1982 |
[Effect of IV hydration with sodium bicarbonate on high-dose methotrexate disposition kinetics].
Topics: Adolescent; Adult; Bicarbonates; Bone Neoplasms; Child; Female; Humans; Hydrogen-Ion Concentration; Infusions, Parenteral; Kinetics; Leukemia, Myeloid, Acute; Lymphoma; Male; Metabolic Clearance Rate; Methotrexate; Neoplasms; Osteosarcoma; Sodium Bicarbonate | 1984 |
Sequential methotrexate and 5-fluorouracil: improved response rate in metastatic colorectal cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Colonic Neoplasms; Drug Administration Schedule; Drug Eruptions; Drug Evaluation; Drug Synergism; Female; Fluorouracil; Humans; Leukopenia; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Peripheral Nervous System Diseases; Rectal Neoplasms | 1984 |
[Therapeutic response of various histological osteosarcoma subtypes to high-dose methotrexate treatment].
Topics: Adolescent; Adult; Bone Neoplasms; Female; Femoral Neoplasms; Humans; Humerus; Lung Neoplasms; Male; Methotrexate; Osteosarcoma; Tibia | 1983 |
Local control of osteogenic sarcoma by radiation and chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Combined Modality Therapy; Doxorubicin; Female; Humans; Male; Methotrexate; Osteosarcoma; Radiotherapy, High-Energy | 1984 |
Systemic rhabdomyosarcoma with diffuse bone marrow involvement. Case report of an unusual presentation.
Topics: Ankle; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Examination; Bone Neoplasms; Child; Combined Modality Therapy; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Methotrexate; Neoplastic Stem Cells; Phagocytosis; Prednisone; Rhabdomyosarcoma; Vincristine | 1984 |
[Adriablastin (doxorubicin) in the combined chemotherapy of patients with disseminated forms of breast cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Evaluation; Female; Fluorouracil; Humans; Lung Neoplasms; Lymphatic Metastasis; Methotrexate; Skin Neoplasms; Time Factors | 1984 |
[Evaluation of the results of treatment of endodermal sinus tumor in children].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child, Preschool; Coccyx; Combined Modality Therapy; Dactinomycin; Female; Follow-Up Studies; Genital Neoplasms, Female; Humans; Infant; Male; Mesonephroma; Methotrexate; Radiotherapy Dosage; Sacrum; Testicular Neoplasms; Vincristine | 1984 |
[Chemotherapy of advanced bone and soft tissue sarcoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Combined Modality Therapy; Doxorubicin; Drug Administration Schedule; Humans; Japan; Methotrexate; Neoplasm Metastasis; Sarcoma; Soft Tissue Neoplasms | 1984 |
Adriamycin, dibromodulcitol, and mitomycin combination chemotherapy for patients with metastatic breast carcinoma previously treated with cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, and prednisone.
Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Leukopenia; Methotrexate; Middle Aged; Mitolactol; Mitomycins; Nausea; Prednisone; Soft Tissue Neoplasms; Thrombocytopenia; Time Factors; Vincristine; Vomiting | 1984 |
Sequential methotrexate and 5-FU in CMFP (cyclophosphamide, methotrexate, 5-FU, and prednisone) therapy for breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Drug Administration Schedule; Female; Fluorouracil; Hematologic Diseases; Humans; Liver Neoplasms; Lung Neoplasms; Methotrexate; Middle Aged; Prednisone; Recurrence | 1984 |
[Use of adriamycin in the treatment of metastatic breast cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Castration; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Lung Neoplasms; Mastectomy; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Time Factors | 1984 |
[The Zurich experience with preoperative high-dose methotrexate in osteosarcomas].
Topics: Adolescent; Adult; Alanine Transaminase; Alkaline Phosphatase; Aspartate Aminotransferases; Bone Neoplasms; Child; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Neoplasm Staging; Osteosarcoma; Premedication; Prognosis | 1983 |
Angiographic-pathologic comparison in osteosarcoma after presurgical chemotherapy.
Topics: Adolescent; Adult; Angiography; Bone Neoplasms; Child; Drug Therapy, Combination; Evaluation Studies as Topic; Female; Humans; Male; Methotrexate; Osteosarcoma | 1983 |
Adjuvant chemotherapy for osteosarcoma at the Singapore General Hospital.
Topics: Adolescent; Adult; Antineoplastic Agents; Bone Neoplasms; Child; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Osteosarcoma; Singapore; Vincristine | 1983 |
[Comprehensive therapy of osteosarcoma using high doses of methotrexate--experience 1980-1983].
Topics: Adolescent; Bone Neoplasms; Child; Combined Modality Therapy; Female; Humans; Male; Methotrexate; Osteosarcoma | 1983 |
[Evaluation of severe side effects of high-dose methotrexate in osteosarcoma].
Topics: Adolescent; Adult; Anaphylaxis; Bone Neoplasms; Child; Drug Administration Schedule; Female; Humans; Male; Methotrexate; Nervous System Diseases; Osteosarcoma; Sensation; Vomiting | 1984 |
Osteogenic sarcoma: alterations in the pattern of pulmonary metastases with adjuvant chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Combined Modality Therapy; Doxorubicin; Follow-Up Studies; Humans; Lung Neoplasms; Methotrexate; Osteosarcoma; Time Factors | 1983 |
Transient encephalopathy during the late course of treatment with high-dose methotrexate.
Topics: Bone Neoplasms; Brain Diseases; Child; Female; Humans; Humerus; Lung Neoplasms; Methotrexate; Osteosarcoma; Time Factors; Tomography, X-Ray Computed | 1984 |
Preoperative administration of high-dose methotrexate for osteosarcoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Combined Modality Therapy; Drug Administration Schedule; Female; Humans; Infusions, Parenteral; Male; Methotrexate; Osteosarcoma | 1984 |
[Treatment of osteosarcoma with pre- and postoperative chemotherapy and non-mutilating surgery].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Female; Humans; Knee Joint; Knee Prosthesis; Male; Methods; Methotrexate; Osteosarcoma | 1984 |
High-dose methotrexate for osteosarcoma: toxicity and clinical results.
Topics: Adolescent; Adult; Bone Neoplasms; Chemical and Drug Induced Liver Injury; Female; Humans; Kinetics; Leucovorin; Male; Methotrexate; Middle Aged; Mucous Membrane; Osteosarcoma | 1983 |
Primary osteogenic sarcoma: eight-year experience with adjuvant chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Agents; Bone Neoplasms; Drug Therapy, Combination; Female; Humans; Leucovorin; Lung Neoplasms; Male; Methotrexate; Osteosarcoma; Preoperative Care; Radiography; Time Factors | 1983 |
High-dose methotrexate with leucovorin rescue plus vincristine in advanced sarcoma: a Southwest Oncology Group study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Dose-Response Relationship, Drug; Drug Evaluation; Humans; Leucovorin; Lung Neoplasms; Methotrexate; Sarcoma; Vincristine | 1984 |
Adjuvant CMF effect on site of first recurrence, and appropriate follow-up intervals, in operable breast cancer with positive axillary nodes.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Mastectomy; Methotrexate; Neoplasm Recurrence, Local; Random Allocation; Soft Tissue Neoplasms; Thoracic Neoplasms; Time Factors | 1981 |
Multiple-drug chemotherapy for the primary treatment of osteosarcoma of the extremities.
Topics: Adolescent; Adult; Antineoplastic Agents; Bone Neoplasms; Child; Doxorubicin; Drug Therapy, Combination; Extremities; Female; Follow-Up Studies; Humans; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Osteosarcoma; Vincristine | 1980 |
Surgical adjuvant chemotherapy of metastatic murine osteosarcoma.
Topics: Amputation, Surgical; Animals; Bone Neoplasms; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Lung Neoplasms; Methotrexate; Mice; Osteosarcoma; Sarcoma, Experimental; Time Factors | 1980 |
Is amputation necessary for sarcomas? A seven-year experience with limb salvage.
Topics: Adolescent; Adult; Aged; Amputation, Surgical; Bone Neoplasms; Child; Child, Preschool; Doxorubicin; Female; Humans; Male; Methotrexate; Middle Aged; Osteosarcoma; Sarcoma; Soft Tissue Neoplasms | 1980 |
[Results of Primary chemotherapy and Delayed Surgical Resection in Osteosarcoma (author's transl)].
Topics: Adolescent; Adult; Antineoplastic Agents; Bone Neoplasms; Child; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Osteosarcoma | 1981 |
Planning discharge for a patient with osteogenic sarcoma.
Topics: Bone Neoplasms; Doxorubicin; Humans; Methotrexate; Osteosarcoma; Patient Discharge | 1981 |
Adjuvant treatment of osteosarcoma.
Topics: Adolescent; Adult; Amputation, Surgical; Antineoplastic Agents; BCG Vaccine; Bone Neoplasms; Child; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Methotrexate; Osteosarcoma | 1981 |
[Therapeutic results of patients with osteogenic sarcoma by the protocol COSS 77 (author's transl)].
Topics: Adolescent; Adult; Antineoplastic Agents; Bone Neoplasms; Child; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Osteosarcoma; Vincristine | 1981 |
High-dose methotrexate in osteogenic sarcoma adjuvant chemotherapy and limb salvage results.
Topics: Amputation, Surgical; Angiography; Bone Neoplasms; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Extremities; Humans; Lung Neoplasms; Methotrexate; Osteosarcoma; Time Factors | 1981 |
Pharmacokinetics of methotrexate and 7-hydroxymethotrexate following infusions of high-dose methotrexate.
Topics: Adolescent; Adult; Bile; Bone Neoplasms; Charcoal; Chromatography, High Pressure Liquid; Gastric Juice; Half-Life; Humans; Infusions, Parenteral; Kinetics; Methotrexate; Middle Aged; Osteosarcoma | 1982 |
High dose methotrexate with leucovorin rescue. Rationale and spectrum of antitumor activity.
Topics: Adult; Bone Marrow; Bone Neoplasms; Breast Neoplasms; Drug Administration Schedule; Female; Gastrointestinal Neoplasms; Head and Neck Neoplasms; Humans; Kidney; Leucovorin; Lung Neoplasms; Lymphoma; Methotrexate; Neoplasms; Urogenital Neoplasms | 1980 |
Leukoencephalopathy following high-dose iv methotrexate chemotherapy with leucovorin rescue.
Topics: Adolescent; Adult; Bone Neoplasms; Brain; Child; Female; Humans; Leucovorin; Leukoencephalopathy, Progressive Multifocal; Male; Methotrexate; Soft Tissue Neoplasms; Tomography, X-Ray Computed | 1980 |
Evaluation of results of new treatments for osteosarcoma.
Topics: Adolescent; Adult; Bone Neoplasms; Doxorubicin; Humans; Leucovorin; Methotrexate; Osteosarcoma; Prognosis | 1980 |
High-dose methotrexate with a safe rescue program.
Topics: Adolescent; Adult; Bone Neoplasms; Child; Female; Humans; Leucovorin; Leukocyte Count; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Osteosarcoma | 1981 |
High-dose methotrexate in osteogenic sarcoma.
Topics: Antineoplastic Agents; Bone Neoplasms; Child; Doxorubicin; Humans; Kinetics; Leucovorin; Lung Neoplasms; Methotrexate; Osteosarcoma; Vincristine | 1981 |
Prognostic factors in the response of primary osteogenic sarcoma to preoperative chemotherapy (high-dose methotrexate with citrovorum factor).
Topics: Adolescent; Adult; Antineoplastic Agents; Bone Neoplasms; Child; Drug Therapy, Combination; Female; Humans; Leucovorin; Male; Methotrexate; Osteosarcoma; Preoperative Care; Prognosis; Retrospective Studies | 1981 |
Adjuvant chemotherapy for osteosarcoma: a decade of experience.
Topics: Amputation, Surgical; Antineoplastic Agents; Bone Neoplasms; Doxorubicin; Drug Therapy, Combination; Humans; Leucovorin; Lung Neoplasms; Methotrexate; Osteosarcoma; Probability; Time Factors; Vincristine | 1981 |
Adjuvant chemotherapy for primary osteogenic sarcoma.
Topics: Amputation, Surgical; Antineoplastic Agents; Bone Neoplasms; Doxorubicin; Drug Evaluation; Drug Therapy, Combination; Humans; Immunization; Leucovorin; Lung Neoplasms; Methotrexate; Osteosarcoma | 1981 |
Selected applications of methotrexate alone and in combination in osteosarcoma.
Topics: Antineoplastic Agents; Bone Neoplasms; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Humans; Leucovorin; Lung Neoplasms; Methotrexate; Osteosarcoma; Prognosis; Vincristine | 1981 |
[H-MTX-CF treatment and osteogenic sarcoma (author's transl)].
Topics: Adolescent; Adult; Bone Neoplasms; Child; Drug Therapy, Combination; Humans; Leucovorin; Methotrexate; Osteosarcoma | 1981 |
Improved three-year disease-free survival in osteogenic sarcoma.
Topics: Adolescent; Adult; Age Factors; Bone Neoplasms; Child; Child, Preschool; Doxorubicin; Female; Humans; Leucovorin; Male; Methotrexate; Osteosarcoma; Sex Factors; Vincristine | 1982 |
Radiographic changes in primary osteogenic sarcoma following intensive chemotherapy. Radiological-pathological correlation in 63 patients.
Topics: Adolescent; Adult; Amputation, Surgical; Antineoplastic Agents; Bone Neoplasms; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Leg; Leucovorin; Male; Methotrexate; Osteosarcoma; Radiography | 1982 |
High-dose methotrexate and adriamycin in osteogenic sarcoma: the children's hospital of Philadelphia study.
Topics: Actuarial Analysis; Adolescent; Amputation, Surgical; Antineoplastic Agents; Bone Neoplasms; Child; Doxorubicin; Drug Therapy, Combination; Female; Humans; Leucovorin; Male; Methotrexate; Neoplasm Metastasis; Osteosarcoma | 1982 |
Chemotherapy of a malignant, metastasizing giant-cell tumor of bone: report of an unusual case and the response to combination chemotherapy.
Topics: Adolescent; Antineoplastic Agents; Bone Neoplasms; Drug Therapy, Combination; Female; Giant Cell Tumors; Humans; Leucovorin; Liver Neoplasms; Lung Neoplasms; Methotrexate; Talus; Tibia; Vincristine | 1982 |
Plasma phenylalanine: tyrosine ratios during high-dose methotrexate-citrovorum "rescue".
Topics: Adolescent; Bone Neoplasms; Child; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Leucovorin; Male; Methotrexate; Osteosarcoma; Phenylalanine; Time Factors; Tyrosine | 1982 |
Chemotherapy for osteogenic sarcoma: an investigative method, not a recipe.
Topics: Adolescent; Adult; Bone Neoplasms; Child; Child, Preschool; Cisplatin; Doxorubicin; Drug Evaluation; Drug Therapy, Combination; Economics; Femoral Neoplasms; Humans; Humerus; Leucovorin; Methotrexate; Osteosarcoma; Prognosis; Tibia | 1982 |
[New therapeutic results in osteosarcoma].
Topics: Amputation, Surgical; Bone Neoplasms; Female; Humans; Humerus; Leucovorin; Methotrexate; Osteosarcoma; Preoperative Care; Prognosis | 1982 |
Treatment by amputation and chemotherapy.
Topics: Amputation, Surgical; BCG Vaccine; Bone Neoplasms; Doxorubicin; Follow-Up Studies; Humans; Leucovorin; Methotrexate; Osteosarcoma | 1982 |
Chemotherapy in osteogenic sarcoma.
Topics: Bone Neoplasms; Cyclophosphamide; Doxorubicin; Humans; Leucovorin; Melphalan; Methotrexate; Osteosarcoma; Vincristine | 1982 |
[Tissue concentration of methotrexate in osteosarcoma after high-dose infusion].
Topics: Adolescent; Adult; Animals; Bone Neoplasms; Child; Female; Humans; Leucovorin; Male; Methotrexate; Mice; Mice, Nude; Osteosarcoma; Tissue Distribution | 1982 |
Adjuvant systemic therapy after ablative surgery for limb osteosarcoma.
Topics: Adolescent; Adult; Bone Neoplasms; Doxorubicin; Drug Therapy, Combination; Female; Humans; Leucovorin; Male; Methotrexate; Osteosarcoma; Postoperative Care | 1982 |
Cutaneous pathobiology mediated by chemotherapy.
Topics: Adolescent; Antineoplastic Agents; Autoradiography; Bone Neoplasms; Epidermis; Female; Humans; Methotrexate; Middle Aged; Osteosarcoma; Psoriasis; Purpura; Skin; Skin Diseases, Vesiculobullous | 1980 |
[Controlled ultra-high dosage methotrexate therapy in three patients with metastatic osteosarcoma (author's transl)].
Topics: Adolescent; Bone Neoplasms; Child; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Immunoenzyme Techniques; Leucovorin; Male; Methotrexate; Osteosarcoma; Prognosis | 1981 |
Neurologic and cardiac toxicity following iv application of methotrexate.
Topics: Bone Neoplasms; Breast Neoplasms; Female; Heart; Humans; Injections, Intravenous; Methotrexate; Middle Aged; Neoplasm Metastasis; Nervous System Diseases | 1982 |
Methotrexate in advanced bladder cancer.
Topics: Bone Neoplasms; Drug Administration Schedule; Humans; Lung Neoplasms; Methotrexate; Neoplasm Recurrence, Local; Prognosis; Retrospective Studies; Urinary Bladder Neoplasms | 1981 |
Radiographic evaluation of therapeutic response in bony metastases of breast cancer.
Topics: Adult; Aged; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Radiography | 1981 |
The predictive value of serial bone scans in assessing response to chemotherapy in advanced breast cancer.
Topics: Adult; Aged; Antineoplastic Agents; Bone and Bones; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Prednisone; Radionuclide Imaging; Retrospective Studies; Vincristine | 1980 |
The non-hormone chemotherapy of prostatic cancer.
Topics: Bone Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Fluorouracil; Humans; Lung Neoplasms; Male; Methotrexate; Prostatic Neoplasms | 1980 |
Limited penetration of methotrexate into human osteosarcoma spheroids as a proposed model for solid tumor resistance to adjuvant chemotherapy.
Topics: Autoradiography; Biological Transport, Active; Bone Neoplasms; Culture Techniques; Diffusion; Drug Resistance; Humans; Methotrexate; Neoplasms, Experimental; Osteoma | 1980 |
Lack of functional retinoblastoma protein mediates increased resistance to antimetabolites in human sarcoma cell lines.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Base Sequence; Bone Neoplasms; Cell Division; Cell Line; Cisplatin; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Fibrosarcoma; Floxuridine; Humans; Liposarcoma; Methotrexate; Molecular Sequence Data; Oligonucleotide Probes; Osteosarcoma; Recombinant Proteins; Retinoblastoma Protein; Tetrahydrofolate Dehydrogenase; Thymidylate Synthase; Transfection; Tumor Cells, Cultured | 1995 |
Osteosarcoma following radiation treatment for meningioma: report of a case and effective treatment with chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Cisplatin; Dactinomycin; Etoposide; Female; Gonadotropin-Releasing Hormone; Humans; Ifosfamide; Lung Neoplasms; Meningeal Neoplasms; Meningioma; Methotrexate; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Osteosarcoma; Tamoxifen; Tomography, X-Ray Computed; Vincristine | 1994 |
Quantitative evaluation of thallium-201 uptake in predicting chemotherapeutic response of osteosarcoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Doxorubicin; Female; Humans; Male; Methotrexate; Osteosarcoma; Prospective Studies; Radionuclide Imaging; Thallium Radioisotopes | 1995 |
Methotrexate loaded acrylic cement in the management of skeletal metastases. Biomechanical, biological, and systemic effect.
Topics: Animals; Biomechanical Phenomena; Bone Cements; Bone Neoplasms; Dose-Response Relationship, Drug; Drug Delivery Systems; Fractures, Spontaneous; Lung Neoplasms; Methotrexate; Methylmethacrylate; Methylmethacrylates; Rabbits | 1995 |
A monocentric therapy study: an approach to optimize the results of the treatment of osteosarcoma by protocols based upon HDMTX, associated with systematic conservative surgery.
Topics: Actuarial Analysis; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Clinical Protocols; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Follow-Up Studies; Humans; Ifosfamide; Leucovorin; Methotrexate; Middle Aged; Osteosarcoma; Pilot Projects; Remission Induction; Salvage Therapy; Treatment Outcome; Vincristine | 1993 |
Osteosarcoma: experience with the Rosen T10 protocol at RCH, Melbourne.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Humans; Leucovorin; Life Tables; Male; Methotrexate; Osteosarcoma; Survival Rate; Treatment Outcome; Victoria; Vincristine | 1993 |
Transient neurological disturbances induced by the chemotherapy of high-dose methotrexate for osteogenic sarcoma.
Topics: Adolescent; Bone Neoplasms; Dose-Response Relationship, Drug; Humans; Leucovorin; Male; Methotrexate; Nervous System Diseases; Osteosarcoma | 1994 |
Osteosarcoma recurrences in pediatric patients previously treated with intensive chemotherapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Doxorubicin; Extremities; Female; Follow-Up Studies; Humans; Ifosfamide; Leucovorin; Male; Methotrexate; Neoplasm Recurrence, Local; Osteosarcoma; Prognosis; Retrospective Studies; Survival Rate; Treatment Outcome; Vindesine | 1994 |
Acute urticaria and hepatitis complicating high-dose methotrexate therapy.
Topics: Acute Disease; Bone Neoplasms; Chemical and Drug Induced Liver Injury; Child, Preschool; Female; Humans; Methotrexate; Osteosarcoma; Urticaria | 1995 |
High-dose methotrexate treatment and liver function in patients with osteosarcoma.
Topics: Adolescent; Adult; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Antipyrine; Bone Neoplasms; Cisplatin; Doxorubicin; Female; Galactose; Humans; Liver; Liver Function Tests; Male; Methotrexate; Osteosarcoma; Prospective Studies | 1994 |
Hyperthermic isolated perfusion using cisplatin for treatment of the extremities.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Chemotherapy, Cancer, Regional Perfusion; Child; Cisplatin; Combined Modality Therapy; Doxorubicin; Female; Femoral Neoplasms; Fibula; Follow-Up Studies; Humans; Hyperthermia, Induced; Infusions, Intra-Arterial; Male; Methotrexate; Necrosis; Osteosarcoma; Tibia; Tissue Distribution; Treatment Outcome | 1993 |
Diffusion of methotrexate from surgical acrylic cement.
Topics: Acrylates; Bone Cements; Bone Neoplasms; Chemotherapy, Adjuvant; Diffusion; Humans; Methotrexate; Neoplasm Recurrence, Local; Osteosarcoma; Pharmaceutical Vehicles | 1993 |
Adjuvant interferon treatment in human osteosarcoma.
Topics: Bone Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Doxorubicin; Follow-Up Studies; Humans; Immunologic Factors; Interferon-alpha; Methotrexate; Neoplasm Recurrence, Local; Osteosarcoma; Survival Rate | 1993 |
[The importance of dose intensity in preoperative chemotherapy for osteosarcoma--retrospective analysis of a short intensive chemotherapy regimen preoperatively using high-dose methotrexate and cisplatinum].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Drug Administration Schedule; Humans; Methotrexate; Osteosarcoma; Preoperative Care; Retrospective Studies; Survival Rate | 1994 |
High-dose, brief duration, multiagent chemotherapy for metastatic breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Neoplasms; Brain Neoplasms; Breast Neoplasms; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Fluorouracil; Follow-Up Studies; Hemorrhage; Humans; Leucovorin; Liver Neoplasms; Lung Neoplasms; Methotrexate; Middle Aged; Neutropenia; Remission Induction; Survival Rate; Thrombocytopenia | 1994 |
Cerebral arterial disturbances in a transient encephalopathy induced by methotrexate.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cerebral Arteries; Cerebrovascular Circulation; Cisplatin; Cyclophosphamide; Doxorubicin; Female; Humans; Leucovorin; Methotrexate; Osteosarcoma; Seizures; Syndrome | 1993 |
[Long-term follow-up results after heavy dose chemotherapy of primary malignant bone tumors of the limbs].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Doxorubicin; Female; Femoral Neoplasms; Follow-Up Studies; Humans; Leucovorin; Male; Methotrexate; Middle Aged; Osteosarcoma; Tibia | 1993 |
Primary chemotherapy and delayed surgery for nonmetastatic osteosarcoma of the extremities. Results in 164 patients preoperatively treated with high doses of methotrexate followed by cisplatin and doxorubicin.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Combined Modality Therapy; Doxorubicin; Extremities; Female; Femur; Humans; Humerus; Infusions, Intravenous; Injections, Intra-Arterial; Male; Methotrexate; Neoplasm Recurrence, Local; Osteosarcoma; Postoperative Complications; Preoperative Care; Remission Induction; Survival Rate; Tibia | 1993 |
Wernicke-encephalopathy in children with cancer.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Combined Modality Therapy; Doxorubicin; Female; Humans; Ifosfamide; Methotrexate; Osteosarcoma; Tibia; Wernicke Encephalopathy | 1994 |
Impact of omeprazole on the plasma clearance of methotrexate.
Topics: Adult; Bone Neoplasms; Contraindications; Humans; Male; Metabolic Clearance Rate; Methotrexate; Omeprazole; Osteosarcoma | 1993 |
Proteinuria due to suboptimal hydration with high-dose methotrexate therapy.
Topics: Adolescent; Bone Neoplasms; Burkitt Lymphoma; Child; Female; Fluid Therapy; Glomerular Filtration Rate; Glucose; Humans; Male; Methotrexate; Neoplasms; Osteosarcoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proteinuria; Sodium Bicarbonate | 1993 |
[A case of nonresectable gastric cancer treated by sequential methotrexate and 5-fluorouracil].
Topics: Adenocarcinoma, Scirrhous; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Drug Administration Schedule; Fluorouracil; Humans; Infusions, Intravenous; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Stomach Neoplasms | 1994 |
[A pharmacokinetic study on high-dose methotrexate administration--the effects of volume changes of parenteral solutions on the elimination rate].
Topics: Bone Neoplasms; Female; Humans; Infusions, Parenteral; Mathematics; Methotrexate; Osteosarcoma | 1994 |
Substitution of l-leucovorin for d,l-leucovorin in the rescue from high-dose methotrexate treatment in patients with osteosarcoma.
Topics: Adolescent; Bone Neoplasms; Child; Drug Administration Schedule; Humans; Kidney Function Tests; Leucovorin; Leukocyte Count; Liver Function Tests; Methotrexate; Osteosarcoma; Retrospective Studies; Stereoisomerism | 1993 |
[32 cases of postoperative osteogenic sarcoma treated by chemotherapy combined with Chinese medicinal herbs].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Combined Modality Therapy; Dexamethasone; Drugs, Chinese Herbal; Female; Humans; Male; Methotrexate; Osteosarcoma; Postoperative Period; Vincristine; Vomiting | 1993 |
Malignant fibrous histiocytoma following bone marrow transplantation for acute leukemia.
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Bone Neoplasms; Combined Modality Therapy; Cytarabine; Daunorubicin; Graft vs Host Disease; Histiocytoma, Benign Fibrous; Humans; Leukemia, Myeloid, Acute; Male; Methotrexate; Radiography | 1993 |
Hormonal therapy in the treatment of mandibular metastasis of breast carcinoma. Report of a case.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Mandibular Neoplasms; Methotrexate; Tamoxifen | 1993 |
Pathological responses to preoperative high-dose methotrexate chemotherapy in osteosarcoma--experience in Korea cancer hospital.
Topics: Adolescent; Adult; Bone Neoplasms; Child; Combined Modality Therapy; Female; Humans; Male; Methotrexate; Osteosarcoma | 1993 |
Improved results in osteogenic sarcoma 1973-79 vs. 1980-86: analysis of results from a single center.
Topics: Adolescent; Adult; Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Doxorubicin; Female; Femoral Neoplasms; Follow-Up Studies; Humans; Life Expectancy; Male; Methotrexate; Osteosarcoma; Platinum; Prognosis; Survival Analysis; Treatment Outcome | 1993 |
Determination of methotrexate in human urine at nanomolar levels by high-performance liquid chromatography with column switching.
Topics: Bone Neoplasms; Chromatography, High Pressure Liquid; Freezing; Humans; Indicators and Reagents; Methotrexate; Nursing; Occupational Exposure; Osteosarcoma; Quality Control | 1993 |
Targeted delivery of antineoplastic agent to bone: biodistribution studies of technetium-99m-labeled gem-bisphosphonate conjugate of methotrexate.
Topics: Animals; Antimetabolites, Antineoplastic; Bone and Bones; Bone Neoplasms; Diphosphonates; Male; Methotrexate; Mice; Osteosarcoma; Rabbits; Radionuclide Imaging; Sodium Pertechnetate Tc 99m; Tissue Distribution | 1996 |
Late cardiotoxicity after treatment for a malignant bone tumor.
Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Arrhythmias, Cardiac; Bleomycin; Body Surface Area; Bone Neoplasms; Child; Cyclophosphamide; Dactinomycin; Dilatation, Pathologic; Doxorubicin; Echocardiography; Electrocardiography; Electrocardiography, Ambulatory; Female; Follow-Up Studies; Heart; Heart Diseases; Heart Rate; Humans; Male; Methotrexate; Middle Aged; Myocardium; Radionuclide Angiography; Stroke Volume; Survivors; Ventricular Dysfunction, Left | 1996 |
Localized cisplatin hyperpigmentation induced by pressure. A case report.
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Doxorubicin; Humans; Hyperpigmentation; Male; Methotrexate; Osteosarcoma; Pressure | 1996 |
High-dose methotrexate-induced bullous variant of acral erythema.
Topics: Adolescent; Antimetabolites, Antineoplastic; Bone Neoplasms; Chondrosarcoma; Erythema; Female; Humans; Methotrexate; Osteosarcoma; Skin Diseases, Vesiculobullous | 1996 |
The value of high-dose methotrexate-based neoadjuvant chemotherapy in malignant fibrous histiocytoma of bone.
Topics: Adolescent; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Disease-Free Survival; Female; Histiocytoma, Benign Fibrous; Humans; Male; Methotrexate; Middle Aged; Survival Rate; Treatment Outcome | 1996 |
[Current aspects of the treatment of osteogenic sarcoma].
Topics: Adolescent; Age Factors; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Doxorubicin; Humans; Immunosuppressive Agents; Leucovorin; Methotrexate; Osteosarcoma; Platinum; Time Factors | 1995 |
Long-term pulmonary toxicity of multiagent chemotherapy including bleomycin and cyclophosphamide in osteosarcoma survivors.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Dactinomycin; Doxorubicin; Forced Expiratory Volume; Humans; Lung; Methotrexate; Osteosarcoma; Pulmonary Diffusing Capacity; Total Lung Capacity | 1996 |
Possible interactions between antiblastic agents and warfarin inducing prothrombin time abnormalities.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Drug Interactions; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Mitral Valve Stenosis; Prothrombin Time; Time Factors; Warfarin | 1996 |
True histiocytic lymphoma following therapy for lymphoblastic neoplasms.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Neoplasms; Child; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Etoposide; Fatal Outcome; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Male; Mediastinal Neoplasms; Mercaptopurine; Methotrexate; Methylprednisolone; Neoplasms, Second Primary; Neoplastic Stem Cells; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prednisone; Remission Induction; Scapula; Spinal Neoplasms; Vincristine | 1996 |
Musculoskeletal tumour disorders.
Topics: Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Bone and Bones; Bone Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Humans; Methotrexate; Necrosis; Osteosarcoma | 1996 |
Treatment of advanced breast cancer: How much chemotherapy is enough?
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Cyclophosphamide; Female; Fluorouracil; Humans; Lung Neoplasms; Mastectomy, Segmental; Methotrexate; Middle Aged; Paclitaxel; Tamoxifen | 1996 |
[A device for rapid elevation of plasma methotrexate (MTX) concentration and its maintenance in high-dose MTX therapy].
Topics: Adolescent; Adult; Bone Neoplasms; Child; Female; Fluorescence Polarization Immunoassay; Humans; Infusions, Intravenous; Male; Methotrexate; Osteosarcoma | 1996 |
[Preoperative and postoperative chemotherapy of osteogenic sarcoma of the limbs in children].
Topics: Adolescent; Age Factors; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Child; Child, Preschool; Cisplatin; Disease-Free Survival; Doxorubicin; Extremities; Female; Follow-Up Studies; Humans; Male; Methotrexate; Multivariate Analysis; Osteosarcoma; Postoperative Care; Preoperative Care; Survival Rate; Time Factors; Vincristine | 1996 |
Positive selection and ex vivo expansion of hematopoietic progenitors as autografts for high-dose chemotherapy, potential importance in patients with bone metastases.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carmustine; Cisplatin; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Fluorouracil; Hematopoietic Stem Cell Transplantation; Humans; Methotrexate; Neoplasm Staging; Remission Induction; Transplantation, Autologous | 1995 |
Relief of pain from osseous metastatic lesions.
Topics: Animals; Antineoplastic Agents; Bone Neoplasms; Diphosphonates; Humans; Methotrexate; Pain Management; Strontium Radioisotopes | 1996 |
Low-dose prednisone and increased risk of development of bone metastases.
Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Bone Resorption; Breast Neoplasms; Cisplatin; Dose-Response Relationship, Drug; Female; Fluorouracil; Humans; Methotrexate; Prednisone | 1996 |
The effect of methotrexate-loaded bone cement on local destruction by the VX2 tumour.
Topics: Animals; Antimetabolites, Antineoplastic; Bone Cements; Bone Neoplasms; Methotrexate; Methylmethacrylate; Methylmethacrylates; Neoplasm Transplantation; Osteoclasts; Rabbits; Tibia | 1996 |
Gestational trophoblastic disease presenting as a large metastasis to the finger.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Dactinomycin; Diagnosis, Differential; Doxorubicin; Etoposide; Female; Fingers; Humans; Leucovorin; Methotrexate; Pregnancy; Pregnancy Complications, Neoplastic; Trophoblastic Neoplasms; Uterine Neoplasms; Vincristine | 1996 |
[Toxicity of high dose methotrexate repeated infusions in children treated for acute lymphoblastic leukemia and osteosarcoma].
Topics: Antineoplastic Agents; Bone Neoplasms; Child; Dose-Response Relationship, Drug; Humans; Infusions, Intravenous; Kidney; Liver; Methotrexate; Neutropenia; Osteosarcoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Thrombocytopenia | 1996 |
Methotrexate serum concentration and histological response to multiagent primary chemotherapy for osteosarcoma of the limbs.
Topics: Adolescent; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Doxorubicin; Extremities; Female; Humans; Male; Methotrexate; Osteosarcoma; Prognosis | 1996 |
Neoadjuvant chemotherapy for pediatric osteosarcoma patients.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Disease-Free Survival; Doxorubicin; Female; Humans; Ifosfamide; Male; Methotrexate; Osteosarcoma; Retrospective Studies | 1997 |
Methotrexate osteopathy in patients with osteosarcoma.
Topics: Adolescent; Adult; Antimetabolites, Antineoplastic; Bone Diseases; Bone Neoplasms; Child; Child, Preschool; Female; Humans; Male; Methotrexate; Osteosarcoma; Radiography; Retrospective Studies | 1997 |
Prognostic significance of chemotherapy dosage characteristics in children with osteogenic sarcoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Cisplatin; Disease-Free Survival; Doxorubicin; Humans; Methotrexate; Multivariate Analysis; Osteosarcoma; Prognosis; Retrospective Studies | 1997 |
Chemotherapeutic induction of long-term remission in metastatic medulloblastoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cerebellar Neoplasms; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Epirubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Medulloblastoma; Methotrexate; Remission Induction; Vincristine | 1997 |
[High-dose methotrexate and cerebral neurotoxicity. Apropos of a case of arachnoiditis].
Topics: Adult; Antimetabolites, Antineoplastic; Arachnoiditis; Bone Neoplasms; Encephalitis; Humans; Infusions, Intravenous; Male; Methotrexate; Osteosarcoma; Tibia | 1997 |
Effect of methotrexate and sulphasalazine on UMR 106 rat osteosarcoma cells.
Topics: Alkaline Phosphatase; Animals; Antirheumatic Agents; Bone Neoplasms; Cell Count; Cell Division; Cell Survival; Dose-Response Relationship, Drug; Endothelium, Vascular; Humans; Leucovorin; Methotrexate; Osteosarcoma; Rats; Sulfapyridine; Sulfasalazine; Tumor Cells, Cultured; Vitamin D | 1997 |
Influence of methotrexate dose intensity on outcome of patients with high grade osteogenic osteosarcoma: analysis of the literature.
Topics: Antimetabolites, Antineoplastic; Bone Neoplasms; Drug Administration Schedule; Humans; Methotrexate; Osteosarcoma | 1997 |
Mitoxantrone in the treatment of metastatic transitional cell carcinoma of the prostate. A case report.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Transitional Cell; Cisplatin; Disease Progression; Doxorubicin; Fatal Outcome; Follow-Up Studies; Humans; Injections, Intravenous; Lung Neoplasms; Male; Methotrexate; Middle Aged; Mitoxantrone; Prostatic Neoplasms; Remission Induction; Vinblastine | 1997 |
Neoadjuvant chemotherapy for osseous malignant fibrous histiocytoma of the extremity: results in 18 cases and comparison with 112 contemporary osteosarcoma patients treated with the same chemotherapy regimen.
Topics: Adolescent; Adult; Amputation, Surgical; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Female; Follow-Up Studies; Histiocytoma, Benign Fibrous; Humans; Ifosfamide; Leg; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Osteosarcoma | 1997 |
Treatment of childhood post-irradiation sarcoma of bone in cancer survivors.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cisplatin; Female; Humans; Ifosfamide; Leucovorin; Male; Methotrexate; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Remission Induction; Retrospective Studies; Rhabdomyosarcoma; Sarcoma; Sarcoma, Ewing; Survivors; Vincristine | 1997 |
Intratumoral differences in methotrexate levels within human osteosarcoma xenografts studied by microdialysis.
Topics: Animals; Antimetabolites, Antineoplastic; Area Under Curve; Bone Neoplasms; Humans; Male; Methotrexate; Microdialysis; Neoplasm Transplantation; Osteosarcoma; Rats; Rats, Nude; Transplantation, Heterologous; Tumor Cells, Cultured | 1997 |
[The application of intraarterial chemotherapy for the treatment of osteogenic sarcoma in children].
Topics: Antineoplastic Agents; Bone Neoplasms; Child; Child, Preschool; Cisplatin; Doxorubicin; Humans; Infusions, Intra-Arterial; Methotrexate; Osteosarcoma | 1997 |
[A case of advanced gastric cancer with multiple bone metastasis successfully treated by both methotrexate and 5-fluorouracil sequential therapy, and endoscopic intratumoral injection of 5-fluorouracil].
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Cancer, Regional Perfusion; Drug Administration Schedule; Fluorouracil; Gastroscopy; Humans; Injections, Intralesional; Male; Methotrexate; Stomach Neoplasms | 1998 |
Predictive factors of histologic response to primary chemotherapy in osteosarcoma of the extremity: study of 272 patients preoperatively treated with high-dose methotrexate, doxorubicin, and cisplatin.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Doxorubicin; Extremities; Female; Humans; Male; Methotrexate; Osteosarcoma; Retrospective Studies | 1998 |
Malignant fibrous histiocytoma of bone: a clinicopathologic study of 81 patients.
Topics: Antimetabolites, Antineoplastic; Bone Neoplasms; Chemotherapy, Adjuvant; Histiocytoma, Benign Fibrous; Humans; Methotrexate; Prognosis; Treatment Outcome | 1998 |
Development of porous apatite ceramic for local delivery of chemotherapeutic agents.
Topics: Antimetabolites, Antineoplastic; Apatites; Bone Neoplasms; Chromatography, High Pressure Liquid; Drug Delivery Systems; Methotrexate; Soft Tissue Neoplasms | 1998 |
Neoadjuvant chemotherapy for extremity osteosarcoma--preliminary results of the Rizzoli's 4th study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Cisplatin; Disease-Free Survival; Doxorubicin; Extremities; Female; Humans; Ifosfamide; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Osteosarcoma; Preoperative Care | 1998 |
Augmentation of anti-tumor effects of methotrexate by distilled water on Dunn osteosarcoma in mouse air pouch.
Topics: Animals; Antimetabolites, Antineoplastic; Bone Neoplasms; Drug Synergism; Male; Methotrexate; Mice; Mice, Inbred C3H; Osteosarcoma; Solutions; Water | 1998 |
Treatment of multifocal lymphoma of bone with intensified ProMACE-CytaBOM chemotherapy and involved field radiotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Prednisone; Survival Analysis; Tomography, X-Ray Computed; Vincristine | 1998 |
Meningeal myeloma in the absence of systemic disease, and as the initial feature of disease progression.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Disease Progression; Doxorubicin; Fatal Outcome; Hematopoietic Stem Cell Transplantation; Humans; Immunoglobulin G; Immunoglobulin lambda-Chains; Injections, Spinal; Male; Meningeal Neoplasms; Methotrexate; Methylprednisolone; Middle Aged; Multiple Myeloma; Myeloma Proteins; Neoplasm Staging; Ribs; Vincristine | 1998 |
Ewing's sarcoma treatment in Scandinavia 1984-1990--ten-year results of the Scandinavian Sarcoma Group Protocol SSGIV.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Child; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Methotrexate; Neoplasm Recurrence, Local; Orthopedic Procedures; Radiotherapy, Adjuvant; Sarcoma, Ewing; Scandinavian and Nordic Countries; Survival Analysis; Treatment Outcome; Vincristine | 1998 |
[Membranous lipodystrophy caused by chemotherapy].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Female; Fluorouracil; Humans; Lipodystrophy; Liver Neoplasms; Methotrexate | 1998 |
[Usefulness of magnetic resonance imaging for evaluation of therapeutic efficacy of bone metastases from bladder cancer: a case report].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Transitional Cell; Cisplatin; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Magnetic Resonance Imaging; Male; Methotrexate; Urinary Bladder Neoplasms; Vinblastine | 1998 |
Effect of methotrexate on distraction osteogenesis.
Topics: Animals; Antimetabolites, Antineoplastic; Blood Cell Count; Bone Neoplasms; Bone Regeneration; Calcification, Physiologic; Calcium; Disease Models, Animal; External Fixators; Female; Humans; Ilizarov Technique; Methotrexate; Osteogenesis, Distraction; Osteosarcoma; Phosphorus; Placebos; Rabbits; Radiography; Random Allocation; Tibia | 1998 |
Chemotherapy and P-glycoprotein expression in chondrosarcoma.
Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bone Neoplasms; Chondrosarcoma; Cisplatin; Cohort Studies; Doxorubicin; Drug Resistance, Neoplasm; Female; Humans; Ifosfamide; Male; Methotrexate; Middle Aged; Pyrimethamine; Retrospective Studies; Survival Analysis; Vinblastine | 1998 |
[Carboxypeptidase-G2 rescue of methotrexate intoxication].
Topics: Adolescent; Antimetabolites, Antineoplastic; Bone Neoplasms; gamma-Glutamyl Hydrolase; Humans; Male; Methotrexate; Osteosarcoma; Poisoning | 1998 |
Ifosfamide/etoposide alternating with high-dose methotrexate: evaluation of a chemotherapy regimen for poor-risk osteosarcoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Drug Administration Schedule; Etoposide; Feasibility Studies; Female; Humans; Ifosfamide; Male; Methotrexate; Osteosarcoma; Recurrence; Retrospective Studies | 1999 |
Accumulation of methotrexate in human tissues following high-dose methotrexate therapy.
Topics: Adolescent; Antimetabolites, Antineoplastic; Bone Neoplasms; Gallbladder; Humans; Kidney; Liver; Male; Methotrexate; Muscle, Skeletal; Osteosarcoma; Tissue Distribution | 1998 |
High-dose leucovorin as sole therapy for methotrexate toxicity.
Topics: Antidotes; Antimetabolites, Antineoplastic; Bone Neoplasms; Child; Creatinine; Drug Administration Schedule; Female; Folic Acid Antagonists; Humans; Kidney; Leucovorin; Methotrexate; Neutropenia; Osteosarcoma; Retrospective Studies; Thrombocytopenia | 1999 |
Omeprazole does not alter plasma methotrexate clearance.
Topics: Adult; Anti-Ulcer Agents; Antimetabolites, Antineoplastic; Bone Neoplasms; Drug Interactions; Humans; Kidney; Male; Methotrexate; Omeprazole; Osteosarcoma | 1999 |
Prognostic factors in non-metastatic limb osteosarcoma: A 20-year experience of one center.
Topics: Adolescent; Alkaline Phosphatase; Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Cohort Studies; Combined Modality Therapy; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Extremities; Female; Humans; Israel; L-Lactate Dehydrogenase; Leucovorin; Life Tables; Male; Methotrexate; Neoplasm Proteins; Neoplasm Staging; Osteosarcoma; Preoperative Care; Prognosis; Retrospective Studies; Risk Factors; Salvage Therapy; Survival Analysis; Treatment Outcome; Vincristine | 1999 |
Prognostic value of DNA ploidy response to chemotherapy in human osteosarcomas.
Topics: Adolescent; Adult; Aged; Aneuploidy; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Cisplatin; Disease-Free Survival; Doxorubicin; Female; Humans; Male; Methotrexate; Microscopy, Fluorescence; Middle Aged; Osteosarcoma; Ploidies; Prognosis | 1999 |
[A case of adriamycin and methotrexate-resistant recurrent breast cancer treated with doxifluridine and mitomycin C].
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Doxorubicin; Drug Resistance, Neoplasm; Female; Floxuridine; Humans; Lymphatic Metastasis; Methotrexate; Middle Aged; Mitomycin; Neoplasm Recurrence, Local | 1999 |
Outcome of radiation-related osteosarcoma after treatment of childhood and adolescent cancer: a study of 23 cases.
Topics: Adolescent; Adult; Antimetabolites, Antineoplastic; Bone Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Disease-Free Survival; Female; Follow-Up Studies; Humans; Infant; Male; Methotrexate; Neoplasm Recurrence, Local; Neoplasms; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Osteosarcoma; Radiotherapy Dosage; Rhabdomyosarcoma; Sarcoma, Ewing | 1999 |
Fatal cardiovascular complication 19 years after treatment for fibrosarcoma.
Topics: Adult; Antineoplastic Agents; Bone Neoplasms; Chemotherapy, Adjuvant; Doxorubicin; Endomyocardial Fibrosis; Fatal Outcome; Fibrosarcoma; Humans; Male; Methotrexate; Radiotherapy; Vincristine | 1999 |
Successful rescue by oral cholestyramine of a patient with methotrexate nephrotoxicity: nonrenal excretion of serum methotrexate.
Topics: Anion Exchange Resins; Antimetabolites, Antineoplastic; Bone Neoplasms; Child; Cholestyramine Resin; Humans; Kidney; Liver; Male; Methotrexate; Osteosarcoma; Tibia; Time Factors; Treatment Outcome | 2000 |
[Primary chemotherapy with the Rosen T10 protocol before conservative surgery in limb primitive osteosarcomas: results about 56 cases].
Topics: Adolescent; Adult; Alkaline Phosphatase; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Humans; L-Lactate Dehydrogenase; Leucovorin; Magnetic Resonance Imaging; Male; Methotrexate; Osteosarcoma; Prospective Studies; Survival Analysis; Tomography, X-Ray Computed; Vincristine | 2000 |
Drug-induced apoptosis in osteosarcoma cell lines is mediated by caspase activation independent of CD95-receptor/ligand interaction.
Topics: Annexin A5; Antineoplastic Agents; Apoptosis; Bone Neoplasms; Caspases; Cisplatin; Doxorubicin; Enzyme Activation; Fas Ligand Protein; fas Receptor; Humans; Membrane Glycoproteins; Methotrexate; Mitochondria; Osteosarcoma; Tumor Cells, Cultured | 2000 |
[The analysis of failures in therapy of osteosarcoma in children treated according to SFOP-94 protocol in the studies of Polish pediatric solid tumors treatment group].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Doxorubicin; Female; Humans; Male; Methotrexate; Osteosarcoma; Poland; Retrospective Studies; Survival Rate; Treatment Failure | 1998 |
[Morphology of a lithic lesion of the bone treated with cement filling with the addition of methotrexate].
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Bone Neoplasms; Cementation; Female; Humans; Male; Methotrexate; Middle Aged; Retrospective Studies | 2000 |
Cytotoxic effect of methotrexate and its solvent on osteosarcoma cells in vitro.
Topics: Antimetabolites, Antineoplastic; Bone Cements; Bone Neoplasms; Cell Division; Cell Survival; Dose-Response Relationship, Drug; Drug Implants; Humans; In Vitro Techniques; Methotrexate; Osteoblasts; Osteosarcoma; Pyrrolidinones; Tumor Cells, Cultured | 1999 |
Anaplastic osteosarcoma with abundant eosinophilic cytoplasm and minimal osteoid production.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Neoplasms; Child; Cisplatin; Cytoplasm; Doxorubicin; Drug Therapy, Combination; Eosine Yellowish-(YS); Fatal Outcome; Humans; Immunohistochemistry; Lung Neoplasms; Male; Methotrexate; Neoplasm Proteins; Osteosarcoma; Staining and Labeling; Tibia; Tomography, X-Ray Computed | 2000 |
Allergic reaction to high-dose methotrexate.
Topics: Adolescent; Anti-Anxiety Agents; Antimetabolites, Antineoplastic; Antipruritics; Bone Neoplasms; Diphenhydramine; Drug Eruptions; Drug Therapy, Combination; Folic Acid Antagonists; Humans; Immunosuppressive Agents; Male; Methotrexate; Ondansetron; Osteosarcoma; Premedication; Tibia; Urticaria | 2000 |
[Two bedridden patients with bone metastases from breast cancer effectively treated with pamidronate therapy].
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Diphosphonates; Female; Fluorouracil; Humans; Mastectomy; Methotrexate; Middle Aged; Pamidronate | 2000 |
Neoadjuvant chemotherapy for high grade osteosarcoma of the extremities: long-term results for patients treated according to the Rizzoli IOR/OS-3b protocol.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Doxorubicin; Extremities; Female; Humans; Ifosfamide; Infusions, Intra-Arterial; Infusions, Intravenous; Male; Methotrexate; Neoadjuvant Therapy; Osteosarcoma; Time Factors; Treatment Outcome | 2001 |
Methotrexate poisoning with acute hepatorenal dysfunction.
Topics: Acute Kidney Injury; Adolescent; Antimetabolites, Antineoplastic; Bone Neoplasms; Chemical and Drug Induced Liver Injury; Female; Hemofiltration; Humans; Liver Diseases; Methotrexate; Osteosarcoma; Plasma Exchange; Renal Dialysis; Treatment Outcome | 2001 |
Histologic response of high-grade nonmetastatic osteosarcoma of the extremity to chemotherapy,.
Topics: Adolescent; Adult; Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Dose-Response Relationship, Drug; Doxorubicin; Extremities; Female; Humans; Ifosfamide; Logistic Models; Male; Methotrexate; Multivariate Analysis; Osteonecrosis; Osteosarcoma; Preoperative Care; Prognosis; Retrospective Studies; Severity of Illness Index; Survival Rate; Treatment Outcome | 2001 |
Neoadjuvant chemotherapy for patients with synchronous multifocal osteosarcoma: results in eleven cases.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cisplatin; Doxorubicin; Female; Humans; Ifosfamide; Male; Methotrexate; Neoadjuvant Therapy; Neoplasms, Multiple Primary; Osteosarcoma; Survival Rate; Treatment Outcome | 2001 |
Long-term local intensive preoperative chemotherapy and joint-preserving conservative surgery for osteosarcoma around the knee.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Chemotherapy, Cancer, Regional Perfusion; Cisplatin; Disease-Free Survival; Doxorubicin; Female; Femoral Neoplasms; Humans; Hyperthermia, Induced; Infusions, Intravenous; Injections, Intra-Arterial; Knee Joint; Male; Methotrexate; Neoplasm Staging; Osteosarcoma; Osteotomy; Preoperative Care; Tibia; Time Factors; Treatment Outcome | 2001 |
[Methotrexate-ciprofloxacin interaction: report of two cases of severe intoxication].
Topics: Adolescent; Anti-Infective Agents; Antimetabolites, Antineoplastic; Bone Neoplasms; Ciprofloxacin; Drug Interactions; Female; Humans; Male; Methotrexate; Neuroblastoma; Osteosarcoma | 2001 |
Leiomyosarcoma, rheumatoid arthritis and methotrexate: an association?
Topics: Aged; Arm; Arthritis, Rheumatoid; Bone Neoplasms; Fatal Outcome; Humans; Leiomyosarcoma; Lung Neoplasms; Male; Mediastinal Neoplasms; Methotrexate; Neoplasm Recurrence, Local | 2001 |
Report of a patient with a high level of parathyroid hormone-related peptide associated with malignant lymphoma involving multiple bony lesions.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Female; Humans; Hypercalcemia; Kidney; Methotrexate; Parathyroid Hormone-Related Protein; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proteins | 2002 |
Adjuvant chemotherapy for osteosarcoma may not increase survival after neoadjuvant chemotherapy and surgical resection.
Topics: Adolescent; Adult; Aged; Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Doxorubicin; Drug Administration Schedule; Female; Humans; Ifosfamide; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Osteosarcoma; Survival Rate | 2001 |
High-dose methotrexate in fibroblastic osteosarcoma.
Topics: Adult; Antimetabolites, Antineoplastic; Area Under Curve; Bone Neoplasms; Dose-Response Relationship, Drug; Half-Life; Humans; Male; Metabolic Clearance Rate; Methotrexate; Osteosarcoma | 2001 |
The cytotoxic effect of methotrexate loaded bone cement on osteosarcoma cell lines.
Topics: Antimetabolites, Antineoplastic; Bone Cements; Bone Neoplasms; Drug Delivery Systems; Drug Screening Assays, Antitumor; Humans; Methotrexate; Osteosarcoma; Tumor Cells, Cultured | 2001 |
[Flow cytometry for testing chemosensitivity of malignant bone tumors].
Topics: Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bone Neoplasms; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flow Cytometry; Fluorouracil; Humans; Methotrexate; Mitomycin; Osteosarcoma | 1999 |
Significant impairment of high-dose methotrexate clearance following vancomycin administration in the absence of overt renal impairment.
Topics: Adult; Anti-Bacterial Agents; Antimetabolites, Antineoplastic; Bone Neoplasms; Drug Interactions; Female; Glomerular Filtration Rate; Humans; Kidney; Kidney Diseases; Male; Metabolic Clearance Rate; Methotrexate; Osteosarcoma; Vancomycin | 2002 |
[A case of subacute transient cerebral dysfunction in a osteosarcoma patient following high-dose methotrexate].
Topics: Adolescent; Antimetabolites, Antineoplastic; Antineoplastic Agents; Bone Neoplasms; Brain Diseases; Cisplatin; Drug Administration Schedule; Humans; Male; Methotrexate; Osteosarcoma | 2002 |
[An autopsy case of pulmonary and central nervous system metastatic osteosarcoma treated with thirty-six courses of chemotherapy over four years].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Carboplatin; Cisplatin; Dacarbazine; Deoxycytidine; Docetaxel; Drug Administration Schedule; Etoposide; Gemcitabine; Humans; Ifosfamide; Lung Neoplasms; Male; Methotrexate; Osteosarcoma; Paclitaxel; Spinal Cord Neoplasms; Survivors; Taxoids; Vincristine; Vindesine | 2002 |
Interaction between methotrexate and ciprofloxacin.
Topics: Adolescent; Anti-Infective Agents; Antimetabolites, Antineoplastic; Bone Neoplasms; Child; Child, Preschool; Ciprofloxacin; Drug Interactions; Female; Humans; Male; Methotrexate; Neuroblastoma; Osteosarcoma | 2002 |
Brief report: successful therapy of a patient with infantile generalized myofibromatosis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Eye Neoplasms; Humans; Infant; Liver Neoplasms; Male; Methotrexate; Myofibromatosis; Treatment Outcome; Vinblastine | 2002 |
[Results of treatment of osteosarcoma in children according to the SFOP-94 protocol in the experience of the Polish Paediatric Solid Tumour Study Group].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Disease-Free Survival; Doxorubicin; Female; Femur; Humans; Humerus; Lung Neoplasms; Male; Methotrexate; Osteosarcoma; Poland; Remission Induction; Retrospective Studies; Tibia; Time Factors | 2000 |
Improvement in the results of treatment of osteogenic sarcoma.
Topics: Adolescent; Adult; Age Factors; Aged; Amputation, Surgical; Bone Neoplasms; Child; Doxorubicin; Hemipelvectomy; Humans; Leg; Lung Neoplasms; Methotrexate; Middle Aged; Neoplasm Metastasis; Osteosarcoma; Palliative Care; Pneumonectomy; Remission, Spontaneous | 1975 |
Eosinophilic meningitis complicating Hodgkin's disease. A report of a case and review of the literature.
Topics: Adult; Bleomycin; Bone Neoplasms; Eosinophils; Female; Hodgkin Disease; Humans; Injections, Spinal; Meningitis; Methotrexate | 1977 |
[Clinical observations on the use of high-dose methotrexate treatment in osteogenic sarcoma (author's transl)].
Topics: Adolescent; Adult; Bleomycin; Bone Neoplasms; Child; Cyclophosphamide; Daunorubicin; Doxorubicin; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Osteosarcoma; Vincristine | 1977 |
[Therapy of malignant tumors through the internist].
Topics: Bleomycin; Bone Neoplasms; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Humans; Melphalan; Methotrexate; Osteosarcoma; Plasmacytoma; Prednisone; Sarcoma, Ewing; Vincristine | 1977 |
Malignant bone tumors: spindle-cell sarcomas.
Topics: Adolescent; Amputation, Surgical; Bleomycin; Bone Neoplasms; Child; Cyclophosphamide; Dactinomycin; Dose-Response Relationship, Drug; Humans; Leucovorin; Methotrexate; Neoplasm Metastasis; Osteosarcoma; Preoperative Care; Prostheses and Implants; Radiography; Vincristine | 1978 |
Malignant small-cell sarcomas of bone.
Topics: Adolescent; Bleomycin; Bone Neoplasms; Child; Cyclophosphamide; Dactinomycin; Diagnosis, Differential; Doxorubicin; Humans; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Neoplasm Metastasis; Radiography; Radiotherapy, High-Energy; Sarcoma, Ewing; Vincristine | 1978 |
Primary osteogenic sarcoma: the rationale for preoperative chemotherapy and delayed surgery.
Topics: Adolescent; Adult; Antineoplastic Agents; Bleomycin; Bone Neoplasms; Brain; Child; Cyclophosphamide; Doxorubicin; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Leucovorin; Male; Methotrexate; Osteosarcoma; Time Factors; Vincristine | 1979 |
Letter: Osteoblastic repair of osteolytic tumor metastases following treatment.
Topics: Adult; Antineoplastic Agents; Bone Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Cyclophosphamide; Female; Fluorouracil; Humans; Methotrexate; Neoplasm Metastasis; Osteoblasts; Radiography; Remission, Spontaneous | 1975 |
Increased serum calcitonin levels in bronchogenic cancer.
Topics: Adenocarcinoma; Adult; Aged; Bone Neoplasms; Calcitonin; Calcium; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cyclophosphamide; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Thyroid Gland | 1976 |
Cyclophosphamide, adriamycin, methotrexate, and procarbazine (CAMP)--effective four-drug combination chemotherapy for metastatic non-oat cell bronchogenic carcinoma.
Topics: Adenocarcinoma; Adenocarcinoma, Bronchiolo-Alveolar; Adult; Aged; Bone Neoplasms; Brain Neoplasms; Carcinoma, Bronchogenic; Carcinoma, Squamous Cell; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Humans; Liver Neoplasms; Lung Neoplasms; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Procarbazine; Skin Neoplasms | 1976 |
Osteogenic sarcoma in a patient with aplastic anemia.
Topics: Adolescent; Anemia, Aplastic; Bone Neoplasms; Chloramphenicol; Humans; Male; Methotrexate; Osteosarcoma; Prednisone; Testosterone | 1977 |
[Serum methotrexate determination by microbiological assay in patients receiving high-dosage methotrexate (author's transl)].
Topics: Bone Neoplasms; Humans; Methotrexate; Osteosarcoma; Radioimmunoassay | 1977 |
Radiation treatment of Ewing's sarcoma and osteogenic sarcoma.
Topics: Adolescent; Adult; Bone Neoplasms; Child; Doxorubicin; Female; Humans; Lung Neoplasms; Methotrexate; Metronidazole; Neoplasm Metastasis; Osteosarcoma; Radiotherapy Dosage; Sarcoma, Ewing | 1977 |
Anaphylactoid type reactions in two patients receiving high dose intravenous methotrexate.
Topics: Adolescent; Adult; Anaphylaxis; BCG Vaccine; Bone Neoplasms; Drug Contamination; Humans; Injections, Intravenous; Male; Methotrexate; Osteosarcoma | 1978 |
Pulmonary resection in children with metastatic osteogenic sarcoma: improved survival with surgery, chemotherapy, and irradiation.
Topics: Adolescent; Bone Neoplasms; Child; Cyclophosphamide; Doxorubicin; Female; Humans; Lung Neoplasms; Male; Methotrexate; Neoplasm Metastasis; Osteosarcoma; Pneumonectomy; Prognosis; Radiography; Vincristine | 1978 |
[Malignant juvenile bone tumors].
Topics: Adolescent; Adult; Aged; Amputation, Surgical; Bone Neoplasms; Child; Diagnosis, Differential; Doxorubicin; Drug Therapy, Combination; Eosinophilic Granuloma; Female; Folic Acid; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Osteomyelitis; Osteosarcoma; Sarcoma, Ewing | 1978 |
[First experiences after exclusive radiotherapy of primary bone tumors (proceedings)].
Topics: Adolescent; Adult; Bone Neoplasms; Chondrosarcoma; Cobalt Radioisotopes; Female; Humans; Male; Methotrexate; Osteosarcoma; Sarcoma, Ewing | 1978 |
[Osteosarcoma 1978 a turning point in prognosis through adjuvant chemotherapy following adequate surgery (author's transl)].
Topics: Adolescent; Amputation, Surgical; Bone Neoplasms; Child; Cyclophosphamide; Female; Femur; Humans; Humerus; Male; Melphalan; Methotrexate; Mitomycins; Osteosarcoma; Prognosis; Prostheses and Implants; Tibia | 1978 |
Adjuvant therapy in the management of osteosarcoma: need for critical reassessment.
Topics: Antineoplastic Agents; Bone Neoplasms; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Humans; Lung Neoplasms; Methotrexate; Neoplasm Metastasis; Osteosarcoma; Vincristine | 1978 |
Primary osteogenic sarcoma: pathologic aspects in 20 patients after treatment with chemotherapy en bloc resection, and prosthetic bone replacement.
Topics: Adolescent; Adult; Amputation, Surgical; Bone Neoplasms; Child; Drug Therapy, Combination; Female; Femoral Neoplasms; Humans; Leucovorin; Male; Methotrexate; Necrosis; Osteocytes; Osteosarcoma; Tibia; Vincristine | 1977 |
Weekly high-dose methotrexate-citrovorum factor in osteogenic sarcoma: pre-surgical treatment of primary tumor and of overt pulmonary metastases.
Topics: Bone Neoplasms; Drug Administration Schedule; Humans; Leucovorin; Lung Neoplasms; Male; Methotrexate; Neoplasm Metastasis; Osteosarcoma; Remission, Spontaneous; Vincristine | 1977 |
Adjuvant multiple drug chemotherapy for osteosarcoma of the extremity.
Topics: Adolescent; Adult; Amputation, Surgical; Antineoplastic Agents; Bone Neoplasms; Child; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Extremities; Female; Humans; Leucovorin; Lung Neoplasms; Male; Methotrexate; Neoplasm Metastasis; Osteosarcoma | 1977 |
Multidisciplinary treatment for childhood sarcoma.
Topics: Adolescent; Age Factors; Antineoplastic Agents; Bone Neoplasms; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Infant; Leucovorin; Lymphatic Metastasis; Male; Methods; Methotrexate; Neoplasm Metastasis; Osteosarcoma; Rhabdomyosarcoma; Sarcoma; Sarcoma, Ewing; Soft Tissue Neoplasms; Vincristine | 1977 |
Osteosarcoma during pregnancy.
Topics: Abortion, Induced; Adolescent; Adult; Amputation, Surgical; Bone Neoplasms; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Extremities; Female; Humans; Leucovorin; Methotrexate; Neoplasm Metastasis; Osteosarcoma; Pregnancy; Pregnancy Complications; Vincristine | 1977 |
Phase II study of combined vincristine, adriamycin, cyclophosphamide, and methotrexate with citrovorum factor factor rescue in metastatic breast cancer.
Topics: Adult; Aged; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Leucovorin; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Remission, Spontaneous; Vincristine | 1977 |
Current concepts in the management of disseminated malignant bone disease in childhood.
Topics: Bone Neoplasms; Child; Cyclophosphamide; Dactinomycin; Doxorubicin; Humans; Leucovorin; Methotrexate; Osteosarcoma; Sarcoma, Ewing; Vincristine | 1977 |
Surgical management of malignant bone tumours.
Topics: Adult; Amputation, Surgical; Bone Neoplasms; Child; Chondrosarcoma; Fibrosarcoma; Humans; Leucovorin; Methotrexate; Osteosarcoma; Sarcoma, Ewing | 1977 |
Effect of hydration on plasma-methotrexate levels.
Topics: Adolescent; Adult; Bicarbonates; Bone Neoplasms; Child; Female; Humans; Infusions, Parenteral; Leucovorin; Male; Methotrexate; Middle Aged; Osteosarcoma; Sodium; Solutions; Water | 1977 |
[Chemotherapy of osteosarcoma (author's transl)].
Topics: Adolescent; Age Factors; Bone Neoplasms; Child; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Humans; Leucovorin; Male; Methods; Methotrexate; Osteosarcoma; Time Factors | 1977 |
Pathologic aspects of chemotherapy response in the treatment of osteogenic sarcoma. An analysis of two cases.
Topics: Adolescent; Antineoplastic Agents; Bone Neoplasms; Doxorubicin; Drug Therapy, Combination; Female; Humans; Leucovorin; Lung Neoplasms; Male; Methotrexate; Neoplasm Metastasis; Osteosarcoma; Tibia | 1977 |
"Single"-agent activity of high-dose methotrexate with citrovorum factor rescue.
Topics: Bone Neoplasms; Drug Therapy, Combination; Humans; Leucovorin; Methotrexate; Neoplasms; Osteosarcoma; Vincristine | 1978 |
[High-dose methotrexate/leucovorin adjuvant chemotherapy of osteogenic sarcoma: biochemical effects in DNA-synthesis of bone marrow cells (author's transl)].
Topics: Bone Marrow; Bone Neoplasms; DNA; Humans; Leucovorin; Methotrexate; Osteosarcoma | 1978 |
[Therapy of malignant bone tumors. Recommendations for the therapy of malignant primary and secondary bone tumors].
Topics: Amputation, Surgical; Bone Neoplasms; Doxorubicin; Humans; Leucovorin; Methotrexate; Neoplasm Metastasis; Vincristine | 1978 |
Osteosarcoma--the winds of change.
Topics: Adolescent; Adult; Bone Neoplasms; Child; Child, Preschool; Doxorubicin; Extremities; Female; Humans; Leucovorin; Lung Neoplasms; Male; Methotrexate; Neoplasm Metastasis; Osteosarcoma; Vincristine | 1978 |
Transient cerebral dysfunction following chemotherapy for osteogenic sarcoma.
Topics: Adolescent; Adult; Bone Neoplasms; Brain Diseases; Drug Therapy, Combination; Female; Femoral Neoplasms; Humans; Humerus; Leucovorin; Male; Methotrexate; Neoplasm Metastasis; Osteosarcoma; Pelvic Bones; Syndrome; Vincristine | 1978 |
High-dose methotrexate and leucovorin rescue in dogs with osteogenic sarcoma.
Topics: Animals; Bone Neoplasms; Dog Diseases; Dogs; Female; Leucovorin; Male; Methotrexate; Neoplasm Metastasis; Osteosarcoma | 1978 |
[High-dose methotrexate therapy in osteogenic sarcoma: plasma pharmakokinetics to predict toxicity (author's transl)].
Topics: Adolescent; Adult; Bone Marrow; Bone Neoplasms; Child; Creatinine; Humans; Leucovorin; Methotrexate; Osteosarcoma; Radioimmunoassay; Stomatitis | 1979 |
Evaluation of overall toxicity of high-dosage methotrexate regimens.
Topics: Adolescent; Age Factors; Bone Marrow; Bone Neoplasms; Child; Dermatitis; Drug Administration Schedule; Female; Humans; Kidney; Leucovorin; Leukopenia; Liver; Male; Methotrexate; Osteosarcoma; Sex Factors; Stomatitis; Thrombocytopenia; Vincristine | 1979 |
Pharmacokinetic monitoring of high-dose methotrexate. Early recognition of high-risk patients.
Topics: Bone Neoplasms; Drug Therapy, Combination; Half-Life; Humans; Kinetics; Leucovorin; Methotrexate; Osteosarcoma; Risk; Time Factors | 1979 |
[Combined treatment of malignant tumors of the bones in children].
Topics: Adolescent; Bone Neoplasms; Child; Child, Preschool; Chondrosarcoma; Cyclophosphamide; Humans; Infant; Lymphoma, Large B-Cell, Diffuse; Melphalan; Methotrexate; Sarcoma, Ewing | 1977 |
Radiation in bone sarcomas: a re-evaluation in the era of intensive systemic chemotherapy.
Topics: Bone Neoplasms; Child; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Therapy, Combination; Humans; Leucovorin; Lung Neoplasms; Methotrexate; Neoplasm Metastasis; Osteosarcoma; Radiation Tolerance; Radiotherapy Dosage; Radiotherapy, High-Energy; Sarcoma, Ewing; Vincristine | 1977 |
Lung function in adolescents receiving high-dose methotrexate.
Topics: Adolescent; Adult; Bone Neoplasms; Dose-Response Relationship, Drug; Female; Humans; Lung Diseases; Male; Methotrexate; Prospective Studies; Respiration; Respiratory Function Tests; Retrospective Studies | 1979 |
Combination chemotherapy for extracranial metastases of a primary malignant cerebral neoplasm.
Topics: Adult; Antineoplastic Agents; Bone Neoplasms; Brain Neoplasms; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Glioma; Humans; Lomustine; Lung Neoplasms; Male; Methotrexate | 1979 |
Complete remissions in metastatic breast cancer treated with combination drug therapy.
Topics: Adult; Antineoplastic Agents; Bone Neoplasms; Brain Neoplasms; Breast Neoplasms; Castration; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; Gastrointestinal Neoplasms; Humans; Methotrexate; Middle Aged; Soft Tissue Neoplasms | 1979 |
Response to chemotherapy of breast carcinoma bone metastases: assessment by bone scan.
Topics: Adult; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Follow-Up Studies; Humans; Methotrexate; Middle Aged; Radionuclide Imaging | 1979 |
Differential distribution of antitumor agents in primary and secondary tumors.
Topics: Animals; Antineoplastic Agents; Bone Neoplasms; Carcinoma 256, Walker; Cyclophosphamide; Daunorubicin; Doxorubicin; Female; Hydroxyurea; Lung Neoplasms; Lymphatic Metastasis; Male; Mercaptopurine; Methotrexate; Methylnitrosourea; Mice; Neoplasm Metastasis; Neoplasms, Experimental; Rats; Sarcoma, Experimental | 1977 |
The treatment of advanced bladder cancer with methotrexate.
Topics: Bone Neoplasms; Humans; Lung Neoplasms; Methotrexate; Neoplasm Metastasis; Time Factors; Urinary Bladder Neoplasms | 1977 |
EORTC/GTO adjuvant chemotherapy program for primary Ewing's sarcoma: results at 5 years.
Topics: Antineoplastic Agents; Bone Neoplasms; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Humans; Methotrexate; Procarbazine; Sarcoma, Ewing; Vincristine | 1978 |
Management of osteogenic sarcoma at the Mayo Clinic.
Topics: Adolescent; Adult; Aged; Bone Neoplasms; Child; Child, Preschool; Doxorubicin; Drug Therapy, Combination; Female; Humans; Immunotherapy; Lung Neoplasms; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Osteosarcoma; Radiotherapy, High-Energy; Transfer Factor; Vincristine | 1976 |
The role of nonspecific immunotherapy in the treatment of breast cancer.
Topics: Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Humans; Immunity; Immunity, Cellular; Immunotherapy; Liver Neoplasms; Lung Neoplasms; Methotrexate; Neoplasm Metastasis; Prognosis; Propionibacterium acnes | 1976 |
Editorial: New therapies for osteogenic sarcoma.
Topics: Amputation, Surgical; Bone Neoplasms; Doxorubicin; Humans; Immunotherapy; Lymphocytes; Methotrexate; Neoplasm Metastasis; Osteosarcoma | 1975 |
[Association of radical surgery and cyclic polychemotherapy (with vincristine, methotrexate and adriamycin) in the treatment of some forms of osteosarcoma. Preliminary results].
Topics: Adolescent; Adult; Amputation, Surgical; Bone Neoplasms; Child; Doxorubicin; Female; Humans; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Osteosarcoma; Postoperative Care; Vincristine | 1975 |
Chemotherapy of osteosarcoma.
Topics: Amputation, Surgical; Bone Neoplasms; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Humans; Lung Neoplasms; Melphalan; Methotrexate; Neoplasm Metastasis; Osteosarcoma; Vincristine | 1975 |
Non-Hodgkin's lymphoma in children: results of treatment with LSA2-L2 protocol.
Topics: Adolescent; Antineoplastic Agents; Asparaginase; Bone Neoplasms; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Drug Therapy, Combination; Female; Humans; Hydroxyurea; Leukemia; Leukemia, Lymphoid; Lymph Nodes; Lymphoma; Male; Mediastinal Neoplasms; Methotrexate; Nasopharyngeal Neoplasms; Ovarian Neoplasms; Skin Neoplasms; Stomach Neoplasms; Thioguanine; Vincristine | 1975 |
7-Hydroxymethotrexate as a urinary metabolite in human subjects and rhesus monkeys receiving high dose methotrexate.
Topics: Adult; Animals; Bone Neoplasms; Carcinoma, Squamous Cell; Child; Female; Histocytochemistry; Humans; Kidney; Lung Neoplasms; Macaca mulatta; Male; Methotrexate; Middle Aged; Osteosarcoma; Time Factors | 1976 |
The results of surgical treatment combined with intra-arterial infusion of anti-cancer agents in osteosarcoma.
Topics: Adolescent; Adult; Bone Neoplasms; Chemotherapy, Cancer, Regional Perfusion; Child; Extremities; Female; Fluorouracil; Humans; Injections, Intra-Arterial; Male; Methotrexate; Mitomycins; Osteosarcoma | 1976 |
Immunotherapy of osteosarcoma patients with virus-modified tumor cells.
Topics: Adolescent; Adult; Antibodies, Neoplasm; Antibodies, Viral; Antibody Formation; Bone Neoplasms; Cell Line; Child; Female; Humans; Immunity, Cellular; Immunization; Immunotherapy; Kinetics; Male; Methotrexate; Orthomyxoviridae; Osteosarcoma; Vaccines | 1976 |
Primary malignant tumours of bone.
Topics: Adolescent; Amputation, Surgical; Animals; Bone Neoplasms; Child; Chondrosarcoma; Dogs; Doxorubicin; Fibrosarcoma; Giant Cell Tumors; Humans; Methotrexate; Middle Aged; Osteosarcoma; Vincristine | 1976 |
Adjuvant chemotherapy associated with surgery in the treatment of osteosarcoma. Preliminary results.
Topics: Adolescent; Adult; Bone Neoplasms; Child; Depression, Chemical; Doxorubicin; Drug Therapy, Combination; Female; Follow-Up Studies; Heparin; Humans; Immunity; Male; Methotrexate; Middle Aged; Osteosarcoma; Vincristine | 1976 |
The rationale for multiple drug chemotherapy in the treatment of osteogenic sarcoma.
Topics: Adolescent; Bone Neoplasms; Child; Cyclophosphamide; Digestive System; Doxorubicin; Drug Therapy, Combination; Evaluation Studies as Topic; Female; Humans; Leucovorin; Male; Methotrexate; Mouth Mucosa; Mucous Membrane; Neoplasm Metastasis; Osteosarcoma; Vincristine | 1975 |
Letter: Osteosarcoma--new hope.
Topics: Bone Neoplasms; Child; Humans; Leucovorin; Methotrexate; Neoplasm Metastasis; Osteosarcoma | 1975 |
The treatment of pulmonary metastasis in osteogenic sarcoma.
Topics: Bone Neoplasms; Humans; Leucovorin; Lung Neoplasms; Methotrexate; Neoplasm Metastasis; Osteosarcoma | 1975 |
Osteogenic sarcoma: state of the art with high-dose methotrexate treatment.
Topics: Bone Neoplasms; Drug Therapy, Combination; Humans; Leucovorin; Methotrexate; Osteosarcoma; Prognosis; Vincristine | 1976 |
High dose methotrexate therapy of solid tumors: observations relating to clinical toxicity.
Topics: Adolescent; Adult; Aged; Bone Neoplasms; Drug Therapy, Combination; Humans; Leucovorin; Melanoma; Methotrexate; Middle Aged; Neoplasms; Sarcoma; Soft Tissue Neoplasms | 1976 |
Chemotherapy of osteosarcoma [proceedings].
Topics: Bone Neoplasms; Child; Dacarbazine; Doxorubicin; Humans; Leucovorin; Methotrexate; Neoplasm Metastasis; Osteosarcoma; Vincristine | 1976 |
Multidisciplinary treatment for macrometastatic osteogenic sarcoma.
Topics: Adolescent; Adult; Bone Neoplasms; Child; Doxorubicin; Female; Humans; Leucovorin; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Methotrexate; Neoplasm Metastasis; Osteosarcoma; Radiotherapy Dosage; Vincristine | 1976 |
Mouse myeloma. A model for studies of cell kinetics.
Topics: Alkylating Agents; Animals; Bone Marrow; Bone Marrow Cells; Bone Neoplasms; Cell Division; Cells, Cultured; Cyclophosphamide; Cytarabine; Disease Models, Animal; Kinetics; Melphalan; Methotrexate; Mice; Mice, Inbred BALB C; Myeloma Proteins; Neoplasms, Experimental; Plasmacytoma; Thymidine; Tritium; Vinblastine; Vincristine | 1975 |
Changes in 87mSr concentractions in skeletal metastases in patients responding to cyclical combination chemotherapy for advanced breast cancer.
Topics: Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Humans; Methotrexate; Neoplasm Metastasis; Radionuclide Imaging; Strontium Isotopes; Vincristine | 1975 |
An effective low-dose intermittent cyclophosphamide, methotrexate, and 5-fluorouracil treatment regimen for metastatic breast cancer.
Topics: Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Methotrexate; Neoplasm Metastasis; Peritoneal Neoplasms; Pleural Neoplasms; Skin Neoplasms | 1975 |
Adriamycin plus vincristine compared to and combined with cyclophosphamide, methotrexate, and 5-fluorouracil for advanced breast cancer.
Topics: Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Evaluation Studies as Topic; Female; Fluorouracil; Humans; Methotrexate; Neoplasm Metastasis; Remission, Spontaneous; Vincristine | 1975 |
Evaluation of therapeutic results in Ewing's sarcoma.
Topics: Adolescent; Bone Neoplasms; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Therapy, Combination; Extremities; Female; Humans; Infant; Infant, Newborn; Male; Mandibular Neoplasms; Methotrexate; Pelvic Bones; Ribs; Sarcoma, Ewing; Scapula; Sternum; Vincristine | 1975 |
[The association of local radiation therapy and systemic chemotherapy in the treatment of clinically localized Ewing's sarcoma].
Topics: Adolescent; Adult; Antineoplastic Agents; Bone Neoplasms; Cesium Radioisotopes; Child; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Radiotherapy Dosage; Sarcoma, Ewing; Vincristine | 1975 |
Combination chemotherapy for advanced breast cancer: response and effect on survival.
Topics: Adult; Bone Neoplasms; Breast Neoplasms; Drug Therapy, Combination; Female; Fluorouracil; Humans; Liver Neoplasms; Methotrexate; Middle Aged; Neoplasm Metastasis; Prednisone; Skin Neoplasms | 1976 |
[Sequential MTX and 5-FU therapy of gastric cancer with systemic bone metastasis and disseminated intravascular coagulation].
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Disseminated Intravascular Coagulation; Drug Administration Schedule; Female; Fluorouracil; Gabexate; Heparin; Humans; Male; Methotrexate; Middle Aged; Stomach Neoplasms | 1992 |
Encapsulation around malignant bone tumors after preoperative adjuvant treatment.
Topics: Adolescent; Adult; Antineoplastic Agents; Bone Neoplasms; Child; Cisplatin; Combined Modality Therapy; Histiocytoma, Benign Fibrous; Humans; Injections, Intravenous; Methotrexate; Middle Aged; Osteosarcoma; Preoperative Care; Vincristine | 1992 |
Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience.
Topics: Adolescent; Adult; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Bone Neoplasms; Child; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Humans; Male; Methotrexate; Osteosarcoma; Proportional Hazards Models; Risk Factors; Survival Analysis | 1992 |
Osteosarcoma after chemotherapy: evaluation with contrast material-enhanced subtraction MR imaging.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Combined Modality Therapy; Contrast Media; Doxorubicin; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Meglumine; Methotrexate; Organometallic Compounds; Osteosarcoma; Pentetic Acid; Remission Induction; Subtraction Technique | 1992 |
Missing neutral DNase activity in lymphocytes and phytohemagglutinin-stimulated lymphocytes after high dose methotrexate therapy.
Topics: Adolescent; Bone Neoplasms; Child; Deoxyribonucleases; DNA-Directed DNA Polymerase; Electrophoresis, Polyacrylamide Gel; Female; Humans; Lymphocyte Activation; Lymphocytes; Male; Methotrexate; Osteosarcoma | 1992 |
[Bone tumors in children. Current trends in therapy].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Humans; Infant; Methotrexate; Osteosarcoma; Sarcoma, Ewing | 1992 |
[Osteogenic sarcoma of the limbs: value of intra-arterial chemotherapy before surgery. Preliminary results].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Cyclophosphamide; Doxorubicin; Humans; Infusions, Intra-Arterial; Methotrexate; Osteosarcoma; Preoperative Care; Vincristine | 1992 |
Use of propofol for the prevention of chemotherapy-induced nausea and emesis in oncology patients.
Topics: Adolescent; Adult; Antiemetics; Antineoplastic Agents; Bone Neoplasms; Cyclophosphamide; Female; Humans; Ifosfamide; Infusions, Intravenous; Injections, Intravenous; Male; Methotrexate; Nausea; Osteosarcoma; Propofol; Vomiting | 1992 |
Possible methotrexate-mezlocillin interaction.
Topics: Adolescent; Bone Neoplasms; Drug Interactions; Female; Humans; Lung Neoplasms; Metabolic Clearance Rate; Methotrexate; Mezlocillin | 1992 |
Assessment of osteosarcoma response to preoperative chemotherapy using dynamic FLASH gadolinium-DTPA-enhanced magnetic resonance mapping.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Contrast Media; Doxorubicin; Female; Gadolinium; Gadolinium DTPA; Humans; Ifosfamide; Magnetic Resonance Imaging; Male; Methotrexate; Necrosis; Organometallic Compounds; Osteosarcoma; Pentetic Acid; Preoperative Care | 1992 |
Ten years' experience in patients with osteogenic sarcoma in Finland.
Topics: Actuarial Analysis; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Child; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Finland; Humans; Male; Methotrexate; Osteosarcoma; Survival Rate | 1990 |
Preoperative intra-arterial chemotherapy in patients with osteosarcoma: case report of seven patients below the age of 18 years.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Child; Cisplatin; Doxorubicin; Drug Administration Schedule; Femoral Neoplasms; Humans; Injections, Intra-Arterial; Methotrexate; Osteosarcoma; Tibia | 1990 |
Disposition of high-dose methotrexate in an obese cancer patient.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Half-Life; Humans; Leucovorin; Methotrexate; Obesity; Osteosarcoma; Tibia; Vincristine | 1991 |
Stage IIB osteogenic sarcoma.
Topics: Adolescent; Adult; Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Child; Child, Preschool; Clinical Protocols; Cohort Studies; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Humans; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; New York City; Osteosarcoma; Osteotomy; Postoperative Care; Predictive Value of Tests; Preoperative Care; Survival Analysis; Survival Rate | 1991 |
Treatment of osteosarcoma of the extremities with the T-10 protocol, with emphasis on the effects of preoperative chemotherapy with single-agent high-dose methotrexate: a Scandinavian Sarcoma Group study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Arm; Bleomycin; Bone Neoplasms; Child; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Humans; Leg; Male; Methotrexate; Osteosarcoma; Survival Analysis | 1991 |
[A case report of relapsed stage D2 prostate cancer successfully treated with intraarterial chemotherapy].
Topics: Adenocarcinoma; Aged; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Doxorubicin; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Male; Methotrexate; Prostate-Specific Antigen; Prostatic Neoplasms | 1991 |
Recurrent disseminated retinoblastoma treated by high-dose chemotherapy, total body irradiation, and autologous bone marrow rescue.
Topics: Antibodies, Monoclonal; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Marrow; Bone Marrow Purging; Bone Marrow Transplantation; Bone Neoplasms; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Eye Enucleation; Eye Neoplasms; Female; Gangliosides; Humans; Mandibular Neoplasms; Methotrexate; Neoplasm Recurrence, Local; Neoplastic Stem Cells; Remission Induction; Retinoblastoma; Transplantation, Autologous; Vincristine; Whole-Body Irradiation | 1991 |
Can primary osteosarcoma act as a third space after high-dose methotrexate?
Topics: Adult; Bone Neoplasms; Half-Life; Humans; Male; Methotrexate; Osteosarcoma | 1991 |
IIB osteosarcoma. Current management, local control, and survival statistics--the Australian experience.
Topics: Adolescent; Adult; Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Australia; Bone Neoplasms; Child; Cisplatin; Combined Modality Therapy; Doxorubicin; Female; Humans; Injections, Intra-Arterial; Life Tables; Male; Methotrexate; Middle Aged; Necrosis; Neoplasm Recurrence, Local; Neoplasm Staging; Osteosarcoma; Osteotomy; Postoperative Complications; Radiotherapy; Remission Induction; Survival Rate | 1991 |
Recent advances in the chemotherapy of metastatic osteogenic sarcoma. 1972.
Topics: Bone Neoplasms; Drug Administration Schedule; Drug Therapy, Combination; History, 20th Century; Humans; Infusions, Intravenous; Leucovorin; Methotrexate; Osteosarcoma | 1991 |
The management of IIB osteosarcoma. Experience from 1976 to 1985.
Topics: Adolescent; Adult; Amputation, Surgical; Austria; Bone Neoplasms; Bone Transplantation; Child; Child, Preschool; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Osteosarcoma; Osteotomy; Postoperative Complications; Prostheses and Implants; Surgical Flaps; Survival Analysis; Survival Rate | 1991 |
IIB osteosarcoma. Current management, local control, and survival statistics--São Paulo, Brazil.
Topics: Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brazil; Cisplatin; Combined Modality Therapy; Doxorubicin; Follow-Up Studies; Humans; Ifosfamide; Methotrexate; Neoplasm Staging; Osteosarcoma; Osteotomy; Postoperative Care; Preoperative Care; Prognosis; Prostheses and Implants; Survival Analysis; Survival Rate | 1991 |
Neoadjuvant chemotherapy for nonmetastatic osteosarcoma of the extremities.
Topics: Adolescent; Adult; Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Bone Lengthening; Bone Neoplasms; Bone Transplantation; Child; Cisplatin; Combined Modality Therapy; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Italy; Male; Methotrexate; Osteosarcoma; Osteotomy; Postoperative Care; Preoperative Care; Prognosis; Prostheses and Implants; Survival Rate | 1991 |
Zürich experience with preoperative, high dose methotrexate-containing chemotherapy in patients with extremity osteosarcomas (OSA).
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Methotrexate; Necrosis; Neoplasm Recurrence, Local; Osteosarcoma; Prognosis; Retrospective Studies; Survival Rate | 1991 |
Osteoblastoma response to chemotherapy.
Topics: Bone Neoplasms; Cervical Vertebrae; Child; Dose-Response Relationship, Drug; Head and Neck Neoplasms; Humans; Male; Methotrexate; Osteoma, Osteoid | 1991 |
Prognostic factors for survival of patients with advanced urothelial tumors treated with methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapy.
Topics: Adult; Age Factors; Aged; Alkaline Phosphatase; Antineoplastic Combined Chemotherapy Protocols; Bilirubin; Bone Neoplasms; Cisplatin; Doxorubicin; Hemoglobins; Humans; Liver Neoplasms; Methotrexate; Middle Aged; Prognosis; Risk; Survival Rate; Urinary Bladder Neoplasms; Vinblastine | 1991 |
Combined treatment of osteosarcoma of the limbs at an advanced stage, including hyperthermic-antiblastic perfusion.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Arm; Bone Neoplasms; Chemotherapy, Cancer, Regional Perfusion; Child; Cisplatin; Female; Humans; Infusions, Intra-Arterial; Leg; Male; Methotrexate; Osteosarcoma; Radiography | 1990 |
[Intra-arterial neoadjuvant chemotherapy of sarcoma of the extremities].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Combined Modality Therapy; Doxorubicin; Extremities; Follow-Up Studies; Histiocytoma, Benign Fibrous; Humans; Infusions, Intra-Arterial; Methotrexate; Middle Aged; Muscular Diseases; Osteosarcoma; Radiography | 1990 |
Neoadjuvant chemotherapy for osteosarcoma of the extremities: the Rizzoli Institute experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Doxorubicin; Follow-Up Studies; Humans; Methotrexate; Osteosarcoma; Postoperative Care; Preoperative Care | 1990 |
[The influence of liver and renal functions on the changes in serum methotrexate (MTX) level in high-dose MTX therapy].
Topics: Adolescent; Adult; Aspartate Aminotransferases; Bone Neoplasms; Child; Child, Preschool; Creatinine; Female; Humans; Kidney; Leucovorin; Liver; Male; Methotrexate; Multivariate Analysis; Osteosarcoma; Regression Analysis | 1990 |
[Adjuvant chemotherapy of osteosarcoma].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cisplatin; Combined Modality Therapy; Doxorubicin; Drug Administration Schedule; Humans; Male; Methotrexate; Osteosarcoma; Prognosis; Survival Rate | 1990 |
[Side effects of high dose methotrexate with citrovorum factor therapy: relationship between clinical data and serum concentration of methotrexate].
Topics: Bone Neoplasms; Humans; Leucovorin; Methotrexate; Soft Tissue Neoplasms | 1990 |
Primary chemotherapy and delayed surgery (neoadjuvant chemotherapy) for osteosarcoma of the extremities. The Istituto Rizzoli Experience in 127 patients treated preoperatively with intravenous methotrexate (high versus moderate doses) and intraarterial ci
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Combined Modality Therapy; Doxorubicin; Extremities; Humans; Infusions, Intravenous; Injections, Intra-Arterial; Methotrexate; Neoplasm Recurrence, Local; Osteosarcoma; Survival Rate | 1990 |
The importance of dose-intensity in neoadjuvant chemotherapy of osteosarcoma: a retrospective analysis of high-dose methotrexate, cisplatinum and adriamycin used preoperatively.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Arm; Bone Neoplasms; Child; Child, Preschool; Cisplatin; Clinical Protocols; Colorectal Neoplasms; Combined Modality Therapy; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Female; Humans; Leg; Male; Methotrexate; Osteosarcoma; Preoperative Care; Retrospective Studies | 1990 |
[The results of using high-dose methotrexate in treating osteogenic sarcoma].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Drug Evaluation; Female; Femoral Neoplasms; Humans; Humerus; Leucovorin; Lung Neoplasms; Male; Methotrexate; Osteosarcoma; Preoperative Care; Tibia | 1990 |
Usefulness and limitations of methotrexate, vinblastine, doxorubicin and cisplatin for the treatment of advanced urothelial cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Transitional Cell; Cisplatin; Doxorubicin; Female; Humans; Liver Neoplasms; Lung Neoplasms; Male; Methotrexate; Middle Aged; Time Factors; Urologic Neoplasms; Vinblastine | 1990 |
The angiographic response of osteosarcoma following pre-operative chemotherapy.
Topics: Adolescent; Adult; Angiography; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Child; Cisplatin; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Humans; Male; Methotrexate; Osteosarcoma; Preoperative Care; Vincristine | 1986 |
Telangiectatic osteogenic sarcoma. Improved survival with combination chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Humans; Leucovorin; Male; Methotrexate; Osteosarcoma | 1986 |
Disparate histologic responses in simultaneously resected primary and metastatic osteosarcoma following intravenous neoadjuvant chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Child; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Necrosis; Osteosarcoma; Postoperative Care; Preoperative Care; Vincristine | 1987 |
Translocation t(9;11)(p21;q23) with acute myelomonocytic leukemia after chemotherapy for osteosarcoma: good response to antileukemic drugs.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 9; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Humans; Leukemia, Myeloid, Acute; Methotrexate; Neoplasms, Multiple Primary; Osteosarcoma; Translocation, Genetic | 1987 |
[The reproduction in France of Rosen's protocol for osteosarcomas].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Administration Schedule; Female; Humans; Male; Methotrexate; Middle Aged; Osteosarcoma; Prognosis | 1988 |
[Experience with protocol T10 in the pediatric service at the Gustave-Roussy Institute].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Administration Schedule; Female; Humans; Infant; Male; Methotrexate; Osteosarcoma; Prognosis | 1988 |
[Preoperative systemic chemotherapy of patients with osteosarcoma: a preliminary study of nine cases].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Child; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Humans; Male; Methotrexate; Osteosarcoma; Premedication | 1989 |
[Mirror-image osteosarcoma of the radius. A case].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Follow-Up Studies; Humans; Methotrexate; Neoplasms, Multiple Primary; Osteosarcoma; Prognosis; Radius | 1989 |
Improved results in the treatment of nasopharyngeal carcinoma using combined radiotherapy and chemotherapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Squamous Cell; Combined Modality Therapy; Cyclophosphamide; Female; Head and Neck Neoplasms; Humans; Male; Methotrexate; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Retrospective Studies; Tegafur; Uracil | 1989 |
Methotrexate clearance and clinical toxicity in osteosarcoma following high-dose methotrexate therapy.
Topics: Adolescent; Adult; Bone Neoplasms; Humans; Methotrexate; Osteosarcoma | 1989 |
[Massive bone allografts in large bone defects after tumor surgery: a clinical long-term study].
Topics: Bone Neoplasms; Bone Transplantation; Chondrosarcoma; Combined Modality Therapy; Doxorubicin; Femoral Neoplasms; Histiocytoma, Benign Fibrous; Humans; Methotrexate; Osteosarcoma; Postoperative Period; Sarcoma; Tibia | 1989 |
Neurologic complications in children with soft tissue and osseous sarcoma.
Topics: Adolescent; Bone Neoplasms; Brain Diseases; Brain Neoplasms; Child; Humans; Methotrexate; Nervous System Diseases; Peripheral Nervous System Diseases; Retrospective Studies; Sarcoma; Seizures; Soft Tissue Neoplasms; Spinal Cord Compression | 1989 |
Methotrexate diffusion from acrylic cement. Local chemotherapy for bone tumours.
Topics: Animals; Bone Cements; Bone Neoplasms; Diffusion; Dogs; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Implants; In Vitro Techniques; Methotrexate; Methylmethacrylates; Osteosarcoma; Rats; Time Factors | 1989 |
[Spontaneous pneumothorax in patients with osteosarcoma treated by combined chemotherapy].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Doxorubicin; Extremities; Female; Humans; Leucovorin; Lung Neoplasms; Male; Methotrexate; Osteosarcoma; Pneumothorax; Time Factors; Vincristine | 1989 |
[Individualization of the dosage of high-dose methotrexate by assaying plasma concentration. Therapeutic value in osteogenic sarcoma].
Topics: Bone Neoplasms; Dose-Response Relationship, Drug; Female; Humans; Male; Methotrexate; Osteosarcoma; Time Factors | 1989 |
Overall results of adjuvant chemotherapy and a chemosensitivity test for osteosarcoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Doxorubicin; Female; Humans; Male; Methotrexate; Middle Aged; Osteosarcoma; Time Factors; Tumor Stem Cell Assay; Vincristine | 1989 |
[Bolus and maintenance infusion of high-dose methotrexate].
Topics: Bone Neoplasms; Humans; Infusions, Intravenous; Methotrexate; Sarcoma; Soft Tissue Neoplasms | 1989 |
[A bone cement containing methotrexate in an experiment and in clinical practice].
Topics: Animals; Bone and Bones; Bone Cements; Bone Neoplasms; Dogs; Humans; Methotrexate | 1989 |
Daily profiles of plasma phenylalanine and tyrosine in patients with osteogenic sarcoma during treatment with high-dose methotrexate-citrovorum rescue.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Combined Modality Therapy; Female; Humans; Leg; Leucovorin; Male; Methotrexate; Osteosarcoma; Phenylalanine; Time Factors; Tyrosine | 1989 |
[Management of the administration of leucovorin calcium in high-dose methotrexate therapy].
Topics: Adult; Blood Cell Count; Bone Neoplasms; Drug Therapy, Combination; Female; Humans; Leucovorin; Male; Methotrexate; Osteosarcoma | 1989 |
Magnetic resonance imaging (MRI) in evaluating in vivo response to neoadjuvant chemotherapy for osteosarcomas of the extremities.
Topics: Adolescent; Adult; Bone Neoplasms; Child; Combined Modality Therapy; Female; Femur; Humans; Humerus; Magnetic Resonance Imaging; Male; Methotrexate; Osteosarcoma; Prospective Studies; Tibia; Tomography, X-Ray Computed | 1989 |
Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Carcinoma, Transitional Cell; Cisplatin; Doxorubicin; Female; Humans; Kidney Neoplasms; Liver Neoplasms; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Ureteral Neoplasms; Urethral Neoplasms; Urinary Bladder Neoplasms; Urologic Neoplasms; Vinblastine | 1989 |
The current management of malignant bone tumours: where do we go from here?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Combined Modality Therapy; Cyclophosphamide; Drug Administration Schedule; Histiocytoma, Benign Fibrous; Humans; Methotrexate; Osteosarcoma; Sarcoma, Ewing | 1988 |
Perioperative chemotherapy for primary sarcoma of bone.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Humans; Intraoperative Care; Male; Methotrexate; Osteosarcoma; Premedication; Vincristine | 1989 |
[Treatment of osteogenic sarcoma].
Topics: Bone Neoplasms; Cisplatin; Combined Modality Therapy; Doxorubicin; Hip Prosthesis; Humans; Joint Prosthesis; Lung Neoplasms; Methotrexate; Osteosarcoma; Prognosis | 1989 |
[Bone metastasis in advanced breast cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Calcitonin; Cyclophosphamide; Doxorubicin; Female; Humans; Hypercalcemia; Methotrexate; Mitomycin; Mitomycins; Plicamycin; Tamoxifen; Tegafur | 1987 |
[Osteogenic osteosarcoma, a model of a disease that is curable using a multidisciplinary treatment approach].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Combined Modality Therapy; Female; Humans; Male; Methotrexate; Osteosarcoma; Prostheses and Implants | 1988 |
Treatment of malignant fibrous histiocytoma of bone. A plea for primary chemotherapy.
Topics: Adolescent; Adult; Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Female; Femoral Neoplasms; Follow-Up Studies; Histiocytoma, Benign Fibrous; Humans; Leucovorin; Male; Methotrexate; Middle Aged; Tibia; Vincristine | 1985 |
[Urinary beta 2-microglobulin as an indicator for impaired excretion of methotrexate].
Topics: beta 2-Microglobulin; Blood Urea Nitrogen; Bone Neoplasms; Creatinine; Humans; Kidney; Kidney Function Tests; Methotrexate; Sarcoma; Soft Tissue Neoplasms | 1988 |
Hypoxanthine:guanine phosphoribosyltransferase activity in primary human osteosarcomas. A rationale for therapy with methotrexate-thymidine rescue?
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Female; Humans; Hypoxanthine; Hypoxanthine Phosphoribosyltransferase; Hypoxanthines; Lung Neoplasms; Male; Methotrexate; Osteosarcoma; Pentosyltransferases; Thymidine | 1987 |
Age and dose of chemotherapy as major prognostic factors in a trial of adjuvant therapy of osteosarcoma combining two alternating drug combinations and early prophylactic lung irradiation. French Bone Tumor Study Group.
Topics: Adolescent; Adult; Aging; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Female; Femoral Neoplasms; Fibula; Humans; Humerus; Lung Neoplasms; Male; Methotrexate; Mitomycin; Mitomycins; Osteosarcoma; Prognosis; Radiotherapy Dosage; Tibia; Time Factors; Vincristine | 1988 |
[Angiographic evaluation of the response of osteosarcoma to neoadjuvant chemotherapy].
Topics: Adolescent; Angiography; Bone Neoplasms; Cisplatin; Female; Humans; Male; Methotrexate; Osteosarcoma | 1988 |
[Experience with Rosen's T10 protocol at the Oscar Lambret Center (Lille) from 1982 to 1985. Apropos of 13 cases of non-metastatic osteosarcomas of the extremities].
Topics: Adolescent; Adult; Amputation, Surgical; Bone Neoplasms; Child; Cisplatin; Combined Modality Therapy; Female; Femoral Neoplasms; Humans; Humerus; Male; Methotrexate; Osteosarcoma; Radius; Tibia | 1988 |
Neoadjuvant chemotherapy for osteosarcoma of the extremities. Good response of the primary tumor after preoperative chemotherapy with high-dose methotrexate followed by cisplatinum and adriamycin. Preliminary results.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Combined Modality Therapy; Doxorubicin; Extremities; Female; Humans; Male; Methotrexate; Osteosarcoma | 1988 |
Importance of age and methotrexate dosage: prognosis in children and young adults with high-grade osteosarcomas.
Topics: Adolescent; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Dose-Response Relationship, Drug; Humans; Methotrexate; Osteosarcoma; Prognosis | 1988 |
The alteration in the pattern of pulmonary metastasis with adjuvant chemotherapy in osteosarcoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Combined Modality Therapy; Doxorubicin; Female; Humans; Lung Neoplasms; Male; Methotrexate; Osteosarcoma; Prognosis | 1988 |
The effects of methotrexate (MTX) on bone. A densitometric study conducted on 59 patients with MTX administered at different doses.
Topics: Adolescent; Adult; Bone and Bones; Bone Neoplasms; Child; Densitometry; Dose-Response Relationship, Drug; Female; Humans; Male; Methotrexate; Minerals; Osteosarcoma | 1988 |
Neoadjuvant chemotherapy in the treatment of osteosarcoma of the extremities: preliminary results in 131 cases treated preoperatively with methotrexate and cisdiamminoplatinum.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Combined Modality Therapy; Follow-Up Studies; Humans; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Osteosarcoma; Prognosis; Random Allocation; Time Factors | 1988 |
[Chemotherapy in the treatment of primary malignant bone tumors].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Doxorubicin; Humans; Leucovorin; Methotrexate; Sarcoma | 1988 |
[Postoperative adjuvant chemotherapy of high dose MTX for osteogenic sarcoma].
Topics: Adolescent; Adult; Amputation, Surgical; Bone Neoplasms; Child; Combined Modality Therapy; Female; Femoral Neoplasms; Humans; Leucovorin; Male; Methotrexate; Osteosarcoma; Postoperative Care; Retrospective Studies; Tibia | 1988 |
[Autologous bone marrow transplantation in osteosarcoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Bone Neoplasms; Child; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Humans; Male; Melphalan; Methotrexate; Osteosarcoma; Transplantation, Autologous | 1987 |
[Clinical effect of prostaglandin E1 on liver dysfunction due to high-dose methotrexate].
Topics: Alprostadil; Bone Neoplasms; Child; Child, Preschool; Female; Humans; Infant; Leukemia, Lymphoid; Liver Diseases; Lymphoma, Non-Hodgkin; Male; Methotrexate; Osteosarcoma | 1988 |
Phase II study of low-dose methotrexate in advanced osteosarcoma followed by escalation after disease progression: a study of the Soft Tissue and Bone Sarcoma Group of the European Organization for Research on Treatment of Cancer.
Topics: Adolescent; Adult; Bone Neoplasms; Drug Administration Schedule; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Osteosarcoma; Random Allocation; Time Factors | 1986 |
Neoadjuvant chemotherapy for high grade osteosarcoma of the extremities: is a good response to preoperative treatment an indication to reduce postoperative chemotherapy?
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cisplatin; Doxorubicin; Extremities; Female; Femoral Neoplasms; Fibula; Humans; Humerus; Infant; Infant, Newborn; Infusions, Intra-Arterial; Injections, Intravenous; Male; Methotrexate; Necrosis; Osteosarcoma; Postoperative Care; Preoperative Care; Tibia; Time Factors | 1986 |
The influence of high-dose methotrexate therapy on serum iron.
Topics: Adolescent; Adult; Bone Neoplasms; Dose-Response Relationship, Drug; Erythropoiesis; Female; Humans; Iron; Male; Methotrexate; Middle Aged; Osteosarcoma | 1986 |
[Surgery and adjuvant chemotherapy of osteosarcoma].
Topics: Adolescent; Antineoplastic Agents; Bone Neoplasms; Combined Modality Therapy; Doxorubicin; Drug Administration Schedule; Humans; Infusions, Intra-Arterial; Male; Methotrexate; Osteosarcoma; Postoperative Care; Preoperative Care | 1986 |
Chemosensitivity testing with tumor colony-forming assay for human osteosarcoma.
Topics: Aclarubicin; Adolescent; Antineoplastic Agents; Bone Neoplasms; Child; Cisplatin; Colony-Forming Units Assay; Doxorubicin; Female; Humans; Male; Methotrexate; Middle Aged; Naphthacenes; Osteosarcoma; Vincristine | 1986 |
[Results of the treatment of osteosarcoma at the National Children's Hospital of Costa Rica].
Topics: Adolescent; Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Costa Rica; Cyclophosphamide; Disarticulation; Doxorubicin; Female; Humans; Injections, Intra-Arterial; Male; Methotrexate; Osteosarcoma; Preoperative Care; Prognosis; Vincristine | 1986 |
Neoadjuvant high-dose methotrexate, cisplatin, and doxorubicin for the management of patients with nonmetastatic osteosarcoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Combined Modality Therapy; Doxorubicin; Extremities; Follow-Up Studies; Humans; Methotrexate; Osteosarcoma | 1986 |
Continuous cisplatin infusion in combination with vincristine and high-dose methotrexate for advanced osteogenic sarcoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Humans; Infusions, Intravenous; Lymphatic Metastasis; Methotrexate; Osteosarcoma; Time Factors; Vincristine | 1987 |
[Rationale of preoperative chemotherapy of osteosarcoma].
Topics: Adult; Alkaline Phosphatase; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Doxorubicin; Humans; Methotrexate; Osteosarcoma; Preoperative Care | 1987 |
[Limb salvage in osteosarcoma. Significance of preoperative isolation perfusion chemotherapy].
Topics: Adolescent; Adult; Aged; Bone Neoplasms; Chemotherapy, Cancer, Regional Perfusion; Child; Cisplatin; Combined Modality Therapy; Doxorubicin; Female; Humans; Hyperthermia, Induced; Male; Methotrexate; Middle Aged; Osteosarcoma; Preoperative Care; Prognosis | 1987 |
Weekly high-dose methotrexate and doxorubicin for osteosarcoma: the Dana-Farber Cancer Institute/the Children's Hospital--study III.
Topics: Actuarial Analysis; Adolescent; Adult; Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Combined Modality Therapy; Doxorubicin; Female; Humans; Male; Methotrexate; Osteosarcoma; Prognosis | 1987 |
[A case of Ewing's sarcoma treated successfully by combination chemotherapy consisting of high-dose methotrexate, aclacinomycin-A and vindesine].
Topics: Aclarubicin; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Combined Modality Therapy; Humans; Laminectomy; Male; Methotrexate; Naphthacenes; Sarcoma, Ewing; Vindesine | 1987 |
[Bone cement containing cytostatic drugs: new aspects in the treatment of malignant bone tumors. I. Experimental studies].
Topics: Animals; Bone and Bones; Bone Cements; Bone Neoplasms; Mammary Neoplasms, Experimental; Methotrexate; Methylmethacrylate; Methylmethacrylates; Mice; Neoplasm Transplantation; Osteosarcoma | 1987 |
[Early discovery and nursing of adverse effects associated with administration of massive dosages of MTX].
Topics: Adolescent; Bone Neoplasms; Humans; Male; Medication Errors; Methotrexate; Osteosarcoma | 1987 |
The eye in acute leukaemia. 2. The management of solitary anterior chamber relapse.
Topics: Anterior Chamber; Bone Neoplasms; Child; Combined Modality Therapy; Eye Neoplasms; Humans; Leukemia, Lymphoid; Methotrexate; Neoplasm Recurrence, Local | 1987 |
Staging and therapy of orbital lymphomas.
Topics: Actuarial Analysis; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Neoplasms; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Humans; Leucovorin; Lymphoma; Male; Methotrexate; Middle Aged; Neoplasm Staging; Orbital Neoplasms; Prednisone; Prognosis; Radionuclide Imaging; Vincristine | 1986 |
[Neo-adjuvant therapy in childhood osteogenic sarcoma: a pilot study of selective postoperative chemotherapy based on response to preoperative high-dose methotrexate].
Topics: Adjuvants, Immunologic; Adolescent; Bone Neoplasms; Child; Drug Administration Schedule; Female; Humans; Leucovorin; Male; Methotrexate; Osteosarcoma; Pilot Projects; Preoperative Care | 1986 |
Experimental studies on high-dose methotrexate with citrovorum factor chemotherapy for 89Sr-induced osteosarcoma murine model.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Injections, Intraperitoneal; Injections, Intravenous; Leucovorin; Male; Methotrexate; Mice; Mice, Inbred Strains; Neoplasms, Radiation-Induced; Osteosarcoma; Strontium Radioisotopes | 1986 |
Pathologic fracture in osteosarcoma. Impact of chemotherapy on primary tumor and survival.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Doxorubicin; Fractures, Spontaneous; Humans; Leucovorin; Lung Neoplasms; Methotrexate; Osteosarcoma | 1987 |
[Spectral EEG analysis in children treated with high-dose methotrexate].
Topics: Bone Neoplasms; Child; Child, Preschool; Electroencephalography; Female; Humans; Infusions, Intravenous; Leucovorin; Lymphoma; Male; Methotrexate; Osteosarcoma | 1987 |
[Significance of surgical adjuvant chemotherapy in osteosarcoma].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Doxorubicin; Humans; Leucovorin; Lung Neoplasms; Male; Methotrexate; Osteosarcoma; Postoperative Care | 1987 |
[Compatibility and toxicity of methotrexate in the treatment of bone tumors].
Topics: Bone Neoplasms; Humans; Leucovorin; Methotrexate; Osteosarcoma | 1987 |
Diffuse hepatic uptake of technetium-99m methylene diphosphonate in a patient receiving high dose methotrexate.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemical and Drug Induced Liver Injury; Child; Female; Humans; Liver Diseases; Methotrexate; Radionuclide Imaging; Technetium Tc 99m Medronate | 1987 |
[Combination of aminoglutethimide and polychemotherapy for the treatment of predominant bone metastasis in breast cancer].
Topics: Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Evaluation; Female; Fluorouracil; Humans; Methotrexate; Vinblastine; Vincristine | 1986 |
[4-component chemotherapy and radiation therapy of breast cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Evaluation; Female; Fluorouracil; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Methotrexate; Radiotherapy Dosage; Time Factors | 1986 |
Adriamycin, vinblastine and mitomycin C as second-line chemotherapy in advanced breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Mitomycin; Mitomycins; Prednisone; Vinblastine; Vincristine | 1986 |
Megestrol acetate therapy for advanced breast cancer.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Drug Evaluation; Female; Fluorouracil; Humans; Male; Megestrol; Megestrol Acetate; Menopause; Methotrexate; Receptors, Estrogen; Receptors, Progesterone | 1985 |
Response of osteosarcoma to preoperative intravenous high-dose methotrexate chemotherapy: CT evaluation.
Topics: Adolescent; Amputation, Surgical; Bone Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Extremities; Female; Humans; Injections, Intravenous; Male; Methotrexate; Osteosarcoma; Tomography, X-Ray Computed | 1985 |
Control of primary osteosarcoma with chemotherapy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Female; Femoral Neoplasms; Follow-Up Studies; Humans; Ilium; Infusions, Intra-Arterial; Leucovorin; Male; Methotrexate; Neoplasm Recurrence, Local; Osteosarcoma; Tibia | 1985 |
Transient neurologic disturbances induced by high-dose methotrexate treatment.
Topics: Bone Neoplasms; Child; Female; Humans; Leucovorin; Male; Methotrexate; Nervous System Diseases; Osteosarcoma | 1985 |
[Criteria for evaluating the efficacy of treatment of breast cancer metastases to the bones].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Evaluation Studies as Topic; Female; Fluorouracil; Humans; Methotrexate; Middle Aged | 1986 |
Limb-salvage procedure in two patients with spindle cell carcinoma of the lower extremities using isolation perfusion.
Topics: Aged; Bone Neoplasms; Carcinoma, Squamous Cell; Chemotherapy, Cancer, Regional Perfusion; Hot Temperature; Humans; Leg; Male; Methotrexate; Middle Aged | 1985 |
[Preoperative adjuvant chemotherapy of skeletal and soft tissue sarcomas].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cisplatin; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Humans; Male; Methotrexate; Middle Aged; Preoperative Care; Radiography; Sarcoma; Soft Tissue Neoplasms; Vincristine | 1985 |
Cytotoxic chemotherapy and androgen priming in patients with advanced carcinoma of the prostate. A phase II trial of the Piedmont Oncology Association.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Drug Evaluation; Fluoxymesterone; Humans; Leukopenia; Male; Methotrexate; Middle Aged; Prostatic Neoplasms; Vincristine | 1985 |
[Apropos of an experience with the polychemotherapy of cancer].
Topics: Adult; Bone Neoplasms; Child; Chlorambucil; Cyclophosphamide; Dactinomycin; Drug Synergism; Dysgerminoma; Female; Fibrosarcoma; Humans; Male; Melanoma; Mesothelioma; Methotrexate; Middle Aged; Myxosarcoma; Neoplasms, Connective Tissue; Neoplasms, Germ Cell and Embryonal; Neurilemmoma; Neurofibromatosis 1; Ovarian Neoplasms; Rhabdomyosarcoma; Testicular Neoplasms; Uterine Neoplasms | 1968 |
Urticaria pigmentosa and acute lymphoblastic leukemia.
Topics: Acute Disease; Asparaginase; Bone Marrow Examination; Bone Neoplasms; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Humans; Leukemia, Lymphoid; Male; Mercaptopurine; Methotrexate; Prednisone; Radiography; Remission, Spontaneous; Urticaria Pigmentosa; Vincristine | 1973 |
Favorable response of metastatic osteogenic sarcoma to pulse high-dose methotrexate with citrovorum rescue and radiation therapy.
Topics: Adolescent; Adult; Bone Marrow; Bone Neoplasms; Child; Dose-Response Relationship, Drug; Humans; Kidney; Leucovorin; Lung Neoplasms; Methotrexate; Neoplasm Metastasis; Osteosarcoma; Radiotherapy Dosage; Skin; Stomatitis | 1973 |
High-dose methotrexate with citrovorum factor rescue and adriamycin in childhood osteogenic sarcoma.
Topics: Adolescent; Age Factors; Alkaline Phosphatase; Aspartate Aminotransferases; Bone Neoplasms; Child; Doxorubicin; Drug Therapy, Combination; Evaluation Studies as Topic; Female; Hematopoietic System; Humans; Leucovorin; Male; Methotrexate; Mucous Membrane; Nausea; Neoplasm Metastasis; Osteosarcoma | 1974 |
Hemangioendothelioma of the penis with late appearing metastases: report of a case with review of the literature.
Topics: Adolescent; Bone Neoplasms; Hemangioendothelioma; Humans; Laminectomy; Lung Neoplasms; Male; Methotrexate; Neoplasm Metastasis; Penile Neoplasms; Radiography; Radionuclide Imaging; Radiotherapy Dosage; Ribs; Spinal Neoplasms; Vinblastine | 1973 |
Pineal germinoma. Long-term survival despite hematogenous metastases.
Topics: Bone Neoplasms; Carotid Arteries; Cerebral Angiography; Cerebral Ventricle Neoplasms; Cerebrospinal Fluid Shunts; Cervical Vertebrae; Child; Cyclophosphamide; Dactinomycin; Electroencephalography; Femur; Humans; Lung Neoplasms; Male; Methotrexate; Neoplasm Metastasis; Pinealoma; Pneumoencephalography; Postoperative Complications | 1973 |
The problems of drug treatment of breast cancer.
Topics: Age Factors; Alkylating Agents; Androgens; Bone Neoplasms; Breast Neoplasms; Corticosterone; Drug Combinations; Estrogens; Female; Fluorouracil; Follow-Up Studies; Hormones; Humans; Lung Neoplasms; Methotrexate; Neoplasm Metastasis; Pleural Effusion; Pleural Neoplasms; Progestins; Time Factors; Vinblastine; Vincristine | 1973 |
Proceedings: Small cell carcinoma of the lung: staging, paraneoplastic syndromes, treatment, and survival.
Topics: Bone Marrow; Bone Neoplasms; Brain Neoplasms; Carcinoma; Cyclophosphamide; Drug Therapy, Combination; Humans; Lung; Lung Neoplasms; Methotrexate; Neoplasm Metastasis; Procarbazine; Remission, Spontaneous; Vincristine | 1974 |
Cyclical combination chemotherapy for advanced breast carcinoma.
Topics: Adrenalectomy; Adult; Alopecia; Bone Marrow; Bone Neoplasms; Breast Neoplasms; Castration; Cyclophosphamide; Drug Combinations; Female; Fluorouracil; Humans; Liver; Liver Neoplasms; Lung Neoplasms; Mastectomy; Menopause; Methotrexate; Middle Aged; Neoplasm Metastasis; Prednisone; Thrombocytopenia | 1974 |
Fluoride therapy for pain in malignant bone disease.
Topics: Adult; Aged; Analgesia; Bone Neoplasms; Breast Neoplasms; Estrogens; Fluorides; Fluoxymesterone; Humans; Male; Methotrexate; Middle Aged; Multiple Myeloma; Neoplasm Metastasis; Paraganglia, Nonchromaffin; Prednisone; Prostatic Neoplasms; Thiotepa | 1968 |
[Metastasizing ganglioneuroblastoma simulating acute leukemia].
Topics: Adrenal Cortex Hormones; Adrenal Gland Neoplasms; Antineoplastic Agents; Bone Neoplasms; Bone Resorption; Child, Preschool; Cyclophosphamide; Diagnosis, Differential; Diagnostic Errors; Femoral Neoplasms; Ganglioneuroma; Humans; Leukemia, Lymphoid; Male; Mercaptopurine; Methotrexate; Neoplasm Metastasis; Neoplastic Cells, Circulating; Norepinephrine; Radiography; Splenic Neoplasms; Vincristine | 1970 |
Prolonged survival in neuroblastoma with multiple skeletal metastases and bone marrow infiltration.
Topics: Adrenal Gland Neoplasms; Bone Marrow; Bone Neoplasms; Child; Child, Preschool; Cyclophosphamide; Female; Humans; Infant; Methotrexate; Neoplasm Metastasis; Neuroblastoma; Prognosis | 1970 |
Combination chemotherapy in the treatment of advanced Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bone Neoplasms; Child; Cyclophosphamide; Drug Synergism; Female; Hodgkin Disease; Humans; Hypersensitivity, Delayed; Liver Neoplasms; Lung Neoplasms; Male; Mechlorethamine; Methotrexate; Middle Aged; Prednisone; Procarbazine; Prognosis; Remission, Spontaneous; Vincristine | 1970 |
Chemotherapy of malignant hemangiopericytoma of childhood. Report of a case and review of the literature.
Topics: Biopsy; Bone Neoplasms; Child, Preschool; Cyclophosphamide; Dactinomycin; Hemangiopericytoma; Humans; Laparotomy; Male; Methotrexate; Neoplasm Metastasis; Radiography; Retroperitoneal Neoplasms; Vincristine | 1971 |
Ewing's sarcoma a study of treatment methods.
Topics: Adolescent; Bone Neoplasms; Child; Chlorambucil; Cyclophosphamide; Female; Humans; Male; Mechlorethamine; Methotrexate; Neoplasm Metastasis; Sarcoma, Ewing | 1966 |